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ABSTRACT 
Fructose 1,6-bisphospbatase (D-ftuctose-1,6-bisphosphate 1 -phosphohydrolase, 
EC 3.1.3.11, FBPase; Fructose 1,6-bisphosphate + H2O o Fructose 6-phosphate + 
Phosphate) is a key regulatory enzyme in gluconeogenesis. It is a homotetramer with 
subunit molecular mass of 37 kDa. There are two different quaternary conformations of 
FBPase: the R-state (the active conformation) and the T-state (the inactive 
conformation). FBPase is inhibited allosterically by AMP. FBPase requires divalent 
metal ions (Mg2r, Mn2", Zn2", or Co2") to hydrolyze fructose 1,6-bisphosphate. Some 
monovalent cations (K~, Rtf, Tl™ or NH3*) maximize the enzyme activity, whereas 
lithium ions inhibit the enzyme. Li1- inhibition of FBPase is similar to its effect on 
inositol monophosphatase, and, indeed FBPase and myo-inositol monophosphatase 
share a common polypeptide fold. FBPase is a target for the development of drugs in 
treating non-insulin dependent diabetes. A dynamic loop 52-72, revealed in a crystal 
structure of a product complex, and interacts with the active site of the enzyme. Loop 
52-72 plays an important role in the allosteric mechanism, existing in two different 
conformations. A new divalent metal site and four monovalent metal sites were 
discovered. All of metal sites could be important in vivo. FBPase might select a 
combination of metals for activity in vivo. AMP competes with divalent metals and 
displaces loop 52-72 from the active site. Two distinct conformations for the 1-OH 
group of fructose 6-phosphate correspond to non-productive and productive states of 
ligation. Direct evidence for the existence of metaphosphate is presented in the active 
vii 
site of FBPase at near atomic resolution. The presence of the metaphosphate implies a 
dissociative mechanism in FBPase catalysis: The cleavage of the ester bond between 
atoms 0-1 and P of the fructose ^-diphosphate precedes the nucleophilic attack of 
water. 
1 
CHAPTER 1. GENERAL INTRODUCTION 
Background of FBPase 
Fructose 1,6-bisphosphatase (D-fructose- 1,6-bisphosphate 1 -phosphohydrolase, 
EC 3.1.3.11, FBPase; Fructose 1,6-bisphosphate + H2O o Fructose 6-phosphate + 
Phosphate) is a key regulatory enzyme in gluconeogenesis (1-7; Figure 1). 
Gluconeogenesis, the synthesis of glucose from non-carbohydrate precursors (8), is the 
reverse process of glycolysis, consumes energy and provides glucose to fasted animals. 
Gluconeogenesis in plants is involved in conversion of light energy into carbohydrate 
metabolites. Glucose or its derivatives are required by all cells for synthesis of 
glycolipids, glycoproteins, and other structural polysaccharides. Furthermore, it is the 
only energy source for mammalian erythrocytes and avian retina, and the main energy 
source for brain tissue. The glucose level in blood is crucial for mammalian. A short 
period of hypoglycemia may lead to irreversible damage to the brain (4). There are three 
regulatory cycles for the control of glucose levels in glycolysis and gluconeogenesis; 
glucose/glucose 6-phosphate cycle, fructose 6-phosphate/ftuctose 1,6-bisphosphate cycle, 
and pyruvate/phosphoenolpyruvate cycle. 
FBPase was discovered by Gomori in 1943 (9). FBPase is mainly present in 
gluconeogenic tissues like liver and kidney, but is also found in mammalian brain and 
skeletal muscle (3-5). FBPase has been isolated from various sources; porcine kidney 
(10), porcine liver (11), rabbit liver, kidney and muscle (12), mouse liver, rat liver (13) 
2 
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Figure 1. Major energy metabolism pathways (7). 
3 
bovine liver (14), yeast (15), rat brain (16), E. coli (17), and spinach chloroplast (18). 
The sequence pile-up of FBPases from different sources is presented in Table 1. 
Mammalian FBPases are all homotetrameric proteins with molecular masses around 150 
kDa. They require divalent cations for activity, and AMP and fructose 2,6-bisphosphate 
are potent inhibitors. Porcine liver FBPase is a homotetramer with a subunit molecular 
weight of 37 kDa. The liver FBPase is identical in amino sequence to porcine kidney 
enzyme. The liver enzyme was cloned and expressed in Escherichia coli by Prof. 
Stayton and his research group at University of Wyoming (11). FBPase used in the 
studies described here is the porcine liver enzyme expressed in E. coli. 
Properties of FBPase 
The subunits of FBPase homotetramer define symmetry unique C1-C2 and C1-C4 
interfaces (Figure 2). The conformational states of the C1-C2 and C1-C4 interfaces are 
linked to the functional properties of the enzyme. There are two different quaternary 
conformations of FBPase: the R-state (the active conformation) and the T-state (the 
inactive conformation). They differ by a 17° rotation of the lower dimer (C3-C4) relative 
to the upper dimer (C1-C2). FBPase is inhibited allosterically by AMP, the binding of 
which is cooperative with a Hill coefficient of 2 (14, 19, 20). Fructose 2,6-bisphosphate 
(F26P2) which binds with high affinity to the active site, inhibits FBPase synergistically 
with AMP (21-23). The AMP binding site is approximately 30 Â from the active site 
(the site of F6P and Pi). AMP and F26P% are involved in the activation of 
4 
Table 1. Sequence pileup of FBPase 5 
1 50 
CYANOBACTERIA (BLUE-GREEN ALGAE); NOSTOCALES 
p48991 
ESCHERICHIA COLI 
p09200 
HAEMOPHILUS INFLUENZAE 
p45292 
SACCHAROMYCES CEREVISIAE (BAKER'S YEAST) 
p09201 PT 
KLUYVEROMYCES LACTIS (YEAST) 
q05079 
SCHIZOSACCHAROMYCES POMBE (FISSION YEAST) 
p09202 
ARABIDOPSIS THALIANA (MOUSE-EAR CRESS) 
p25851 MAASAATTTS SHLLLSSSRH VASSSQPSIL SPRSLFSNNG KRAPTGVRNH 
PISUM SATIVUM (GARDEN PEA) 
p46275 CVFDAK SVLSSSRRKH 
TRITICUM AESTIVUM (WHEAT) 
p09195 MA AATTTTSRPL LLSRQQAAAS SLQCRLPRRP GSSLFAGQGQ 
SPINACIA OLERACEA (SPINACH) 
p!4766 
SOLANUM TUBEROSUM (POTATO) 
p46276 
BRASSICA NAPUS (RAPE) 
p46267 
HOMO SAPIENS (HUMAN) 
p09467 
SUS SCROFA (PIG) 
p00636 
OVIS ARIES (SHEEP) 
p09199 
RATTUS NORVEGICUS (RAT) 
pl9112 
RHODOBACTER SPHAEROIDES (RHODOPSEUDOMONAS SPHAEROIDES) 
p22780 
RHODOBACTER SPHAEROIDES (RHODOPSEUDOMONAS SPHAEROIDES) 
p27994 
XANTHOBACTER FLAWS 
p23014 
ALCALIGENES EUTROPHUS 
p!9911 
" GCG package (25 ) was used for the pileup. Accession IDs are from SWISSPROT. The 
sequence of porcine liver FBPase is shown in bold letters (P00636). The conserved 
residues are shown in color, in blue are residues identical in mammalian FBPases, in red 
are residues identical in all available FBPase sequences. 
5 
Table 1. (Continued) 
51 100 
p48991 MAK ASESLDLSVN ESTDKALDRD CTTLSRHVLQ QLQSFSADAQ 
p09200 MKTLGEFIVE KQHEFSHATG 
p45292 MKTLSEFIVE RQAEYPNAKG 
p09201 LVNGPRRDST EGFDTDIITL PRFIIEHQK. Q FKNATG 
q05079 AGIKHRRDSA ESINTDIITL SRFILDQQHL S AKNATG 
p09202 MKKDL DEIDTDIVTL SSFILQEQRR YNQKHKNEEG KPCIIQEASG 
p25851 QYASGVRCMA VAADA.SETK TAARKKSGYE LQTLTGWLLR QE.MKGEIDA 
p46275 VNGSGVRCMA VK.EATSETK KRSGYE IITLTSWLLQ QE.QKPIIDA 
p09195 ASTPNVRCMA WDTASAPAP AAARKRSSYD MITLTTWLLK QE.QEGVIDN 
pl4766 M DHAGDAMRTD LMTITRYVLN EQSKRPESRG 
p4 627 6 M DHAADRHRTD LMTITRFVLN EQTKHPESRG 
p46267 M DHEADAFR.D LMTITRFVLN EQSKYPESRG 
p09467 -ADQAPFDTD VNTLTRFVM. EEGRKARGTG 
1 11 21 
p00636 — -TDQAAFDTN IVTLTRFVM. EEGRKARGTG 
p09199 -TDEAPFDTN IVTVTRFVM. EEGRKARGTG 
pl9112 -VDHAPFETD ISTLTRFVL. EEGRKAGGTG 
p22780 MA IELEDLGLSP 
p27994 MKP FPTHPDAIPA 
p23014 MLEPNADHRA AVAQAAGVAA SRITLTVMLD EWAGADARRR 
pl9911 MP EVQRMTLTQF LIEERRRYPD ASGGFNGLIL 
101 
p48991 DLSALMNRIA 
p09200 ELTALLSAIK 
p45292 ELSGILSSIR 
p09201 DFTLVLNALQ 
q05079 EFSMLLNSLQ 
D09202 ELSLLLNSLQ 
p25851 ELTIVMSSIS 
p46275 ELTIVLSSIS 
p09195 EMTIVLSSIS 
pl4766 DFTILLSHIV 
p46276 DFSILLSHIV 
p46267 DFTILLSNIV 
p09467 ELTQLLNSLC 
31 
p00636 KMIQLUISLC 
p09199 EMTQLLNSLC 
pl9112 EMTQLLNSLC 
p22780 DVADVMQRLA 
p27994 ELQDVMDRLG 
p23014 AVADTVCALA 
pl9911 NVAMACKEIA 
LAGKLVARRL SRAGLMEGVL 
LGAKIIHRDI NKAGLVD.IL 
LLAKIIHRDI NKAGLTN.IL 
FAFKFVSHTI RRAELVN.LV 
FAFKFISQTI RRAELVN.LI 
FSFKFIANTI RKAELVN.LI 
LACKQIASLV QRAGISN.LT 
MACKQIASLV QRANISN.LT 
TACKQIASLV QRAPISN.LT 
LGCKFVCSAV NKAGLAK.LI 
LGCKFVCTAV NKAGLAK.LL 
LGCKFVCSAV NKAGLAK.LI 
TAVKAISSAV RKAGIAH.LY 
41 51 
TAVKAISTAV RKAGIAH.LY 
TAVKAISTAV RKAGIAH.LY 
TAIKAISSAV RQAGIAQ.LY 
RVGAGIARII SRNGLERDL. 
SVAIEVANRI ARGGIDEDL. 
TGCASLAAAI AEGPLAGDL. 
RAVAFGALGG LHGKASNQA. 
150 
GFTGEVNVQG ESVKKMDVYA 
GASGAENVQG EVQQKLDLFA 
GQSGIENVQG ESQMKLDLFA 
GLAGASNFTG DQQKKLDVLG 
GLAGASNSTG DQQKKLDVLG 
GLSGIVNSTG DEQKKLDKIC 
GVQGAINIQG EDQKKLDVIS 
GTQGAVNIQG EDQKKLDVIS 
GVQGATNVQG EDQKKLDVIS 
GLAGETNIQG EEQKKLDVLS 
GLAGETNVQG EDQKKLDVLS 
GLAGDTNIQG EEQKKLDVLS 
GIAGSTNVTG DQVKKLDVLS 
61 71 
GIAGSTNVTG DQVKKLDVLS 
GIAGTTNVTG DQVKKLDVLS 
GIAGSTNVTG DQVKKLDILS 
GAGVGTNAGG DGQKALDVIA 
AGLCGTNTDG DGQKALDVIA 
ARTLSSGEAG EGQKALDVIS 
GEAGAVNVQG EIQQKLDVLS 
6 
Table 1. (Continued) 
151 200 
p48991 NDVFISVFKQ SGLVCRLASE EMDE.PYYIP ENCPIGRYTL LYDPIDGSSM 
p09200 NEKLKAALKA RDIVAGIASE EEDEIWF. . EGCEHAKYW LMDPLDGSSN 
p45292 HNTMKAALMA REEVAGFASE EEESFIAFDT ERGRNAKYII LTDPLDGSSN 
p09201 DEIFINAMRA SGIIKVLVSE EQED.LIVFP TN. .TGSYAV CCDPIDGSSN 
q05079 DEIFINAMKA SGNVKVLVSE EQED.LIVFR NS. .PGKYAV CCDPIDGSSN 
p09202 NDIFITAMKS NGCCKLIVSE EEED.LIWD SN. ..GSYAV TCDPIDGSSN 
p25851 NEVFSNCLRS SGRTGIIASE EEDVPVAVEE SY. .SGNYW VFDPLDGSSN 
p46275 NEVFSNCLRS SGRTGIIASE EEDVPVAVEE SY. . SGNYIV VFDPLDGSSN 
p09195 NEVFSNCLRW SGRTGVIASE EEDVPVAVEE SY. .SGNYIV VFDPLDGSSN 
pl4766 NEVFVKALTS SGRTCILVSE EDEEATFIEP SL. .RGKYCV VFDPLDGSSN 
p4 627 6 NEVFIKALVS SNRTCILVSE EDEEATFVRP AN. .RGKYCV VFDPLDGSSN 
p46267 NDVFVKALVS SGRTSVLVSE EDEEATFVES SK. .CGKYCV VFDPLDGSSN 
p09467 NDLVMNMLKS SFATCVLVSE EDKHAIIVEP EK. . RGKYW CFDPLDGSSN 
81 91 101 111 121 
p00636 NDLVINVLKS SFATCVLVSE EDKNAIIVEP BK. .RGKYW CFDPLDGSSN 
p09199 NDLWNVLKS SFATCVLVSE EDKHAIIVEP EK. .RGKYW CFDPLDGSSN 
pl9112 NDLVINMLKS SYATCVLVSE EDTHAIIIEP EK. .RGKYW CFDPLDGSSN 
p22780 DDAFRAALE. GSAVAYYAS E EQDEWTL. G • • • E.GSLAL AIDPLDGSSN 
p27994 DDAFRVALE. GSAVRFYASE EQDTAVTL.N • • . EAGTLAL AIDPLDGSSN 
p23014 NDIVIGALK. AAPVAAVASE ENDAPVLL.D PTAPLLV AIDPLDGSSN 
pl9911 NTTFLRVNEW GGYLAGMAS E EMEAPYQI.P DHYPRGKYLL VFDPLDGSSN 
201 250 
p48991 TDTNLSLGSI FSI.RQQE GDDSDGQ AKDLLTNGRK 
p09200 IDVNVSVGTI FSIYRRVT PVGTPVT EEDFLQPGNK 
p45292 I DVNVSVGT I FSIYRRVS PIGSPVT LEDFMQPGNK 
p09201 LDAGVSVGTI ASIFR L LPDSSGT INDVLRCGKE 
q05079 LDAGVSVGTI VSLFK IHENQNG NSGEEDSEGT INDVARCGRE 
p09202 IDAGVSVGTI FGIYK LR PGSQGD ISDVLRPGKE 
p25851 IDAAVSTGSI FGIYSPNDEC IVD..DSDDI SALGSEEQRC IVNVCQPGNN 
p46275 LDAAVSTGSI FGIYSPNDEC LPDFGDDSDD NTLGTEEQRC IVNVCQPGSN 
p09195 IDAAVSTGSI FGIYSPSDEC HI GOD ATLDEVTQMC IVNVCQPGSN 
pl4766 IDCGVSIGTI FGIYMVKDFE TATLED VLQPGKN 
p46276 IDCGVSIGTI FGIYMIKDGH EPTLDD VLQPGMN 
p4 6267 IDCGVSIGTI FGIYTMEHSD EPTTKD VLKPGNE 
p09467 IDCLVSVGTI FGIYRKKSTD EPSEKD ALQPGRN 
131 141 151 
p00636 IDCLVSIGTI FGIYRKNSTD EPSEKD ALQPGRN 
p09199 IDCLVSIGTI FGIYKKISKD DPSEKD ALQPGRN 
pl9112 IDCLASIGTI FGIYRKTSAN EPSEKD ALQPGRN 
p22780 IDVNVSIGTI FSIFPAAAGP EAS FLRPGTE 
p27994 IDTNLSVGTT FAIWPAAPRP NPS FLRLGSE 
p23014 IDTDISVGTI FAVFPRPEGA DASEPS AFLQNGRD 
pl9911 IDVNVSVGSI FSVLRAPEGA SAVTEQ DFLQPGSA 
7 
Table 1. (Continued) 
p48991 
p09200 
p45292 
p09201 
q05079 
p09202 
p25851 
p46275 
p09195 
pl4766 
p46276 
p46267 
p09467 
p00636 
p09199 
pl9112 
p22780 
p27994 
p23014 
pl9911 
251 
QIAAGYILYG 
QVAAGYWYG 
QVAAGYIVYG 
MVAACYAMYG 
MVAACYTMYG 
MVAAGYTMYG 
LLAAGYCMYS 
LLAAGYCMYS 
LLAAGYCMYS 
MVAAGYCMYG 
MLAAGYCMYG 
MVAAGYCMYG 
LVAAGYALYG 
161 
LVAAGYALYG 
LVAAGYALYG 
LVAAGYALYG 
QIAGGYIIYG 
LIAAGYVIYG 
MLAAGYVIYG 
QVAAGYALYG 
PSTMLVYTMG 
SSTMLVYTTG 
SSTMLVYTTG 
SSTHLVLTLG 
ASTHLVLTTG 
ASAHLLLTTG 
SSVIFVLTLG 
SSVIFVLTIG 
SSVIFVLTIG 
SSCTLVLSTG 
SSCTLVLSTG 
SSCMLVLSTG 
SATMLVLAMD 
171 
SATMLVLAMV 
SATMLVLAMV 
SATMLVLAMN 
PQCALVCSFG 
PQVCMMVSFG 
PHTAMMLTLG 
PTTMLVLTVG 
TGVHSFTLDP 
CGVHAFTYDP 
NGVNGFTYDP 
DGVDGFTLDT 
AGVNGFTLDN 
HRVNGFTLDT 
KGVFSFTLDP 
KGVFVFTLDP 
TGVYVFTLDP 
SGVNGFTLDP 
SGVNGFTLDP 
TGVHGFTLDP 
CGVNCFMLDP 
181 
NGVHCEMLDP 
NGVNCFMLDP 
CGVNCFMLDP 
QGVQHWVLDL 
KGTQKYVLDP 
AGTWHFALD. 
NGVNGFTLDP 
SLGEFILSEE 
SLGVFCLCQE 
SIGTFCLSHE 
NLGEFILTHP 
NLGEFILTYP 
DIGEFILTHR 
MYGEFVLTQE 
LYGEFVLTQE 
MYGEFVLTQE 
SLGEYILTHP 
SLGEFILTHP 
SLGEFILTHP 
AIGEFILVDK 
191 
AIGEFILVDR 
AIGEFILVDR 
SIGEFILVDR 
DAGIFRRMPD 
GSRSFVLVDR 
RAGLFRLVDA 
NLGEFFLTHP 
300 
NIRIPDHGAV 
RMRFPEKGKT 
NMQMPKEGKI 
NLRIPPQKAI 
ELRLPEQKSI 
NMKMPLQHSI 
NIEIPKAGRI 
NLQIPKSGKI 
KVQIPKSGKI 
DIKIPNKGKI 
DIKIPKKGKI 
DIKIPKKGNI 
DVKIKKKGKI 
201 
DVKIKKK6SI 
DVKIKKKGSI 
DVKIKKKGNI 
IRPLPAETSE 
AVKVPPSSTE 
EVKVKEGAAE 
NLQVPADTQE 
301 
p48991 YSVNEGNFWQ WEESMREYIR 
p09200 YSINEGNYIK FPNGVKKYIK 
p45292 YSINEGQYLK FPQGVKKYIK 
p09201 YSINEGNTLY WNETIRTFIE 
q05079 YSINEGNTCY WEPTIADFIA 
p09202 YSINEGYTAF WDEKIARFIA 
p25851 YSFNEGNYQM WDDKLKKYID 
p46275 YSFNEGNYKL WDENLKKYID 
p09195 YSFNEGNYAL WDDKLKKYMD 
pl4766 YSVNEGNAKN WDGPTTKYVE 
p4 6276 YSVNEGNAKN WDSPTSKYVQ 
p46267 YSVNEGNAQN WDGPTTKYVE 
p09467 YSLNEGYAKD FDPAVTEYIQ 
211 221 
p00636 YSINEGYA1Œ FDPAITKYIQ 
p09199 YSLNEGYAKD FDPALTEYVQ 
pl9112 YSINEGYAKD FDPAINEYIQ 
p22780 FAINASNYRH WPQPIRAFVD 
p27994 FAINASNYRH WPKPIRAYID 
p23014 FAINMSNYHH WDVPVRDYVD 
pl9911 FAINASNSRF WEAPVQRYIA 
350 
YVHR.TE GYTARYSG AMVSDIHRIL 
FCQE.EDKST NRPYTSRYIG SLVADFHRNL 
YCQE.EDKAT HRPYVSRYIG SLVADFHRNL 
KVKQPQADNN NKPFSARYVG SMVADVHRTF 
KLKENSEENN GKPYSARYIG SMVADVHRTL 
HLKESTPDK. .KPYSARYIG SMVADMHRTI 
DLKDPGP..T GKPYSARYIG SLVGDFKRTL 
DLKEPGP..S GKPYSARYIG SLVGDFHRTL 
SLKEPGT..S GKPYSARYIG SLVGDFHRTM 
KCKFPTD..G SSPKSLRYIG SMVADVHRTL 
SCKYPAD..G SSPKSLRYIG SMVADVHRTL 
RCKYPKD..G SPAKSLRYVG SMVADVHRTL 
RKKFPPD..N SAPYGARYVG SMVADVHRTL 
231 241 251 
BKKTPPD..H SAPYGARYVG SMVADVHRTL 
RKKFPPD..N SAPYGSRYVG SMVADVHRTL 
RKKFPPD..N SAPYGARYVG SMVADVHRTL 
DLVAGAEGPR GKNFNMRWIA SLVAETHRIL 
DCVAGTEGPR GRNFNMRWLA SLVAETHRIL 
DCLAGKKGPR ERDFNMRWVA SMVADAHRIF 
ECMAGKSGPR GKDFNMRWIA SMVAEAHRIL 
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Table 1. (Continued) 
351 
p48991 VQGGVFLYPG TIQNP. .EGK 
p09200 LKGGIYLYPS TASHP. . DGK 
p45292 LKGGIYIYPS ATNYP. • NGK 
p09201 LYGGLFAYPC DKKSP. .NGK 
q05079 LYGGLFSYPG DKKNP. .NGK 
p09202 LYGGLFAYPC SKGN.. .NGK 
p25851 LYGGIYGYPR DAKSK. .NGK 
p46275 LYGGIYGYPR DECKS K. .NGK 
p09195 LYGGIYGYPS DQKSK. .NGK 
pl4766 LYGGIFLYPG DKKSP. .NGK 
p46276 LYGGIFLYPG DKKSP. .NGK 
p46267 LYGGIFLYPA DKKSP. .NGK 
p09467 VYGGIFLYPA NKKSP. .NGK 
261 271 
p00636 VYGGIBMÏPA NKKSP. .KGK 
p09199 VYGGIFMYPA DKKSP. .SGK 
pl9112 VYGGIFLYPA NKKNP. . SGK 
p22780 MRGGVFLYPG DERKGYERGR 
p27994 ARGGVFLYPR DSRKGYEQGR 
p23014 QRGGIYLYPG DGRKGYTHGR 
pl9911 MRGGVFMYPR DSKDPAKPGR 
400 
LRLLYESAPL AFLIQQAGGR ATTG.LVDIL 
LRLLYECNPM AFLAEQAGGK ASDG.KERIL 
LRLLYEGNPI AFLAEQAGGV ATDG.YRRIL 
LRLLYEAFPM AFLMEQAGGK AVNDRGERIL 
LRLLYEAFPM AFLVEQAGGK AVNDRGERIL 
LRLLYECFPM AFLVEQAGGI AVNDKGDRIL 
LRLLYECAPM SFIVEQAGGK GSDGH.SRVL 
LRLLYECAPM SFIVEQAGGK GSDGH.QRVL 
LRLLYECAPM SFIAEQAGGK GSDGH.QRVL 
LRVLYEVFPM SFLMEQAGGQ AFTGK.QRAL 
LRVLYEVFPM SFLMEQAGGQ AFTGK.QRAL 
LRVLYEVFPM AFLMEQAGGQ AFTGK.KRAL 
LRLLYECNPM AYVMEKAGGM ATTGK.EAVL 
281 291 301 
LKLLYEQmi AXVHEKAGGL ATTGK.EAVL 
LRLLYECDPM AYVIEKAGGM ATTGK.EAVL 
LRLLYECNPI AYVMEKAGGL ATTGN.EDIL 
LRHVYECAPI AFLIANVGGG ATDGCAD.IL 
LRYLYECAPI AFVITQAGGG ATDGENP.IL 
LRLLYEAFPV AFLMEQASGS ATDGRGA.IL 
LRLLYEANPI AFLMEQAGGR ASTGRQT.LM 
401 
p48991 DWPKKLHQR TPLIIGSKED 
p09200 DIIPETLHQR RSFFVGNDHM 
p45292 DIEPTALHER VPLFVGSEDM 
p09201 DLVPSHIHDK SSIWLGSSGE 
q05079 DLVPQHIHDK SSIWLGSSGD 
p09202 DLVPKTLHGK SSIWLGSKHE 
p25851 DIQPTEIHQR VPLYIGSTEE 
p46275 DIQPTEIHQR VPLYIGSTEE 
p09195 DIMPTAVHQR VPLYVGSVEE 
pl4766 DLIPTKIHER SPVFLGSYDD 
p46276 DLVPEKIHER SPIFLGSYDD 
p46267 DLVPKKIHER SPIFLGSYDD 
p09467 DVIPTDIHQR APVILGSPDD 
311 321 
p00636 DIVPTDIHQR APIILGSPED 
p09199 DIVPTDIHQK VPIILGSPED 
pl9112 DIVPTEIHQK APVIMGSTED 
p22780 TALPDRLHAR TPFVFGCASK 
p27994 GQTPSRLHAR TPFVFGSAEK 
p23014 DLSATGLHQR VPFIFGSRDE 
pl9911 SVAPGALHQR IGVIFGSRNE 
450 
VAKVESFIQN GH 
VEDVERFIRE FPDA — 
VKKAQEMMEE FKE 
IDKFLDHIGK SQ~~ 
VDKYLKHIGK L 
VEEYINFIK 
VEKLEKYLA 
VEKVEKYLA 
VEKVEKFLSS E 
VEDIKALYAA QEKTA 
VEEIKKLYAA EEQN 
VEEIKALYAE EEKN — 
VLEFLKVYEK HSAQ 
331 
VTELLEIYQK HAAK~ 
VTEFLEIKKY TAK~~~~~~~ — — — 
VQEFLEIYNK DKAKSRPSLP LPQSRARESP 
VARVAAYHDL A..CEETSAL FGSRGLFRS~ 
VARITAYHDL P..EQETSAL FGNRGLFRS-
VARVSRYHLE PNGHGERSPL FARRGLFI— 
VERIEGYHTD QTDPDLPSPL FNERSLFRAS 
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Table 1. (Continued) 
451 
p4 8 991 
p09200 
p45292 
p09201 
q05079 
p09202 
p25851 
p46275 
p09195 
pl4766 
p46276 
p4 6267 
p09467 
p00636 
p 0 919 9 ~ ~ — 
p!9112 VHSICDELF 
p2 2 7 8 0 
p27994 
p23014 
pl9911 A 
10 
F6P 
(Active site) 
AMP 
(Allosteric 
site) 
R-state (the active form) T-state (the inhibited form) 
Figure 2.. R- and T-state tetramers of FBPase with product. A 17° rotation of the dimer 
C1/C2 relative to the dimer C3/C4 is the quaternary conformational difference between 
R- and T-state. 
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phosphofructokinase, the glycolic counter part of FBPase (6, 24; Figure 3). The 
inhibition of FBPase in mammals results in reduced levels of serum glucose in the 
fasting state. Hence, FBPase is a target for the development of drugs in treating non-
insulin dependent diabetes. Diabetes type II affects over 15 million people in the United 
State (26). 
FBPase requires divalent metal ions (Mg2-, Mn2*, Zn2", or Co2*) for activity (3, 
5). Monovalent cations (K", Rb*, Tl™ or NHO further activate the enzyme (27-29). 
Divalent metal activation of FBPase is pH dependent. Plots of velocity versus Mg2" are 
sigmoidal at neutral pH, but hyperbolic at pH 9.6 (30, 31). Tejwani et al. (32) proposed 
K" eliminates inhibition of FBPase by high concentrations of divalent metal ions. In 
other studies it was suggested that monovalent cations eliminate the substrate inhibition 
(33). In the presence of monovalent metal, the enzyme becomes more sensitive to AMP 
inhibition (27). On the other hand, lithium ion is a strong inhibitor. Nakashima and 
Tuboi (34) proposed that the effects of monovalent cations on FBPase are size dependent. 
The mechanisms of action of monovalent cations on FBPase are still not understood. 
Inositol monophosphatase (LMPSase) is similar in tertiary structure to FBPase (35), and 
shares the same metal binding motif. Furthermore, like FBPase, IMPSase requires 
divalent metals for catalysis, is activated by some monovalent cations and is inhibited by 
lithium. IMPSase is one of the potential targets of lithium ions in the therapeutic 
treatment of manic depression (36, 37). 
Site-directed mutagenesis studies of FBPase indicated several fundamentally 
important residues (Table 2). Asp74 and Œu98 are crucial for catalysis (38, 39). They 
12 
Glycolysis 
ATP _ . . . ADP 6-Phosphomicto-1-kinase 
Fructose 6-phosphate Fructose 1,6-bisphosphate 
r 
Pi H,0 
Gluconeogenesis 
Figure 3. Frutose 6-phosphate / fructose 1,6-bisphosphate cycle in glycolysis and 
gluconeogeneis. 
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Table 2. Kinetic parameters for wild type and mutant forms of fructose-1,6-
bisphosphatase 
Enzyme Ac* AT^fisp: A amp ATa,Mg2~ Hillcoeff. Reference 
(s*1) (HM) (UM) (mM) (Mg2*) 
Wild-type 14 4.0 21 0.50 2.0 40 
N9D 31 0.90 127 0.87 2.19 43 
R15A 21 2.45 7.52 4.63 1.90 44 
M18I 20 1.68 22.4 24.3 1.88 43 
M18R 28 1.76 0.51 0.74 1.84 43 
E19Q 20 1.32 17.0 2.59 1.78 44 
R22K 22 2.12 622 0.55 1.85 44 
R22M 41 2.54 2.99 0.33 2.44 44 
T27A 21 1.00 27608 1.08 2.11 44 
E29Q 13 2.03 135 0.28 2.0 45 
T31V 16 2.0 1170 0.26 0.2 45 
Q32L 32 1.42 37.9 1.43 1.82 46 
K42E 19 1.63 17.7 7.63 1.70 46 
K42T 18 1.53 12.1 8.48 1.91 46 
R49L 24 3.44 32.9 3.62 1.94 47 
R49D 20 4.42 18.7 4.02 1.62 47 
R49C 23 4.07 45 1.76 2.19 47 
K50M 22 4.02 6.34 2.56 1.74 47 
14 
Table 2. (Continued) 
Enzyme Ac* Afm.ii6P2 A amp Ki, m8:* Hillcoeff. Reference 
(s-1) QiM) QiM) (mM) (Mg2*) 
N64A 7 1.5 13 6 1.4 38 
D68E 6.4 1.3 27.2 7.19 1.43 38 
L71A 16 2.8 189 0.27 1.2 38 
L71.72M 34 1.6 3525 0.29 1.78 38 
D74N 0.01 ND ND ND ND 38 
D74A 0.0004 ND ND ND ND 38 
S87A 21 1.91 43.1 0.85 2.10 43 
E97Q 0.007 4.0 1.84 4.55 1.46 41 
E98Q 0.013 10 0.93 5.5 1 0 39 
D118N 0.016 1.5 2.32 1.32 1.66 41 
D118A6 0.003 2.5 42 
D121A6 0.001 2.9 42 
G122A 1.0 8.2 1370 11 1.06 48 
S123A 5 1.5 0.025 1.6 1.9 49 
D127T 14 39 0.052 2.1 1.9 49 
C128G 5 119 581 6.5 1.9 49 
" toll coefficient for AMP. 
6 Human FBPase: Ac* of wild type is 15 s"1 and Km, FI6P2 of wild type is 2.1 gM. 
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Table 2. (Continued) 
Enzyme A«t &,amp A^Mg2* Hill coeff. Reference 
(s'1) (|iM) (nM) (mM) (Mg2l 
D187A 22 0.7 13 0.5 1.4 50 
I190T 21 1.81 10 4.37 1.65 46 
G191A 24 0.84 14.7 10.7 1.53 46 
Q192E 13 1.6 13.4 1.16 1.8 50 
Q192A 15 3.3 17 0.95 1.4 50 
D212A 14 116 435 0.82 1.7 50 
A243M 3.3 67 560 1.62 1.51 40 
Y244F 13.3 155 406 0.74 1.33 40 
Y258F 2 1.8 13 1.9 1.7 49 
Y264F 18 20 295 0.34 1.48 40 
K274L 12.2 94 250 1.1 1.36 40 
R276M 0.13 3.1 37 2.8 1.18 51 
E280Q 0.015 4.6 3.8 1.5 1.53 41 
16 
interact with the P; at the 1-phosphoryl site and metals through water molecules. 
Arg276 and Glu280 are also important to the kinetics of monovalent cation activation 
(41, 51). Mutants of Glu97, Aspl 18 and Aspl21 (residues binding to divalent cations) 
show large changes in the kinetic parameters (41, 42). In a recent study, mutation of 
Asp68 caused the for Mg2' to increase 30-fold (Iancu, Fromm and Honzatko, 
unpublished). 
Questions Regarding the AUosteric Regulation by AMP and the Role of Loop 52-72 
The first three-dimmensional structure of FBPase was determined by Prof. W.N. 
Lipscomb and his research group at Harvard University in 1989 (52). There are two 
dozens published FBPase structures from various sources and with different states of 
ligation (Table 3). Even though the enzyme from mammalian sources has been studied 
for several decades by a variety of techniques, some of the most fundamental properties 
of FBPase are not understood at the atomic level. 
AMP competes with Mg2* (30, 53), but in past crystal structures, the number of 
metal cations bound to the active site is insensitive to the presence of AMP at its 
allosteric site. Two Mn2" ions or two Zn2~ ions bind to the active site in the presence and 
absence of AMP in crystal structures (54-56). The Hill coefficient for Mg2" is 
approximately 2, but only one Mg2" ion binds to the active site in crystal structures (54). 
Mutations of residues in loop 52-72 have resulted in dramatic changes in the functional 
properties of FBPase (38; Table 2). The residues 53, 56, 58, 61, 64, 67, 68, 71, and 72 
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Table 3. FBPase Structures deposited in Protein Data Bank (www.rcsb.org) 
PDB Deposition Resolution Source Ligands Reference 
code year 
5FBP 1991 2. 1 Porcine F6P 63 
4FBP 1991 2. 5 Porcine AMP 59 
3FBP 1990 2. 8 Porcine F26P, 52 
2FBP 1990 2. 8 Porcine 52 
1SPI 1994 2. 8 Spinach 65 
1RDY 1996 2. 2 Porcine(R243A) * AMP, F6P 66 
1RDZ 1996 2. 05 Porcine(R243A) ' AMP, F6P 66 
1RDX 1996 2. 75 Porcine(R243A) J F6P 66 
1FTA 1993 2. 30 Human AMP 67 
1FSA 1996 2. 30 Porcine(K42A)J AMP, F6P, Mn 58 
1FRP 1994 2. 0 Porcine AMP, F26P, , Zn 55 
1FPL 1995 2. 3 Porcine AHGC, AMP, T1 62 
1FPK 1995 3. 0 Porcine T1 62 
1FPJ 1995 2. 2 Porcine AHG", AMP, T1 62 
1FPI 1995 2. 3 Porcine AHGb, AMP, K 62 
1FPG 1994 2. 3 Porcine AHG6, AMP, Mn (300uM) 56 
1FPF 1994 2. 1 Porcine AHGb, AMP, Mn(15uM) 56 
1FPE 1994 2. 2 Porcine AHGb, AMP, Mn(lOOuM) 56 
1FPD 1994 2. 1 Porcine AHGb, AMP, Mn (5uM) 56 
1FPB 1992 2. 6 Porcine F26P2 60 
1 Structure of FBPase mutant. 
b 2,5-anhydroglucitol-l,6-diphosphate. 
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Table 3. (Continued) 
PDB Deposited Resolution Source Ligands 
code year 
Reference 
1FBP 
1FBH 
1FBG 
1FBF 
1FBE 
1FBD 
1FBC 
1DBZ 
1BK4 
1CNQ 
1EYI 
1EYJ 
1EYK 
1FJ6 
1FJ9 
1990 
1992 
1992 
1992 
1992 
1992 
1992 
1999 
1998 
1998 
2000 
2000 
2000 
2000 
2000 
2.5 Porcine 
2.5 Porcine 
3.0 Porcine 
2.7 Porcine 
3.0 Porcine 
2.9 Porcine 
2.6 Porcine 
2.65 Pea 
2.30 Rabbit 
2.27 Porcine 
2.32 Porcine 
2.28 Porcine 
2.23 Porcine 
2.50 Porcine(Y57W)' 
2.50 Porcine(Y57W)* 
AMP, F6P, Mn 
F16P 
AHMC, Mn 
AHMC, Mg 
AHGfc, Zn 
AHGb, Mn 
AHGb, Mg 
F6P, Pi, Zn 
F6P, Pi, Mg 
F6P, Pi, Mg, AMP 
F6P, Pi, Zn, AMP 
F6P, Pi, Zn 
F6P, Pi, Zn, AMP 
64 
54 
54 
54 
54 
54 
54 
68 
69 
70 
71 
71 
71 
72 
72 
1 Structure of FBPase mutant. 
b 2,5-anhydroglucitol-1,6-diphosphate 
c 2,5-anhydromannitol-1,6-diphosphate 
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are highly conserved (Table 1). Mutations of active site residues (128, 243, 244, 264, 
274, 280) affect not only binding of F16P and metals but also inhibition by AMP (Table 
2). Mutants T27A and T31A, which are in the AMP binding site, resulted in weaker 
binding of AMP but stronger binding for F16P2 (44, 45). 
All the above indicates that there is more than a single site for Mg2- and that the 
binding of divalent cations and AMP is mutually excusive. Prof. Lipscomb's group 
proposed that a pathway of communication between those sites might occur through an 
eight stranded 3 sheet and three helixes, or possibly through loop 52-72 (Figure 4). 
However, no one demonstrated that the loop 52-72 is involved in the allosteric regulation, 
since the corresponding loop in all crystal structures is disordered (35, 52, 54-64; Table 
3). 
The Role of Loop 52-72 and Allosteric Transition 
The study of wild type FBPase in a complex of F6P, P; and Zn2- showed the first 
crystallographic structure containing loop 52-72 with a well defined conformation. This 
is described in Chapter 2. Loop 52-72, disordered in all prior structures of FBPase, 
makes contacts with functionally important residues in the active site, and there are three 
Zn2* binding sites. Asp68 of the loop hydrogen bonds with Arg276 and coordinates a 
zinc cation located at the putative potassium activation site. Leu56 and Tyr57 of the loop 
pack against hydrophobic residues from two separate subunits of FBPase. A mechanism 
of allosteric regulation of catalysis is presented, in which AMP, by binding to its 
20 
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Figure 4. Summary of interactions by Liang et al. (70). 
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allosteric pocket, displaces loop 52-72 from the active site. 
It was believed that divalent metal site 1 was a structural metal, whereas site 2 
was the catalytic metal (61). Subsequent studies presented in chapter 3, showed that the 
structure of the product complex with Mg2"" (PDB code: leyi) was different from that 
with Zn2* (PDB code: lcnq). In the Mg2" complex electron density is weaker for loop 
52-72, and the 1-OH group of fructose 6-phosphate coordinates the metal at site 1. The 
observed interaction between metal site 1 and F6P supports a catalytic mechanism 
involving both metal sites. 
Monovalent Metal Sites 
FBPase is both activated and inhibited by monovalent cations. Binding sites for 
monovalent metals were determined by Prof. Lipscomb's group (62). However, in the 
Lipscomb study, divalent cations were omitted and/or AMP was added to crystallization 
experiments. Under these conditions, FBPase is inactive, so the question remains 
unanswered: How do monovalent cations enhance catalysis by an active FBPase? In 
order to characterize the monovalent sites, crystal structures were determined under 
conditions in which FBPase is catalytically competent (in the presence of FI6P2 and 
divalent metals). The determination of metal sites in the Lipscomb study was based on 
coordination geometry and electron density from an fo-fc omit map. Work, in this thesis, 
employs anomalous difference maps which give direct evidence regarding the type of 
metal at each site. Structures complexed with products, magnesium and various 
concentrations of thallium are discussed in Chapter 4. 
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The discovery of a potassium binding site was complicated by the formation of 
crystalline super lattices. Whenever crystals of FBPase were grown in high 
concentrations of potassium, the unit cell increased by 7-fold (usual unit cell dimensions 
are a=52Â, ô=80À, c=l65Â, a=90°, (3=90°, 7=90°, but the typical cell dimensions with 
potassium were a=80À, 6=165Â, c=383À, ot=90°, 3=90°, y=90°). Attempts to solve the 
superlattice structure have not been successful by molecular replacement methods (74, 
75). Single Isomophorous Replacement Anomalous Scattering (SIRAS) using either 
cocrystallization or soaking with heavy atoms has also failed. Finding different 
crystallization conditions also failed as crystallization screens (76, 77) gave the same 
condition, currently in use. 
As an alternative to K~, Tf is used in the study of the monovalent metal role 
in FBPase. Thallium is putatively an analogue of potassium (28, 62). The AT, for Tf for 
rabbit liver/muscle enzyme is 16 mM (2, 6). Thallium is a heavy metal, easily 
distinguishable in crystal structures. Its atomic number is 81 and it has large anomalous 
difference for both synchrotron sources and home data collections at CuKa. Thallium is 
a group 13 / in A metal among Al, Ga, and In. It can exist as Tf or Tl3+, but Tf is more 
stable. D-block elements are soft Lewis acids in their low oxidation states. The relative 
affinities for hard and soft donors suggest that Tf is harder than Tl3+ Thus, it is 
transported into cells along with hard metals such as K", and allcali metal hydroxides 
(78). Toxicity of Tf is attributed to its competition with K~ in biological systems (79). 
There was a possibility that the super lattice crystal form is an artifact of 
cryogenic freezing prior to data collection at 120 K. Room temperature data collection 
23 
was attempted, but failed due to high crystal mosaicity, fast crystal decay, and detector 
limitations. Therefore, crystallization with cryoprotectants was tried. Crystals, which 
grew from cryoprotectant crystallization solutions, have the usual unit cell (a=52À, 
â=80Â, c=165Â, a=90°, 3=90°, y=90°), and diffract to atomic resolution. The data for 
the Mg2"" and K+ complex (200 mM potassium) was collected in BIOCARS at Argonne 
National Laboratory, and the results are discussed in Chapter 5. 
The central approach here to distinguish different metals in crystal structures is 
the application of anomalous scattering signals (80, 81). Anomalous scattering is widely 
used in order to solve the phase problem in crystal structures. The intensity of X-ray 
diffraction from atoms is determined by the scattering factor (f). If the energy of incident 
radiation is smaller than the energy for the corresponding natural frequency, the 
scattering factor is a real number. However, if the energy of excitation exceeds the work 
energy of an atom-bound electron, the scattering factor becomes a complex quantity. The 
scattering factor is composed of a dispersive component, which has a real value (f ) and a 
Bijvoet component which has a complex value (f'). For complex values of the scattering 
factor, Friedel's law (the reflections h, k, 1 and -h, -k, -1 are equal) does not hold. The 
difference in the intensity of Friedel reflections is a function of wavelength and can be 
related to f and f'. Hence, single wavelength of anomalous scattering data can identify 
the type of atom in metal complexes of FBPase because anomalous scattering data 
provides information about the identity of the scattering atom. 
24 
Catalytic Mechanism of FBPase 
Phosphate hydrolysis has been proposed to occur through two different 
mechanisms (82-88). The first is an associative mechanism, in which a nucleophile 
attacks the phosphate, creating a pentacovaient transition state (Figure 5). The second is 
a dissociative mechanism which occurs through the elimination of metaphosphate (Figure 
6). However, these two mechanisms are difficult to distinguish in enzyme catalyzed 
reactions. Metaphosphate (monomeric metaphosphoric acid, HPO3) was first proposed 
as a transition state intermediate in the early 1950s (89, 90). However, HPO3 is an 
unstable molecule and there is only indirect evidence for its existance in solution (91-97). 
Metaphosphate was traped in the active site of FBPase at 1.3 Â and 1.6 Â resolution 
(Chapter 5). 
Two catalytic mechanisms are proposed for FBPase, on the based of crystal 
structures. Zhang et. al. in 1993 (54) proposed the mechanism illustrated in Figure 7. 
A water molecule is activated by binding to the metal ion 2. The activated water 
molecule is positioned for a nucieophilic attack at the 1-phospharyl group from the 
direction opposite to that of the scissile P-0 bond. The attack is facilitated by the side 
chain of Glu98, which deprotonates the water molecule. The second mechanism by Choe 
et al. is shown in Figure 8, is based on the direct coordination between 1-OH of F6P and 
Mg2-. The presence of a proton on the 1-phosphoryl group of FI6P2, shared in a 
hydrogen bond with Asp68, initiates the reaction. Asp74 and Glu98 together generate a 
hydroxide anion coordinated to the Mg2* at site 2, then displace F6P. Charge on the 1-
oxygen atom of F6P is stabilized by its coordination to the Mg2+ at site 1. 
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K-ROH 
Y—POjH" 
Figure 5. SN2 associative reactions. It has in line displacement (85). 
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Figure 6. SnI, dissociative reactions. It occurs by eliminating of a metaphosphaste 
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HO OH 
Figure 7. Schematic representation of catalytic mechanism proposed by Zhang et al. (27). 
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Figure 8. Proposed mechanism for the hydrolysis of FI6P2 by Choe et al. (71) 
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The presence of metaphosphate indicates that the catalytical mechanism of 
FBPase could be dissociative. The mechanism of FBPase starts with the cleavage of the 
ester bond of 1-phosphoryl of the fructose ^-diphosphate. The reaction might be 
assisted by the guanidine group of Arg276, carboxyl side chains of Asp 121 and Glu280 
associated with metal site 1. The reaction yields an intermediate metaphosphate and 
fructose 6-phosphate. The metaphosphate (HPO3) associated with three metals is 
transformed to H2PO4 by an attacking water molecule. 
Dissertation Organization 
This dissertation contains six chapters and three appendixes. Chapter 1 is a 
general introduction, describes the general properties of FBPase, research problems and 
overview of the dissertation. Chapter 2 and 3 are papers published in peer reviewed 
journals. Chapter 4 and 5 are manuscripts that will be submitted to scientific journals for 
publication. Chapter 2 discusses the role of loop 52-72. Chapter 3 describes the 
mechanism of catalysis and allosteric inhibition of the enzyme. Chapter 4 is about the 
monovalent metal bind sites at different concentrations of Tf. The hydrolysis 
mechanism of FBPase and binding sites of K~ are presented in Chapter 5. The research 
results are summarized in Chapter 6 with a general conclusion. Three appendixes are 
published FBPase papers as second and third author. They are about enzyme kinetics and 
mutagenesis. 
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CHAPTER 2. ROLE OF DYNAMIC LOOP IN CATION 
ACTIVATION AND ALLOSTERIC REGULATION OF 
RECOMBINANT POCINE FRUCTOSE 1,6-
BISPHOSPHAT ASE 12 
A paper published in BIOCHEMISTRY3 
Jun-Yong Choe, Bradley W. Poland, Herbert J. Fromm, and Richard B. Honzatko4 
Abstract 
A disordered loop (loop 52-72, residues 52-72) in crystal structures of 
fructose-1,6-bisphosphatase (FBPase) has been implicated in regulatory and catalytic 
phenomena by studies in directed mutation. A crystal structure of FBPase in a complex 
with three zinc cations and the products fructose 6-phosphate (F6P) and phosphate (Pi) 
reveals loop 52-72 for the first time in a well defined conformation with strong electron 
density. Loop 52-57 interacts primarily with the active site of its own subunit. Asp68 of 
the loop hydrogen bonds with Arg276 and a zinc cation located at the putative potassium 
activation site. Leu56 and Tyr57 of the loop pack against hydrophobic residues from two 
separate subunits of FBPase. A mechanism of allosteric regulation of catalysis is 
1 This work was supported in part by National Institutes of Health Research Grant NS 
10546 and National Science Foundation Grants MCB-9603595 and MCB-8316244. This 
is Journal Paper J-17923 of the Iowa Agriculture and Home Economics Experiment 
Station, Ames, Project 3191. 
2 Coordinates and structure factors for the structure described in this paper have been 
deposited with the Brookhaven Protein Data Bank (accession number lbfl).. 
3 Reprinted with permission of Biochemistry, 1998, 37, 11441-11450. 
4 Coordinates and structure factors for the structure described in this paper have been 
deposited with the Brookhaven Protein Data Bank (accession number lbfl). 
39 
presented, in which AMP, by binding to its allosteric pocket, displaces loop 52-72 from 
the active site. Furthermore, the current structure suggests that both the a- and 3-anomers 
of F6P can be substrates in the reverse reaction catalyzed by FBPase. Mechanisms of 
catalysis are proposed for the reverse reaction in which Aspl21 serves as a catalytic base 
for the a-anomer and Glu280 serves as a catalytic base for the 3-anomer. 
Introduction 
Fructose-1,6-bisphosphatase (FBPase, EC 3.1.3.11) plays a central role in 
gluconeogenesis, hydrolyzing fructose 1,6-bisphosphate (FI6P2) to fructose 6-phosphate 
(F6P) and phosphate (Pi) (1-6). The enzyme is inhibited allosterically by AMP, the 
binding of which is cooperative with a Hill coefficient of approximately 2 (7-9). The 
regulator fructose 2,6-bisphosphate (F26P2) is a potent inhibitor, which binds to the 
active site competitively with respect to the substrate FI6P2 (10-12). FBPase requires 
divalent cations (Mg2-r, Mn2", and/or Zn2") for activity, and certain monovalent cations 
(K*, NRT, and Tl*) further enhance catalysis (3, 5, 13). Plots of enzyme activity as a 
function of divalent cation concentration are sigmoidal at pH 7.5 (Hill coefficient of 
approximately 2) and hyperbolic at pH 9.6 (8, 14). The mammalian enzyme is a 
homotetramer and exists in distinct conformational states (T and R), depending on the 
relative concentrations of active site and allosteric site ligands (15). AMP and F26P2 
synergistically stabilize the T state conformation, which is an inactive form of the 
enzyme. FI6P2 stabilizes the R state (kinetically active conformer). 
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Even though the enzyme from mammalian sources has been studied for several 
decades by a variety of techniques, some of the most fundamental properties of FBPase 
are not understood at the atomic level. AMP competes with Mg2" (16, 17), but in crystal 
structures, the number of metal cations bound to the active site is insensitive to the 
presence of AMP at its allosteric site. Two Mn2" ions or two Zn2" ions bind to the active 
site in the presence and absence of AMP in crystal structures (18-20). The Hill 
coefficient for Mg2" is approximately 2, but only one Mg2" ion binds to the active site 
(18). Mutant structures of FBPase have been presented which have dramatically altered 
kinetic properties, yet their corresponding crystallographic structures deviate in only 
trivial ways from that of the wild-type enzyme (21, 22). Recently, mutations of residues 
in loop 52-72 have resulted in dramatic changes in the functional properties of FBPase 
(23), yet the corresponding loop in all crystal structures is disordered (15, 18-22, 24-28). 
Reported below is a crystallographic study of wild-type FBPase in a complex of 
F6P, Pi, and Zn2". The crystallographic structure is the first instance of a complete, 
product complex of FBPase. Loop 52-72, disordered in all prior crystallographic 
structures of FBPase, has moved into the active site and makes numerous hydrophobic 
contacts and hydrogen bonds with other residues important to the functional properties of 
the enzyme. Among the new interactions is a salt link between Asp68 and Arg276, which 
is stabilized by Zn2", bound to the putative K" activation site. The structure provides new 
insights regarding not only K" activation but also the essential role played by Arg276 in 
the structural organization of the active site. The structure also serves as a basis for new 
mechanisms of catalysis and allosteric regulation of FBPase. 
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Experimental Procedures 
Expression and Purification of Wild-Type FBPase. FBPase-deficient Escherichia coli 
strain DF657 \tonA22, ompF627(T2R), relAl, pitlO, spoTl, A(fbp)287\ Genetic Stock 
Center at Yale University, New Haven, CT] was employed in the expression of 
recombinant wild-type porcine FBPase. Expression and purification of FBPase followed 
the procedures of Burton et al. (29) with minor modification. After centrifugation to 
remove cell debris, the supernatant fluid was subjected to heat treatment, 30-70% 
ammonium sulfate precipitation, Sephadex G-100 column chromatography, and CM-
Sepharose column chromatography. FBPase eluted as a single peak with CM-Sepharose 
chromatography, using a NaCl gradient (20 to 400 mM) in 10 mM malonate at pH 6. 
Crystallization of the Product Complex. Crystals of FBPase were grown by the method 
of hanging drops. Equal parts of a protein solution [FBPase (10 mg/mL), KP, at pH 7.4 
(10 mM), Tris-malonate at pH 7.4 (2.5 mM), ZnCh (5 mM), and F6P (5 mM)] and a 
precipitant solution [Trismalonate at pH 7.4 (2.5 mM) and polyethylene glycol 3350 (6% 
w/v)] were combined to give a 4 uL droplet. Wells contained 500 uL of the precipitant 
solution. Crystals with the dimensions 0.4 mm x 0.4 mm x 0.3 mm belonging to the 
space group P2i2i2 (a = 52.34 Â, b = 166.77 Â, and c = 82.82 Â), grew in approximately 
3 days at 4 and 37 °C. Structures of crystals grown at 37 and 4 °C are identical. Data 
presented below are from a crystal grown at 37 °C. 
Data Collection. Data were collected at Iowa State University on a rotating 
anode/Siemens area detector at 100 K, using CuKa radiation passed through a graphite 
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monochoromator. Data were reduced by XENGEN (30) and were 90% complete to a 
resolution of 2.3 Â (Table 1). 
Structure Determination. Crystals grown for this study are not isomorphous with respect 
to any known crystal form reported in previous studies of FBPase. Hence, a structure 
determination was initiated by molecular replacement. Using programs of the CCP4 (31) 
package and the canonical R state for FBPase (accession identifier IFBE), rotation and 
translation functions (32, 33) provided dominant peaks and an unambiguous solution 
(initial R-factor of 0.50). Rigid body refinement followed by one cycle of simulated 
annealing [using XPLOR (34)] reduced the R-factor to 0.31. 
Model Building and Refinement. The electron density map resulting from the above 
molecular replacement solution revealed an extensive region of strong electron density, 
which did not correspond to any part of previous FBPase models. Residues 52-72 were 
built into this electron density along with conformational adjustments to residues 22-27, 
122-127, and 267-272, using the program XTALVIEW (35) and a Silicon Graphics 
workstation (Indigo2 XL). Added to each independent subunit were three Zn2-r atoms, 
two molecules of Pi (active site and AMP site), and one molecule of F6P. (Ligands and 
metal cations were removed from the model used in molecular replacement and the first 
cycle of simulated annealing. Hence, loop 52-72, the zinc cations, Pi, and F6P were fit to 
an omit map.) Two models were generated for the 3Zn2+-product complex which 
differed from each other in the choice of F6P anomer. The resulting models underwent 
one round of refinement using XPLOR (34) with force constants and parameters of 
stereochemistry from Engh and Huber (36). A cycle of refinement consisted of slow 
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Table 1: Statistics of data collection and refinement. 
Resolution limit (Â) 2.27 
Number of measurements 145 331 
Number of unique refl. 31 028 
Completeness of data set (%) 90 
Completeness of data 56.4 
In the last resolution shell(%) 
Rsym 5.5 
Number of refl. in refinement^ 22 526 
Number of atoms0 6974 
Number of solvent sites 266 
R-Factord 0.186 
R-Free® 0.282 
Mean B (Â2) for protein chain A 14.3 
RMS deviations 
Bond lenghts (Â) 0.011 
Bond angles (deg) 1.68 
Dihedral angles (deg) 24.5 
Improper dihedral angles(deg) 1.35 
1R$ym = 2j Zi 11 ij - < I j > | / Si Ej Iij, where i runs over multiple obervations of the same 
intensity, and j runs over all crystallographically unique intensities. 
bAll data in the resolution ranges indicated. 
'Includes hydrogens linked to polar atoms. 
dR&cto,= 2 || Foi» I-1 Fci= || /2 | F* I, | Fob, I >0. 
eRfactor based upon 10% of the data randomly culled and not used in the refinement. 
44 
cooling from 2000 to 300 K in steps of 25 K, followed next by 120 cycles of conjugate 
gradient minimization, and finally by the refinement of individual B-parameters with 
restraints of 1.5 Â2 on nearest neighbor and next to nearest neighbor main chain atoms, 
2.0 À2 on nearest neighbor side chain atoms, and 2.5 À2 on next to nearest neighbor side 
chain atoms. In subsequent cycles of refinement, water molecules were fit to a difference 
electron density of 2.5a or better and were added until no significant decrease was 
evident in R^. Included in the final model were water molecules which make suitable 
donor-acceptor distances to each other and the protein and have B-parameters of less than 
47 A2. 
Results 
General Features of the 3Zn2'-Product Complex of FBPase. Wild-type FBPase used in 
crystallization experiments suffered no proteolytic degradation and, on the basis of 
SDS-PAGE (data not shown), is greater than 95% pure. Coordinates and structure 
factors have been deposited with the Brookhaven Protein Data Bank (accession code 
1BFL). Statistics for data collection and refinement are given in Table 1. Uncertainty in 
coordinates is approximately 0.25 Â. The stereochemistry of the model is generally 
better than what is typical for a structure with a nominal resolution of 2.3 Â, as 
determined by PROCHECK (37). Thermal parameters vary from 7.0 to 49 Â2. The 
model begins with interprétable electron density at Thrl2 and continues without 
interruption to Ala335. Weak electron density is present for residues before Thrl2, but 
the interpretation of that density is ambiguous. The electron density associated with 
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residues 22-27 (loop connecting helices HI and H2) is weak, as reflected by high thermal 
parameters. The rest of the polypeptide chain, however, is covered by substantial 
electron density. 
The crystal form presented here has not been reported in prior investigations of 
FBPase. The space group (P2|2%2) is identical to that associated with the canonical T 
state confornation (25), but the unit cell parameters differ (a = 51.34 Â, b = 166.77 A, 
and c = 82.82 Â as opposed to a = 61.0 A, 6 = 166.5 A, and c = 80.0 A for canonical T 
state structures). As with previous FBPase crystals in space group P2i2;2, the asymmetric 
unit consists of the CI and C2 subunits of the tetramer (Figure 1); a crystallographic 
2-fold axis coincides with the molecular 2-fold axis that relates the CI and C4 subunits. 
Ca's related by noncrystallographic symmetry show a root-mean-square deviation of 
approximately 0.2 A, regardless of whether the AMP and/or the FBP domain is used as a 
basis of superposition. (Residues 1 - 199 and 200 - 335 comprise the AMP and FBP 
domains, respectively.) Noncrystallographic restraints were not used in refinement so 
that the root-mean-square deviation above is another measure of coordinate uncertainty. 
No pair of Ca's related by noncrystallographic symmetry deviate by more than 1.4 A 
after superposition, and only for the disordered loop 22-27 do the discrepancies exceed 
0.7 A. As the relative positions and orientations of the AMP and FBP domains in the 
subunits related by noncrystallographic smmetry are the same, either subunit can be used 
in structural comparisons to the canonical R and T states of FBPase. 
Rigid-Body Conformational Changes. The R to T state transition entails a 17 A rotation 
between dimers CI-C2 and C3-C4 (Figure 1). The enzyme here is unambiguously in the 
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RForm T Form 
FIGURE 1: Schematic of R and T state tetramers of FBPase as defined by the 
3Zn2+-product complex in the context of previous FBPase structures. Gray prisms 
represent residues 90-335 of subunits C1-C4. Shown explicitly are helixes H1-H3 as 
shaded cylinders. A 17° rotation of the dimer C1-C2 relative to the dimer C3-C4 is the 
major quaternary conformational change. In the R state conformer, loop 52-72, 
connecting helix H2 to helix H3, is ordered, whereas the same loop becomes disordered 
in the T state (dashed line). This figure was drawn in part with RASTER3D (47). 
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canonical R state conformation. The root-mean-square deviation in corresponding Ca's of 
the tetramer, excluding the loop 52-72, is 0.88 À against the canonical R state and 2.96 Â 
against the canonical T state. Hence, R state conformers are now available in two 
different crystal forms. Superposition of the 3Zn2"-product complex onto the canonical R 
state, using Ca atoms of either the FBP or AMP domain as the basis for superposition, 
yields similar values for root-mean-square deviations (Table 2). The AMP and FBP 
domains exhibit root-mean-square deviations approximately 0.15 Â lower if the same 
domain is used as the basis of superposition and comparison (Table 2). The discrepancy 
may be a consequence of a small difference in the relative orientation of the AMP and 
FBP domains in the canonical R state and the product complex. Whether this difference 
in orientation has functional significance, however, is doubtful. Indeed, the small 
discrepancy above may stem from differences in packing environments of the two crystal 
forms. 
The AMP domain rotates by approximately 2° relative to the FBP domain in the 
R to T state transition (27). The 2° rotation putatively transforms the functional active 
site (which lies at the interface between AMP and FBP domains) to the inhibited active 
site (20). Superposition of the 3Zn2+-product complex onto the canonical T state of 
FBPase, using (as above) the AMP or FBP domains as a basis of superposition, reveals 
again a small discrepancy in root-mean-square deviations (Table 2). As in the case of the 
canonical R state, the relative position and orientation of the AMP and FBP domains in 
the product complex do not differ appreciably from those of the canonical T state (Figure 
2). Again, it is unclear whether small differences in the relative orientation and position 
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Table 2: Root-Mean-Square Deviations (in Angstroms) between Ca's of selected 
structural elements of the 3Zn2+-product complex and the canonical R and T states of 
FBPase after superpostion based on selected Ca's of the FBP domain or AMP domain. 
structural element FBP domain" AMP domain6 
R stated vs product complex 
FBP domain" 0.50 0.63 
AMP domain6 0.63 0.48 
helix Hf 1.68 1.40 
helix md 0.53 0.35 
helix H3e 0.65 0.42 
T state8 vs product complex 
FBP domain" 0.33 0.66 
AMP domain6 0.55 0.47 
helix HI' 4.81 1.51 
helix H2' 1.06 1.05 
helix H3e 0.62 0.41 
* Residues 201-335, excluding residues 267-272. 
6 Residues 90-200, excluding residues 122-127. 
c Residues 12-22. 
d Residues 28-50. 
* Residues 74-89. 
^Protein Data Bank entry IFBE. 
9 Protein Data Bank entry 1FPI. 
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FIGURE 2: Superposition of the 3Zn2*-product complex (solid line) onto the canonical T 
state of FBPas (dashed line). Ca's of residues belonging to the central (3-sheet of the 
AMP domain (residues 90-199, excluding residues 122-127) are the basis for the 
superposition. Differences due to the rigid-body motion of the AMP domain relative to 
the FBP domain are small. However, residues 12-72 (helix HI, helix H2, and loop 
52-72), 122-127 (helix H4), and 267-272 undergo significant conformational change 
(top). Helix H2 of the 3Zn2+-product complex (solid line) moves 0.9 Â along its axis 
relative to the T state (gray line), and loop 52-72 goes from a state of disorder to an 
ordered conformation (bottom). The top orientation of the subunit corresponds to that of 
subunit C4 in Figure 1. The bottom is related to the top illustration by a 90° rotation 
about the horizontal axis. This figure was drawn with MOLSCRIPT (48). 
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of the AMP and FBP domains in various crystal forms of FBPase are functionally 
significant or just a consequence of different packing environments. Non-rigid-body 
conformational changes described below may play a more significant role in determining 
the functional state of FBPase. 
Non-Rigid-Bodv Conformational Changes. Superpositions of the 3Zn2"-product complex 
onto the canonical R and T state reveal significant differences for Ca atoms 12-72, 
122-127, and 267-272 (Table 2 and Figure 2). Helix HI (residues 12-22) adopts a 
different position relative to the corresponding elements in the canonical R and T state. 
The connecting element between helix HI and H2 (residues 23-27) is disordered in the 
3Zn2-r-product complex (as in the canonical R state), so conformational differences here 
may be simply a consequence of coordinate uncertainty. The corresponding element is 
ordered, however, in the canonical T state, reflecting the stabilizing influence of bound 
AMP. The relative position of helix H2 (residues 28-51) in the 3Zn2"-product complex 
corresponds to that of the canonical R state, being displaced relative to helix H2 of the T 
state by approximately 0.9 Â along the helix axis (Figure 2). Residues 52-72 of the 
3Zn2+-product complex are ordered (Figure 2), whereas the corresponding element in the 
canonical R and T states is disordered. Residues 52-61 of the canonical T state take up a 
decidedly different conformation relative to the same residues of the 3Zn2+-product 
complex (Figure 2). Helix H4 of the 3Zn2*-product complex adopts an ordered 
conformation which differs from that of the poorly ordered H4 in the canonical R and T 
state structures. Finally, the conformation of loop 267-272 of the 3Zn2+-product complex 
differs from that of the canonical R and T states. 
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Helix HI, loop 52-72, helix H4, and loop 267-272 have conformations which are not 
observed in either the canonical R or T state. In fact, the ordering of loop 52-72 and 
conformational displacements in helix HI, helix H4, and loop 262-267 may be coupled 
phenomena. We suggest that the canonical R state of FBPase represents an incomplete 
transition, showing principally the displacement in helix H2, but not the displacements 
involving helix HI, loop 52-72, helix H4, and loop 262-267. 
Interactions of Loop 52-72. In its ordered conformation, loop 52-72 interacts 
predominantly with the AMP domain of its own subunit (Table 3 and Figure 3). It makes 
significant contacts as well with the FBP domain of its own subunit and the AMP domain 
of the subunit related by noncrystallographic symmetry (that is, a C1-C2 or C3-C4 
contact in Figure 1). Leu56 and Tyr57 pack onto a hydrophobic patch at the surface of 
two separate AMP domains, and in so doing form new hydrophobic clusters (Figure 3). 
The side chain of Leu56 is within 4.5 À of the side chains of Ala47, Ala51, Ala54, Leu73, 
and Leu76, complementing the hydrophobic interactions between helix H2 and H3. The 
side chain of Tyr57 is within 4.5 À of those of AlaSl, Ilel26, Leul29, Alal70#, and 
Metl85#; its interactions with Ilel26 and Leul29 may be responsible in part for the 
conformational ordering of helix H4 (the symbol # designates the subunit related by 
noncrystallographic symmetry). 
In addition to the aforementioned hydrophobic contacts, numerous polar contacts 
presumably stabilize the observed conformation of loop 52-72. Backbone amides 54, 55, 
and 56 hydrogen bond with backbone carbonyls 50, 51, and 52 (Table 3). The model for 
the canonical R state ends at De53. Hence, the above backbone interactions are absent in 
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Table 3: Selected Donor-Acceptor Distances Involving Atoms of loop 52-72° 
atom from loop 52-72 contact atom distance fÂ) 
Ala54 N Lys50 0 2.97 
His55 N Ala510 2.99 
Gly52 0 3.05 
Leu56N Ala510 2.78 
Tyr57 0 Lys72 NZ 2.67 
Gly58 0 Lys72 N 3.02 
Ala60N Val70 0 2.7 
Ser62 N Gln69 OE1 3 
Ser62 0 Gln69 Oel 2.78 
Val70 N 2.63 
Asn64N Asp68 0 3.01 
Asn64 0 Gly67 N 2.73 
Asn64 OD I Thr66 OG1 3.1 
Gly67 N 3.11 
Asp68 N 2.8 
Asn64 ND 1 Glu98 OE1 3.4 
Thr66 0 Arg313 NH2 2.99 
Thr66 OG 1 Arg276 NH1 2.83 
Asp68 OD2 Arg276 NH1 3.2 
Zn2+ (site 3) 2.19 
LysTIN Asp74 OD1 2.67 
LysTIO Asp74N 2.86 
Lys71 NZ Serl23 OG 2.91 
" Distance taken from polypeptide chaine B 
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Thr66 
FIGURE 3: Loop 52-72 in its engaged conformation. Well?defined electron density in an 
omit map covers loop 52-72 at a 3s contour level and a cutoff radius of 1 A (top). Loop 
52-72 (yellow) interacts with the AMP and FBP domains of the same subunit (blue) and 
the AMP domain of a symmetry?related subunit (purple) (bottom). This figure was drawn 
with XTALVIEW (35), MOLSCRIPT (48), and RASTERSD (47). 
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the disordered conformation of the loop. Asn64 hydrogen bonds weakly with Glu98, 
which is an essential residue for catalysis at neutral pH (38). Asp68 coordinates to zinc 
at site 3, but perhaps of greater significance is its hydrogen bond with Arg276, a residue 
important in catalysis (39). The side chains of Lys71 and Serl23 hydrogen bond with 
each other, and in addition, backbone carbonyis 58 and 71 interact with backbone amides 
72 and 74, respectively. Perhaps more significant, however, is the hydrogen bond 
between backbone amide 71 and the side chain of Asp74. Mutations of Asp74 reduce kat 
by 50000-fold (23). Interactions involving residues 71, 74, and 123 are absent in the 
disordered conformation of loop 52-72. 
We have up to now described loop 52-72 as existing in two conformational states 
(ordered and disordered), but in fact, 10 donor-acceptor interactions among residues 57-
70 (Table 3) could stabilize the observed conformation for this portion of the loop even in 
its disordered state. Hence, a relatively rigid element of secondary structure defined here 
by residues 57-70 could be hinged to the AMP domain by flexible elements spanning 
residues 50-56, 71, and 72. Given the above as a possible scenario, we prefer the 
terminology engaged and disengaged (instead of ordered and disordered, respectively) in 
referring to the conformational state of loop 52-72. 
Ligand and Divalent Cation Interactions. The zinc cations occupy metal binding 
sites 1-3 defined in previous studies of FBPase (18, 28), but the coordination of each 
metal ion differs. The side chain of Aspl21 is in the inner sphere of the Zn2""" at site 1 for 
the product complex (Table 4 and Figure 4), as opposed to other R state structures where 
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Table 4. Selected Distances between Ligands and the Active Site" 
ligand atom contact atom distance (Â) 
Zn2+ (site 1) AspllS 0D1 2.04 
Asp 121 0D1 2.20 
Glu280 0E1 2.17 
Pi 01 1.88 
Zn2"" (site 2) Glu97 0E1 2.13 
AspllS 0D2 2.16 
Leu120 0 2.15 
Pi 02 2.36 
Pi 03 2.17 
Zn2+ (site 3) Asp68 0D2 2.19 
Glu97 0E2 2.32 
Pi 01 1.97 
D. 
Pi 03 2.57 
"i 
01 Arg276 NH2 2.79 
Zn (site 3) 1.97 
F6P01 2.73 
02 Zn2+ (site 1) 1.88 
Zn2+ (site 2) 2.36 
03 Zn2+ (site 2) 2.17 
Zn2+ (site 3) 2.57 
Wat615 2.72 
04 Glyl22 N 2.86 
Serl23 N 2.89 
F6P02 2.84 
F6P 
01 Pi 01 2.73 
02 Pi 04 2.84 
Wat563 2.99 
Wat592 2.71 
03 Aspl21 0D1 2.71 
Met248 N 2.91 
04 Wat538 2.74 
05 Lys274 NZ 3.05 
06 Lys274 NZ 3.03 
Wat604 3.10 
* Distances taken from polypeptide chain B. 
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Table 4. (Continued) 
ligand atom contact atom distance (À) 
061 Tyr215 OH 2.64 
Tyr264 OH 2.70 
Wat576 2.87 
062 Arg2436 NH2 2.82 
Wat 604 2.57 
063 Asn212 ND2 2.95 
Tyr244 OH 2.72 
6 Residue belongs to polypeptide chain A 
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W215 <Tyr215 
Met 248 
Glu 280 
Met 248 
Glu 280 
FIGURE 4: Stereoview of the active site. Donor-acceptor interactions are indicated by 
dashed lines. The figure was drawn with XTALVIEW (35). 
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it is 2.8 Â from the metal atom (18). The coordination at site 2 involves two oxygen 
atoms from Pi instead of a single oxygen from the 1-phosphoryl group of 2,5-AnG-l,6-P2 
(18). Zn2+ at site 3 coordinates two oxygen atoms of Pi, and one oxygen each from 
Asp68 and Glu280. In the 3K*-2,5-AnG-l,6-P2-AMP complex (28), the K* at site 3 did 
not interact with Asp68 as loop 52-72 is disordered, but does interact with Glu97 and the 
1-phosphoryl group of the inhibitor. 
F6P and Pi in this structure retain many of the interactions (Table 4 and Figure 4) 
observed for F16P2 and 2,5-AnGl,6-P2 in previous structures (18), but with some 
significant differences. The P-anomer of F6P provides the best fit to the electron density 
of the 3Zn2*-product complex. The a-anomer of F6P can account for most of the 
electron density; however, its 1-OH group must be positioned out of electron density and 
away from the Pi molecule to avoid steric conflict, and even then, CI of the a-anomer of 
F6P makes a close contact (less than 2.5 À) with 01 of Pi. The corresponding contact for 
the P-anomer is a strong hydrogen bond between the 2-OH of F6P and Pi (Table 4). The 
Pi molecule participates in coordinate bonds to all three zinc cations and hydrogen bonds 
to the 1- and 2-OH groups of the F6P molecule (Table 4 and Figure 4). The Pi molecule 
hydrogen bonds as well to backbone amides 122 and 123 and to the Arg276. The 
3Zn2~-product complex fundamentally differs from the 2,5-AnG-l,6-P2 complexes (18) 
in the tight packing of its active site. Indeed, the three cations, the products, and 
interacting side chains exhibit a complex network of hydrogen bonds (Figure 4), which 
restricts the conformational freedom in the active site of the 3Zn2+-product complex 
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rivals that of the hydrophobic cores of the AMP and FBP domains, as measured by 
averaged thermal parameters. 
Discussion 
Model for Allosteric Regulation. The 3Zn2"-product complex, in conjunction with 
structures of the canonical T state, is the basis here for a new model of catalytic 
regulation for FBPase. The principal feature of this new model is the participation of 
loop 52-72 (Figure 5). Essentially all but one of the regulatory properties of FBPase can 
be explained in the context of a two-state subunit. AMP cooperativity is the only property 
necessarily linked to the tetramer. 
The new R state subunit of FBPase at neutral pH has loop 52-72 engaged with the 
AMP and FBP domains as described above. When metal sites 1 and 2 are occupied and 
when FI6P2 is bound, loop 52-72 closes onto the active site. Interactions between loop 
52-72 and the rest of the tetramer putatively position Asp74 so that it can abstract a 
proton from a water molecule bound to the cation at site 2 (23). Mutation of Asp74 to 
alanine or asparagine reduces by 50000-fold (23). In addition, the engaged 
conformation of loop 52-72 also permits Asn64 to hydrogen bond with and orient the side 
chain of Glu98, which putatively works in concert with Asp74 as a catalytic base (23, 
38). Finally, the engaged loop also stabilizes the hydrogen bond of Asp68 with Arg276, 
completing the coordination site for metal 3. In the absence of a metal at site 3, Asp68 
will feel the electrostatic repulsion of the 1-phosphoryl group of the substrate. That 
repulsive interaction can be offset by the protonation of the 1-phosphoryl group or by the 
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R-State Subunit 
Ill-defined 
AMP site 
H2 
F6P 
H3 
Loop 52-72 
engaged 
T-State Subunit 
(AMP) Loop 52-72 
disengaged 
H2 
H3 
.•••••-
FIGURE 5: Scheme for allosteric regulation of FBPase catalysis. The engaged 
conformation of loop 52-72 (top) and the AMP-bound state (bottom) are antagonistic. 
Dashed lines represent poorly ordered structure. See the text for details. 
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presence of a cation at site 3. Hence, the structural origin of monovalent cation activation 
is probably the stabilization of the Asp68—Arg276 hydrogen bond by neutralization of 
electrostatic charge on the 1-phosphoryl group. At neutral pH, the new model accounts 
for the Hill coefficient of 2 for Mg2+, requiring metals at sites 1 and 2. 
The canonical T state subunit of FBPase is represented by the 
3K*-2,5-AnG-l,6-P2-AMP structure (28). AMP, by binding to the allosteric pocket, 
drives a conformational change which perturbs the position of helix H2 by a translation 
of 0.9 Â along its axis (Figures 2 and 5). The coupling of AMP binding and the 
movement of helix H2 may be indirect. For instance, AMP could bind to loop 52-72 and 
stabilize a conformation which favors the T state tetramer. Interactions between subunits 
CI and C4 of the T state tetramer (Figure 1) then could displace helix H2. The small 
displacement of helix H2 putatively disengages loop 52-72 from the rest of the tetramer, 
which in turn perturbs Asp74 and Glu98 (catalytic base tandem). Conceivably, the 
disengagement of loop 52-72 in the T state will lessen the affinity of Mg2+ for site 1 
and/or site 2. Indeed, the complex of 2,5-AnG-l,6-P2 with Mg2- (loop 52-72 disengaged) 
has metal at site 1 only (18). Hence, the observation of competition between AMP and 
Mg2* (16,17) may be linked to the dynamics of loop 52-72. F26P2 and AMP are 
synergistic inhibitors of FBPase, a phenomenon which is easy to understand if AMP and 
F26P2 both stabilize the same conformational state (disengaged loop 52-72). Indeed, the 
2-phosphoryl group of F26P2 does not (and evidently cannot) interact with Arg276 in 
crystal structures of F26P2 complexes (19, 26). Furthermore, the 2-phosphoryl group 
cannot be in the inner coordination sphere of the cation at site 3. Hence, the structural 
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elements that contribute most to interactions with the side chain of Asp68 are not in place 
in F26P2 complexes of FBPase. 
FBPase is just one of a growing list of enzymes which employ one or more 
flexible loops in its biochemical function (for examples, see refs 40-42). The new model 
for allosteric regulation of catalysis requires that loop 52-72 have at least two 
conformational states and that at least one of these states (the engaged conformation) be 
important in catalysis. Investigations of directed mutations confirm a significant role for 
loop 52-72 in regulation and catalysis (23), but why until now has loop 52-72 been 
disordered in all crystal structures of the R state? Perhaps, as discussed below, the R 
state exists in solution as a manifold of conformational states with different functional 
properties, and under a specific set of conditions, only one of these states is selected by 
the process of crystallization. On the other hand, in previous studies of the R state, 
crystals of FBPase were grown in the presence of F6P without metal cations (15, 18), and 
desired ligands and cations were difiused into the resulting P3221 crystal form. Crystal 
packing interactions of the P3221 crystal form, which presumably stabilize a partially 
ligated conformation of FBPase, may inhibit the complete transformation to an active 
conformer in the presence of metal ions and substrate analogues. The crystal form 
presented here results from the cocrystallization of cations and a complete set of 
products. Crystals isomorphous with respect to those of the 3Zn2"-product complex have 
been grown in the presence of F6P and Pi along with Mg2", Mg2* and K*, Mg2, Zn2*, 
and K~, and Mn2+. (Preliminary results show occupancy levels ranging from 
approximately 50 to 100% for the engaged conformation of loop 52-72 in the presence of 
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Mg2* alone or in combination with other metals.) No crystallization experiment in our 
hands involving metal cations and products, however, has resulted in the P3221 crystal 
form of the canonical R state. 
Mechanism of Catalysis. F6P and Pi are products of the forward reaction mediated by 
FBPase. In the presence of only Zn2" at 5 mM, FBPase hydrolyzes FI6P2 at a rate that is 
approximately 70% of that in the presence of 5 mM Mg2* (J.-Y. Choe and R B. 
Honzatko, unpublished). The 3Zn2*-product complex then should not be far removed 
from a productive complex. The presence of an unambiguous product complex in the 
crystal structure is consistent with the reported thermodynamic equilibrium constant (K«,, 
approximately 200 M) for the conversion of FI6P2 to F6P and P, (3). Hence, this 
structure should provide some information relevant to the catalytic mechanism of 
FBPase. 
To make the reverse reaction go, a catalytic base (catalytic acid in the forward 
direction) must abstract a proton from the 1-OH of F6P. If the torsion bond between CI 
and C2 of F6P is rotated by 120° into an alternative staggered conformation, a favorable 
geometry exists between the zinc cation at site 1, the side chain of Glu280, the Pi 
molecule, and the 1-OH of F6P (Figure 6). As the hydrogen atom of the 1-OH group 
bonds with Glu280, the 01 atom can form a transient coordinate bond with Zn2* at site 1. 
Such interactions should activate the 1-OH group as a nucleophile in the reverse reaction. 
Furthermore, the 1-OH group takes up near-perfect, in-line geometry with respect to the 
phosphorus atom of P. and the leaving group (oxygen atom of P. coordinated to the Zn2* 
at site 2). The leaving oxygen could be protonated directly by Asp74 and Glu98 
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(catalytic acid tandem in the reverse reaction), but more likely, the water molecule 
hydrogen bonded with Asp74 (Figure 4) would mediate proton transfer. The 
structure-based mechanism described above would require that Asp74, Glu98, Glu280, 
and metal cations at sites 1 and 2 be essential for catalysis, which is consistent with 
investigations in kinetics and directed mutation. Also, the 2-OH group of F6P hydrogen 
bonds with Pi, an interaction which may promote the close approach of the 01 atom of 
F6P and the phosphorus atom of Pi. Analogues of FI6P2 which lack a 2-OH group are 
not substrates for FBPase (43). 
The above model, however, may be at odds with other studies regarding the 
conformationally active form of the substrate. Putatively, the a-anomer of FI6P2 is 
necessary for catalysis (44), even though the P-anomer is favored thermodynamically in 
solution (45) and may bind more tightly to the active site (43). Although the a-anomer of 
F6P cannot account for electron density at the active site (see above), a model for the 
a-anomer can be positioned into the cavity of the active site of the 3Zn2*-product 
complex. The active site can then be relaxed to the model for the a-anomer by energy 
minimization to ensure a set of allowable interactions (Figure 6). The 01 atom of the 
a-anomer of F6P is 2.8 A from the zinc cation at site 1 and 2.8 Â from the side chain of 
Aspl21. The 01 atom of the a-anomer is in line with the phosphate atom and the 
oxygen atom of P, coordinated to the cation at site 2. Asp 121 would serve as the 
catalytic base in the reverse reaction, consistent with its putative role as a catalytic acid in 
the forward reaction (18). 
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P-D-F6P 
' 2.4, 9sI 9 , 
# *2 2*051 
Zn#2 Zn#l 
Glu280 
«-D-F6P 
Zn#2 Zn#l 
. Aspl21 
FIGURE 6: Models for early transition states of the reverse reaction of FBPase, based on 
the 3Zn2~-product complex. Glu280 is the putative catalytic base for the P-anomer of 
F6P (top), and Aspl21 is the catalytic base for the a-anomer (bottom). See the text for 
details. This figure was drawn with MOLSCRIPT (48) and RASTERSD (47). 
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Clearly, this issue of anomeric specificity is not resolved, as any crystallographic 
structure can provide only an approximation of the transition state. The structure 
reported here and/or previously published structures may be dead-end complexes of 
FBPase. The kinetic evidence supporting the a-anomer as the substrate (44, 46), 
however, is equally indirect and relates to catalysis by FBPase in the presence of Mn2". 
Indeed, in the presence of Mg2-, data from rapid quenching kinetics infer utilization of 
both a- and (3-anomers of FI6P2 (3). Furthermore, no data (aside from this study) 
regarding the anomeric specificity of the reverse reaction catalyzed by FBPase are 
available. Differences in reaction rates catalyzed by FBPase in the presence of Zn2". 
Mn2" and/or Mg2+ may stem from fundamentally different catalytic mechanisms. Under 
in vivo conditions, different catalytic combinations at the active site may result in a 
mixture of FBPases capable of using both anomers of the substrate. If so, the structure of 
the 3Zn2"-product complex may reflect the mechanism of one of many active forms of 
FBPase, distinguished principally by the cations located at the active site. At the very 
least, the 3Zn2*-product complex should motivate further investigation of the regulatory 
and catalytic mechanisms of FBPase in the presence of various cation and ligand 
combinations. 
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CHAPTER 3. CRYSTAL STRUCTURES OF FRUCTOSE 1,6-
BISPHOSPHATASE : MECHANISM OF CATALYSIS AND 
ALLOSTERIC INHIBITION REVEALED IN PRODUCT 
COMPLEXES12 
A paper published in BIOCHEMISTRY3 
Jun-Yong Choe, Bradley W. Poland, Herbert J. Fromm, and Richard B Honzatko4 
Abstract 
Crystal structures of metal-product complexes of fructose 1,6-bisphosphatase 
(FBPase) reveal competition between AMP and divalent cations. In the presence of 
AMP, the Zn2'-product and Mg2"-product complexes have a divalent cation present only 
at one of three metal binding sites (site 1). The enzyme is in the T-state conformation 
with a disordered loop of residues 52-72 (loop 52-72). In the absence of AMP, the 
enzyme crystallizes in the R-state conformation, with loop 52-72 associated with the 
active site. In structures without AMP, three metal-binding sites are occupied by Zn2^ 
1 This work was supported in part by National Institutes of Health Research Grant 
NS-10546 and National Science Foundation Grant MCB-9603595. This is Journal Paper 
J-18833 of the Iowa Agriculture and Home Economics Experiment Station, Ames, 
Project 3191, and is supported by Hatch Act and State of Iowa Binds. 
2 Coordinates and structure factors (codes lenq, leyi, leyj, and leyk) for the structures 
described in this paper have been deposited with the Protein Data Bank, Research 
Collaborator for Structural Bioinformatics (RCSB), http://www.rcsb.org/pdb/. 
3 Reprinted with permission of Biochemistry, 2000,39, 8565-8574. 
4 Corresponding author. Telephone: (515) 294-6116. Fax: (515) 294-0453. E-mail: 
honzatko@iastate.edu. 
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and two of three metal sites (sites 1 and 2) by Mg2". Evidently, the association of AMP 
with FBPase disorders loop 52-72, the consequence of which is the release of cations 
from two of three metal binding sites. In the Mg2" complexes (but not the Zn2-
complexes), the 1-OH group of fructose 6-phosphate (F6P) coordinates to the metal at 
site 1 and is oriented for a nucleophilic attack on the bound phosphate molecule. A 
mechanism is presented for the forward reaction, in which Asp74 and Glu98 together 
generate a hydroxide anion coordinated to the Mg2" at site 2, which then displaces F6P. 
Development of negative charge on the 1-oxygen of F6P is stabilized by its coordination 
to the Mg2" at site 1. 
Introduction 
Fructose 1,6-bisphosphatase (FBPase, EC 3.1.3.11) hydrolyzes fructose 
1,6-bisphosphate (FI6P2) to fructose 6-phosphate (F6P) and phosphate (Pi) (1-6). The 
enzyme plays a central role in gluconeogenesis, and is inhibited allosterically by AMP, 
the binding of which is cooperative with a toll coefficient of 2 (7-9). Fructose 
2,6-bisphosphate (F26P2), which binds with high affinity to the active site, inhibits 
FBPase synergistically with AMP (10- 12). FBPase requires divalent cations (Mg2", 
Mn2", and/or Zn2~) for activity, and certain monovalent cations (K~, NRT, and Tf) 
further enhance catalysis (3, 5, 13). Enzyme activity increases sigmoidally as a function 
of divalent cation concentration at pH 7.5 (Hill coefficient of approximately 2), but at pH 
9.6, the variation is hyperbolic (8, 14). 
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*>17° 
FIGURE 1: Schematic of the T-state conformation of FBPase. A rotation of the subunit 
pair C1-C2 by 17° as shown transforms the T-state into the R-state conformer. Dotted 
ovals represent ligand binding sites on faces of the tetramer hidden from view. Distances 
measured from atom C-2 of F6P of subunit C2 to atoms C-l' of four bound AMP 
molecules are presented. 
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The mammalian enzyme is a homotetramer (Figure 1), which exists in distinct 
conformational states, depending on the relative concentrations of active site ligands and 
AMP (15). In the absence of AMP, FBPase, with or without metal cofactors and/or other 
active site ligands, is in its R-state. In the presence of AMP, however, the top pair of 
subunits rotates 17° relative to the bottom pair, resulting in the T-state conformer. The 
minimum distance separating AMP molecules from any given active site is 
approximately 30 Â (16, 17). Yet on the basis of kinetics, NMR, and fluorescence 
studies, the binding of AMP and Mg2- is mutually exclusive (11, 18, 19). 
In published crystal structures, however, the number of metal cations bound to the 
active site is insensitive to the state of ligation of the AMP site. Two Mn21- or two Zn2"" 
ions bind to the active site in the presence or absence of AMP (20, 21). Mn2" association 
at site 2 is evidently weaker in FBPase complexes with AMP relative to those without 
AMP (21), but conformational changes in FBPase which cause metal-AMP competition 
are unsettled. Weaker metal binding to site 2 may arise from the relative rotation of the 
two folding domains of the FBPase subunit (21). Choe et al. (23), however, in a 
Zn2"-product complex of FBPase find little support for rigid body rotations of domains 
within subunits of FBPase. On the other hand, in that same complex, loop 52-72 
associates with an active site that includes three zinc cations. Asp68 of the loop 
coordinates directly to the Zn2+ at metal site 3, and all Zn2* ions are bound firmly to the 
enzyme, as evidenced by their low thermal parameters. Hence, Choe et al. (23) propose 
an alternative mechanism, in which FBPase has an ordered loop in the active R-state with 
three bound metals and a disordered loop in the T-state with significantly reduced affinity 
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for metal cations. Yet to be demonstrated, however, is whether AMP, by binding to its 
allosteric site, displaces loop 52-72 and/or metals from the active site of metal-product 
complexes of FBPase. 
Presented here are crystallographic structures of product complexes of 
recombinant porcine FBPase in the presence and absence of AMP. In the absence of 
AMP, FBPase is in the R-state and loop 52-72 associates with the active site, whereas in 
the presence of AMP, the enzyme crystallizes in the T-state with a disordered loop. The 
products (F6P and Pi) are present in crystal structures with and without AMP, but metal 
ligation of the active site differs significantly. In the absence of AMP, Zn2" binds to all 
three metal sites and Mg2" to two of three metal sites, whereas in the presence of AMP, 
divalent cations (either Zn2" or Mg2") bind to a single common site. Furthermore, in only 
the Mg2* complexes, the 1-OH group of F6P directly coordinates to the metal at site 1, 
suggesting a direct role for that metal in the catalytic mechanism of FBPase. 
Experimental Procedures 
Expression and Purification of Wild-Tvpe FBPase. FBPase-deficient Escherichia coli 
strain DF657 [tonA22, ompF627(T2R), relAl, pit 10, spoTl, A(fbp)287\ Genetic Stock 
Center at Yale University, New Haven, CT] was used in the expression of recombinant 
wild-type porcine FBPase. Expression and purification of FBPase followed the 
procedures of Burton et al. (24) with minor modification. After centrifugation to remove 
cell debris, the supernatant fluid was subjected to heat treatment, centrifugation, volume 
reduction of the supernatant by pressure concentration through an Amicon PM-30 
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membrane, and then CMSepharose column chromatography. FBPase eluted as a single 
peak, using a NaCl gradient (from 20 to 400 mM) in 10 mM Tris-malonate (pH 6.0). 
Crystallization of the Product Complex. Crystals of FBPase were grown by the method 
of hanging drops. Crystals of T-state complexes grew from equal parts of a protein 
solution [10 mg/mL FBPase, 10 mM KPi (pH 7.4), 2 mM ZnCl2 or 5 mM MgCk, 5 mM 
F6P, and 5 mM AMP] and a precipitant solution [100 mM Hepes (pH 7.0) and 10% (w/v) 
polyethylene glycol 3350]. Crystals of R-state complexes grew from equal parts of a 
protein solution [10 mg/mL FBPase, 10 mM KPi (pH 7.4), 5 mM ZnCl? or 5 mM MgCfe, 
and 5 mM F6P] and a precipitant solution [2.5 mM Tris-malonate (pH 7.4) and 6% (w/v) 
polyethylene glycol 3350]. The droplet volume was 4 uL. Wells contained 500 uL of the 
precipitant solution. Crystals with dimensions of 0.4 mm x 0.4 mm x 0.3 mm grew in 
approximately 3 days at 4 and 37 °C. Structures of crystals grown at 37 and 4 °C are 
identical. Data presented below are from crystals grown at 37 °C. 
Data Collection. Data were collected at Iowa State University on a rotating 
anode/Siemens area detector at 120 K, using CuKa radiation passed through a graphite 
monochromator. Data were reduced by XENGEN (25). 
Structure Determination. Model Building, and Refinement. Crystals grown for this study 
are isornorphous to either the Zn2+-product complex (23) or AMP complexes reported by 
Lipscomb and co-workers (16). Phase angles, used in the generation of initial electron 
density maps, were based on models from which water molecules, metal cations, 
smallmoiecule ligands, and residues 52-72 had been omitted. Residues 52-72 were built 
into the electron density of omit maps, with reference to the Ca coordinates of loop 
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52-72 from the Zn2+-product complex (23), using the program XTALVIEW (26) and a 
Silicon Graphics workstation (Indigo2). Added to the single independent subunit of 
crystals grown in the absence of AMP were two molecules of P; (active site and AMP 
site), one molecule of F6P (active site), and either three zinc or two magnesium cations 
(active site). Subunits of crystals grown in the presence of AMP each had one molecule 
of Pi, F6P, and AMP, and one metal cation (either Mg2- or Zn2"). Two models were 
generated for all complexes, which differed in the choice of F6P anomer (a or 3). The 
resulting models underwent refinement using CNS (27) with force constants and 
parameters of stereochemistry from Engh and Huber (28). A cycle of refinement 
consisted of slow cooling from 2500 to 300 K in steps of 25 K, followed by 120 cycles of 
conjugate gradient minimization, and concluded by the refinement of individual 
B-parameters. B-Parameter refinement employed restraints of 1.5 Â2 on nearest neighbor 
and next-to-nearest neighbor main chain atoms, 2.0 Â2 on nearest neighbor side chain 
atoms, and 2.5 À2 on next-to-nearest neighbor side chain atoms. 
In subsequent cycles of refinement, water molecules were fit to a difference 
electron density of 2.5a, or better and were added until no significant decrease was 
evident in the Rfne value. Included in the final model were water molecules which make 
suitable donor-acceptor distances with respect to each other and the protein, and have 
B-parameters of <65 A2. 
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Results 
General Features of Metal-Product Complexes of FBPase. Recombinant wild-type 
FBPase that is used here is free of proteolysis, and is greater than 95% pure on the basis 
of SDS-PAGE (data not shown). 
Crystals grown in the presence of AMP belong to space group ?2\2\2 (Zn2" 
complex, a = 60.12 A, b = 166.14 A, and c = 79.53 A; Mg2" complex, a = 59.86 A, b = 
165.92 A, and c = 79.51 Â), and are isomorphous with respect to those reported by 
Lipscomb and co-workers (16). Two subunits of FBPase are in the asymmetric unit of 
this crystal form. Ca coordinates of the independent subunits superimposed (excluding 
residues 63-70) with a root-mean-square deviation of 0.20 A. The two subunits are 
identical to within experimental uncertainty. As noncrystallographic restraints were not 
used in the refinement, the deviation reported above is a reasonable estimate of 
coordinate uncertainty. The enzyme is in the canonical T-state (16). AMP occupies the 
allosteric pocket, and P;, F6P, and one metal cation (either Zn2" or Mg2") occupy the 
active site (Figure 2). Regions of weak or absent electron density include residues 1-8 
and 63-70. The model begins at residue 9 and continues to the last residue of the 
sequence, but residues 63-70 are unreliable, as evidenced by high thermal parameters. 
When residues 63-70 are excluded, thermal parameters vary from 5 to 52 Â2. 
Crystals grown in the absence of AMP belong to space group 1222 (Zn2" complex, 
a = 52.34 A, b = 82.82 A, and c = 165.77 A; Mg2" complex, a = 52.12 A, b = 82.51 A, 
and c = 165.49 A). Failure to detect systematic absences, because of an error in a 
commercial software package, led to the initial space group assignment of P2%2i2 (a = 
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FIGURE 2: Stereoviews of a single FBPase subunit in the T- and R-states. The subunit 
here is in the orientation of subunit C2 of Figure 1. Loop 52-72 is engaged with the 
active site (top), whereas loop 52-72 is disengaged from the active site in the T-state 
(bottom). Residues 63-70 of the T-state are known only approximately from crystal 
structures. This figure is drawn with MOLSCRIPT (38) and RASTER3D (39). 
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52.34 À, b = 165.77 À, and c = 82.82 Â), reported by Choe et al. (23). Evaluation of the 
packing of FBPase tetramers and inspection of the data clearly indicate the 
higher-symmetry space group. The Zn2"-product structure reported by Choe et al. (23) is 
not changed, but the statistics of refinement (due to the rejection of systematic absences) 
are much improved in the new space group. The enzyme is in the R-state, but has an 
ordered loop 52-72, associated with the active site (Figure 2). P; occupies the allosteric 
pocket, binding to the 5'-phosphoryl site of AMP, and Pi, F6P, and either two Mg2" or 
three Zn2" ions occupy the active site. The model begins at residue 7, with weak or 
absent electron density for residues 1-6 and 22-25. When these regions of weak or absent 
electron density are excluded, thermal parameters vary from 5 to 67 A2. Conformational 
differences relevant to the structure and function of FBPase are discussed below. 
Statistics for data collection and refinement for all the structures are given in 
Table 1. Uncertainty in coordinates is approximately 0.25 À. The models have 
stereochemistry generally better than what is typical for structures of a nominal resolution 
of 2.0 A, as determined by PROCHECK (29). 
Metal-Product Complexes of FBPase in the T-State. In the presence of AMP, the 
Mg2+-product and Zn2-r-product complexes adopt identical global conformations, similar 
to T-state structures of FBPase reported by other investigators (16, 30-32). Nonetheless, 
the structures here represent the first instances of product complexes of FBPase in the 
T-state, and as such are necessary complements to product complexes of FBPase in the 
R-state. 
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Table 1 : Statistics of Data Collection and Refinement 
R-state Zn2+ R-state Mg2" T-state Zn2+ T-state Mg2" 
resolution limit (Â) 2.27 2.32 2.23 2.28 
no. of reflections 72666 72680 119374 122394 
no. of unique reflections 15519 15014 36815 35127 
completeness (%) of data set 99 99 99 99 
completeness (%) of last shell 90 96 94 95 
(approximately 2.3-2.4 Â) 
Rsym 0.055 0.078 0.106 0.083 
no. of reflections used in 12016 11506 27861 27847 
refinement6 
no. of atomsc 2749 2718 5473 5512 
no. of solvent sites 194 164 389 428 
R-factor* 0.170 0.187 0.217 0.197 
Rte 0.220 0.238 0.271 0.255 
mean B (A2) 
protein 16 22 24 21 
active site ligands (F6P/Pj/metals) 7/9/17 19/35/21 17/29/19 18/51/22 
allosteric site ligands (AMP or P.) 33 39 26 17 
root-mean-square deviations 
bond lengths (Â) 0.005 0.006 0.007 0.007 
bond angles (deg) 1.30 1.31 1.36 1.34 
dihedral angles (deg) 23.2 22.9 23.8 23.6 
improper dihedral angles (deg) 0.77 0.76 0.81 0.80 
aRsym = Sj Zi 11 ij - < I j > | / li Ej Iij, where i runs over multiple obervations of the same 
intensity, and j runs over all crystallographically unique intensities. 
bAll data in the resolution ranges indicated. 
c Includes hydrogens linked to polar atoms. 
R&ctor= S || Fobs |~ | Fcalc II / S | Fobs |, | Fobs | > 0. 
"R&ctor based upon 10% of the data randomly culled and not used in the refinement. 
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In the T-state, AMP binds to the allosteric pocket, and is covered by strong 
electron density. The AMP molecule is in the anti conformation (% = - 166°), with a 
3-endo ribosyl group (a pseudo puckering angle of 9°), and an 05I-C5,-C4'-C3' torsion 
angle (y) of 56°. A sphere of distinct electron density appears between N-7 of the purine 
base and the S'-phosphoryl group of AMP in each of the symmetry unique subunits of the 
T-state complexes. Thermal parameters for water molecules refined here averaged to 
approximately 22 Â2. In the crystal structure of an AMP complex of recombinant human 
FBPase, AMP binds to its allosteric pocket in the anti conformation with a water 
molecule between N-7 of the purine base and the 5-phosphoryl group (32). In crystal 
structures of natural and recombinant pig kidney FBPase (the amino acid sequence of 
which is identical to that of recombinant porcine FBPase), the AMP molecule is present 
in an anti conformer, a syn conformer, or an equally weighted mixture of syn and anti 
conformers with no water molecule bridging the N-7 and y-phosphoryl groups (16, 17, 
31). Reported instances of syn conformers may reflect the inherent difficulty of 
interpreting electron density from low-resolution diffraction data. Electron density from 
a water molecule near the N-7 atom could merge with the purine base of AMP, leading to 
the assignment of a syn conformer. Alternatively, the presence of a bridging water 
molecule between the purine base of AMP and its 5-phosphoryl group may be sensitive 
to conditions of crystallization. 
F6P binds to the active site as the p-anomer in both the Mg2* and Zn2* complexes, 
but only in the Mg2* complex is the 1-OH group coordinated to the cation at site 1 
(Figures 3 and 4). The coordination of the 1-OH group to the site 1 metal was not 
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Table 2: Selected Distances to Metal Ions and P, in Product Complexes of FBPase 
distance (À) 
R-state R-state T-state T-state 
interaction Zn2+ Mg2+ Zn2+ Mg2' 
metal site 1 
Pi 02 2.01 2.00 2.14 1.98 
AspI18 0D1 1.88 2.23 2.27 2.07 
Aspl21 ODI 2.17 1.90 1.87 2.08 
Glu280 OEI 2.07 2.08 2.19 2.08 
F6P01 4.99 2.28 4.73 2.29 
metal site 2 
Pi 02 2.35 2.31 
Pi 03 2.20 2.37 
Glu97 OEI 1.95 2.24 
AspllS 0D2 2.14 2.09 
Leu120 0 2.35 2.06 
water 2.28 2.17 
metal site 3 
Pi 03 2.47 
Pi 01 2.14 
Asp68 0D2 2.38 
Glu97 0E2 2.38 
Pi, or 
F6P01 2.68 3.05 2.62 2.82 
Arg276 N112 2.92 2.72 3.17 6.80 
Asp68 0D2 3.20 3.37 18.26 18.67 
GIu97 OEI 3.93 3.44 3.20 3.22 
Pi 02° 
Glu97 3.13 3.28 
Arg276 3.45 3.58 3.11 8.69 
water 3.15 
Pi 03° 
Serl23 OG 4.43 2.80 4.13 3.43 
water 2.77 2.87 
Pi 04 
F6P02 2.63 3.33 2.78 3.40 
Glyl22N 2.91 3.04 3.02 2.73 
Glyl23 N 2.86 2.83 3.00 2.67 
" Does not include coordination to metal sites listed above in the table. 
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FIGURE 3: Stereoviews of the active site for T- and R-state, Zn2+-product complexes. 
The R-state has three metal cations (top). The T-state has one metal cation at site 1 
(bottom). Dashed lines represent donor-acceptor interactions or coordinate bonds. Bold 
lines represent ligands; (F6P and Pi). The 1-OH group of F6P does not coordinate to the 
cation at site 1. 
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FIGURE 4: Stereo views of the active site for T- and R-state, Mg2+-product complexes. 
The R-state has two metal cations at sites 1 and 2 (top). The T-state has one metal cation 
at site I (bottom). Dashed lines represent donor-acceptor interactions or coordinate 
bonds. Bold lines represent ligands (F6P and Pi). The 1-OH group of F6P makes a 
coordinate bond to the Mg2* at site 1. 
86 
observed either in the R-state, Zn2*-product complex (23) or in substrate-analogue 
complexes of FBPase (20). The significance of this coordination is discussed below. Pi 
binds to the putative l-phosphoryl site of FI6P2, directly coordinating the divalent cation 
(either Mg2" or Zn2*) at metal site I. Pi and F6P retain many of the hydrogen bonds and 
nonbonded contacts observed in the R-state, metal product complexes. Metal cations, 
however, do not occupy sites 2 and 3 in the T-state complexes. Loop 52-72, which 
putatively mediates allosteric inhibition by AMP, is disordered. Asp68 of loop 52-72 no 
longer hydrogen bonds with Arg276, a residue important for catalysis (33). Asp74, an 
essential catalytic residue (34), is poorly ordered, and does not hydrogen bond with 
backbone amide 71. As the major difference in crystallization conditions for the R- and 
T-state complexes reported here is the concentration of AMP (either 0 or 5 mM, 
respectively), the displacement of loop 52-72 and metal cations from the active site must 
result from AMP ligation of the allosteric pocket. 
Metal-Product Complexes of FBPase in the R-State. Loop 52-72 is in the engaged 
conformation (23) in each of the R-state complexes reported here. Even so, at least two 
significant differences exist between the Zn2*-product and Mg2*-product complexes. As 
noted previously for the Zn2+-product complex (23), the 1-OH group of F6P is not in the 
proper orientation for a nucleophilic attack on the Pi molecule. In the Mg2+-product 
complex, however, the 1-OH group coordinates directly to the metal at site 1, as it does in 
its T-state complex, and is positioned ideally with respect to the P; molecule for a 
nucleophilic displacement reaction (Figure 5). The distance separating the 1-oxygen 
atom of F6P and the phosphorus atom of Pi is 2.9 Â (in the T-state, which has two 
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FIGURE 5: Stereo view of electron density from a 2Fd*- F«ic map covering active site 
ligands of the R-state, Mg2+-product complex. The contour level is 1 o with a cover 
radius of 1.5 A. The black dot represents the location of metal site 3 in the Zn2*-product 
complex. Dashed lines indicate atoms proximal to this site, with distances varying from 
2 to 2.5 Â. The density labeled OW#2 may be a water molecule or a KT at low 
occupancy. 
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subunits per asymmetric unit, the corresponding distances average to 3.2 ± 0.1 A). Hence, 
unlike the Zn2+-product complex, the Mg2+-product complex should be catalytically 
viable, even in the crystalline state. 
The second major difference between the R-state complexes regards metal 
binding to the active site. In the Zn2"-product complex, divalent cations are present at full 
occupancy at three sites (Figure 3). Metals at sites 1-3 coordinate directly to Pj at the 
l-phosphoryl site of FI6P2. In the Mg2--product complex, however, divalent cations 
occupy sites 1 and 2, both of which coordinate to Pi (Figure 4). Electron density in the 
Mg2"-product complex, which coincides with metal site 3 in the Zn2*-product complex, 
appears as an extension of density from the Pi molecule (Figure 5). The electron density, 
here, could reflect the presence of Mg2" at low occupancy, or be simply a noise artifact. 
A sphere of electron density, located approximately 2 Â away from the location of metal 
site 3 (as defined in the Zn2+-product complex), however, could represent a water 
molecule or an alternative cation binding site (Figure 5). A water molecule, here, must 
bond exclusively as a proton donor and tolerate several nonbonded contacts involving 
oxygen atoms from the protein (Asn64, Asp68, Asp74, and Glu98) and/or the bound P, 
molecule. Alternatively, the electron density could represent bound K* at low 
occupancy. On the basis of kinetics, the affinity constant for K* in the presence of 5 MM 
Mg2+ is approximately 25 mM, whereas the concentration of K+ (present as a counterion 
of Pi) is 10 mM. 
More subtle differences between the R-state Mg2* and Zn2" complexes extend 
beyond metal site 3 and the coordination of the 1-OH group of F6P by the metal at site 1. 
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The conformations of Arg276 and Glu97 differ modestly in the two complexes. Serl23 
hydrogen bonds with Pi in the Mg2*-product complex, and the side chain of Lys71 is in 
weak electron density; on the other hand, in the Zn2"-product complex, Serl23 hydrogen 
bonds to the side chain of Lys71. Finally, the fbranosyl moiety of F6P occupies positions 
differing by approximately 0.2 À in the two R-state complexes. Alone, the differences 
described above could be attributed to coordinate uncertainty and/or an artifact of 
refinement; however, taken together, they probably represent real differences in the 
Mg2*- and Zn2+-coordinated active sites. 
Even though site 3 is largely unoccupied by metal in the Mg2*-product complex, 
the side chain of Asp68 and the bound P, molecule are within 0.2 Â of their respective 
positions in the Zn2~-product complex. In fact, the side chain of Asp68 and the Pi 
molecule may be at times hydrogen bonded to each other in the absence of metal (donor 
acceptor distance of 3.4 Â). The significance of a shared proton between Asp68 and the 
Pi molecule is discussed below. 
Discussion 
The structures presented here confirm the main features of a model for allosteric 
regulation of catalysis in FBPase proposed by Choe et al. (23). AMP alone displaces 
loop 52-72 from its engaged conformation and abolishes metal association with sites 2 
and 3 (Figure 2). Studies in kinetics (11), fluorescence (18), and NMR (19) consistently 
reflect competition in the binding of AMP and metal cations to FBPase. The work here 
confirms the mutually exclusive relationship between metal cation and AMP association 
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with FBPase, at least in the presence of bound products. The structures implicate AMP in 
the release of metal cations only from sites 2 and 3. The metal cation is present at site 1 
regardless of AMP ligation and the conformation of loop 52-72. Conceivably, metal 
cation affinity is reduced for site 1 in the T-state, but the conditions employed here (5 
mM Mg2* or 2 mM Zn2") do not permit a quantitative measure of binding affinities for 
cations. 
Heretofore, we have considered only two conformational states for FBPase: 
disengaged loop, T-state or engaged loop, R-state. Loop 52-72 can be disengaged, 
however, in the R-state as well, especially in the absence of metal cations (17). The 
disengaged loop in the R-state is disordered entirely from residues 52 to 72, in contrast to 
the disengaged loop of the T-state, which is disordered only from residues 63 to 70. 
Hence, T-state FBPase selects a specific conformation for residues 52-62, which is 
incompatible with an engaged loop conformation. The key interactions here include 
nonbonded contacts between IlelO of an adjacent subunit of the tetramer with residues 
52-55 (Figure 6). 
The binding of AMP to the allosteric, effector site sets into motion a series of 
conformational changes, which transform FBPase from an engaged loop, R-state 
conformation to a disengaged loop, T-state conformation. The mechanism by which 
AMP promotes the R- to T-state transition has been analyzed by Zhang et al. (15). AMP 
triggers a conformational change in the connecting loop between helices HI and H2, 
which in turn facilitates new interactions across the C1-C4 interface of the T-state (such 
as the hydrogen bond between Thr27 and Arg22). Evidently, the conformational 
FIGURE 6: Schematic of the interaction between loop 52-72 and the N-terminal segment 
of an adjacent subunit. The orientation of the C3-C4 subunit pair is consistent with that 
of Figure 1. 
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response requires the entire AMP molecule, as the enzyme remains in an R-state 
conformation, even though P; saturates the binding site for the S'-phosphoryl group of 
AMP. 
The concentration of Mg2* employed here is comparable to that used in assays of 
FBPase activity. The concentration of K* (approximately 10 mM), however, is well 
below the affinity constant for K* activation (25 mM), measured in the presence of 5 mM 
Mg2+. We do not expect then appreciable levels of bound K~ in the Mg2"-product 
complex. As sites 1 and 2 are completely occupied by Mg2*, whereas site 3 is virtually 
unoccupied, we tentatively regard site 3 as the locus for K~ association. Other studies 
also implicate site 3 in monovalent cation activation. Chemical modification of an 
arginine abolishes K~ activation (35). Arg276 and Arg313 are 3.9 and 8.3 A, 
respectively, from metal site 3. T-State crystals, grown in the presence of 500 mM KC1, 
reveal three K* binding sites (30), which superimpose approximately on the three metal 
sites reported here in R-state product complexes. Mutations, which destabilize an 
engaged loop 52-72, also abolish K+ activation and increase the Mg2* affinity constant (S. 
Nelson, J.-Y. Choe, R. B. Honzatko, and H. J. Fromm, unpublished observations). Of the 
three metal sites, loop 52-72 interacts directly with the cation at site 3 only. 
The zinc cation binds to site 3 at a concentration of 5 mM in R-state, product 
complexes, perhaps due to its high affinity for Pi relative to that of Mg2+ and K* Mg2* 
may also bind to site 3 at concentrations of >5 mM, but in kinetic assays, such levels of 
magnesium cation cause inhibition. Indeed, Zn2* is nearly as effective as Mg2* in 
supporting FBPase catalysis, but at the high concentration of zinc used here, enzyme 
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activity is well below its optimal level (J.-Y. Choe, H. J. Fromm, and R. B. Honzatko, 
unpublished observations). Inhibition of FBPase at high Mg2* and Zn2" concentrations 
may originate in part from the binding of metal cation to site 3, as observed in the 
Zn2*-product complex. A cation at site 3 could impair a proton-transfer step in the 
catalytic mechanism, as discussed below. 
If a metal at site 3 is indeed inhibitory, then from which site does potassium 
enhance FBPase activity? K* could coordinate oxygen atoms from Pi, Asn64, Asp68, 
Asp74, and/ or Glu98 (Figure 7). In the Mg2"-product complex, electron density at this 
site, tentatively assigned to a water molecule, can support two hydrogen bonds (three 
hydrogen bonds in the case of a hydronium ion). K* can support more interactions than a 
water molecule, and could stabilize an active site with a superior arrangement of 
functional groups. We emphasize here, however, that this proposed site of K" interaction 
is not identical to metal site 3 of the Zn2*-product complex. Small cations, such as Lf 
and Zn2\ may bind to metal site 3 and cause inhibition, whereas large cations (K*, NKT, 
and IT"), which enhance catalysis, may bind to the more spacious site in place of the 
observed water molecule. Product complexes of FBPase, cocrystallized with Mg2* and 
monovalent cations under conditions similar to those used in kinetic assays, may further 
clarify the role of the third metal site in the catalytic mechanism of FBPase. 
The direct coordination of the 1-OH group of F6P to the Mg2"1" at site 1 implicates 
that metal cation in the catalytic mechanism of FBPase. In contrast, Zn2' at site 1, 
perhaps because of its small ionic radius relative to Mg2* may not easily accept the 1-OH 
group of F6P as a fifth coordinating ligand. Mg2* at site 1 probably stabilizes the 
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FIGURE 7: Model for the K*-ligated active site of FBPase in the R-state. K can interact 
with several oxygen atoms, but the means by which it enhances catalysis is uncertain. 
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product complex: (A) F16P2 complex, (B) transition state, and (C) product complex. See 
the text for farther explanation. 
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development of negative charge on the 1-oxygen atom of FI6P2 in the forward reaction 
and the same atom of F6P in the reverse reaction. Hence, the metal at site 1 in productive 
complexes may be five-coordinate. The Mg2" at metal site 2, however, is six-coordinate 
(Table 2), and probably has two water molecules in its inner sphere at the onset of the 
forward reaction (Figure 8). Asp74 and GIu98, both essential to catalysis at pH 7.5 (34, 
37), hydrogen bond to one of two water molecules coordinated to the Mg2* at site 2. That 
water molecule acts as a catalytic base in the abstraction of a proton from the second 
coordinated water molecule (which could be a hydroxide ion at higher pH). The resulting 
hydroxide anion is the attacking nucleophile in the displacement of F6P. Charge on the 
1-oxygen atom of F6P is stabilized by its coordination to the Mg2* at site 1. In addition, 
we suggest the presence of a proton on the 1-phosphoryl group of F16P2, shared in a 
hydrogen bond with Asp68 prior to the start of the reaction, which moves to the 1-oxygen 
atom of F6P late in the transition state. Hence, a small cation (such as Mg2*, Zn2* or Li*), 
interacting with the 1-phosphoryl group and Asp68, as observed in the Zn2*-product 
complex, would displace this proton and impair the mechanism of proton transfer. The 
role of the monovalent cation, then, may be to maintain Asp68 in proximity to the 
1-phosphoryl group of FI6P2, without directly coordinating either functional group. 
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CHAPTER 4. INTERACTION OF TL+WITH PRODUCT 
COMPLEXES OF FRUCTOSE-l,6-BISPHOSPHATASE 1 
A paper to be submitted in Biochemistry 
Jun-Yong Choe, Scott W. Nelson, Herbert J. Fromm, and Richard B. Honzatko 2 
Abstract 
Fructose-1,6-bisphosphatase (FBPase) requires divalent cations (Mg2", Mn2", or 
Zn2~) for catalysis, but a diverse set of monovalent cations (K", Tf, Rb", or NH»") will 
further enhance enzyme activity. Previous crystallographic investigations examined 
interaction of monovalent cations with inactive (divalent cation absent) and/or inhibited 
(AMP present) FBPase. Here, the interaction of Tl" with FBPase is explored under 
conditions that support catalysis. In initial velocity kinetics, Tl" enhances catalysis by 20% 
with a AT, of 1.3 mM and a Hill coefficient near unity. Crystal structures of 
Mg2+/"H7product-FBPase complexes, in which the concentration of Tl" is 1 mM or less, 
reveals Mg2* at metal sites 1, 2 and 3 of the active site, but little or no bound Tl". 
Intermediate concentrations of Tl" (5—20 mM) displace Mg2* from site 3, loop 52—72 
1 This work was supported in part by National Institutes of Health Research Grant 
NS-10546 and National Science Foundation Grant MCB-9603595. This is Journal Paper 
J-18833 of the Iowa Agriculture and Home Economics Experiment Station, Ames, Project 
3191, and is supported by Hatch Act and State of Iowa funds. 
2 Corresponding author. Telephone: (515) 294-6116. Fax: (515) 294-0453. E-mail: 
honzatko@iastate.edu. 
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from its engaged conformation, the 1-OH group of fructose 6-phosphate from an in-line 
geometry with respect to the bound orthophosphate. At 100 mM Tl*, metal site 1 becomes 
unoccupied. Tl* does not bind to metal sites 1 or 2 in the presence of Mg2*, but for all Tl* 
concentrations equal to or in excess of 5 mM, Tl* occupies 4 other sites. Tl* does not 
saturate any of these sites, and in fact the sum over Tl" occupancy factors is approximately 
unity, suggesting significant antagonism amongst the Tf binding sites. The significance of 
the Tl* complexes to the functional properties of FBPase is discussed. 
Introduction 
Fructose-1,6-bisphosphatase (FBPase1, EC 3.1.3.11) hydrolyzes fructose 1,6-
bisphosphate (FI6P2) to fructose 6-phosphate (F6P) and phosphate (Pi) (1-6). The enzyme 
plays a central role in gluconeogenesis, and is inhibited allosterically by AMP, the binding 
of which is cooperative with a Hill coefficient of 2 (7-9). Fructose 2,6-bisphosphate 
(F26P2), which binds with high affinity to the active site, inhibits FBPase synergistically 
with AMP (10-12). Divalent cations (Mg2*, Mn2* and/or Zn2*) are an absolute requirement 
for FBPase activity. Enzyme activity increases sigmoidally as a function of divalent cation 
concentration at pH 7.5 (Hill coefficient of approximately 2), but at pH 9.6 the variation is 
hyperbolic (8,14). 
The mammalian enzyme is a homotetramer, which exists in distinct conformational 
states, depending on the relative concentrations of active site ligands and AMP (15). With 
or without metal cofactors and/or other active-site ligands, but in the absence of AMP, 
FBPase is in its R-state (16,17). In the presence of AMP, however, the top pair of subunits 
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rotates 17° relative to the bottom pair, resulting in the T-state conformer (18-20). The 
minimum distance separating AMP molecules from any given active site is approximately 
28 Â (18-20). Yet studies in kinetics, NMR, fluorescence, and X-ray crystallography 
reveal competition between AMP and Mg2* divalent cations (11,20-22). Significant 
evidence now indicates the participation of loop 52—72 in mediating allosteric inhibition 
of catalysis by AMP. Loop 52—72 can adopt engaged, disordered and disengaged 
conformations (17,20,23). The engaged conformation is arguably required for binding 
divalent cations with high affinity and in stabilizing the transition state (17,23-26). The 
disordered conformation of the loop may facilitate product release and substrate 
association. In the R-state the loop oscillates between engaged and disordered 
conformations. The T-state, however, favors a single (disengaged) conformation for the 
loop, which cannot stabilize divalent cation association at the active site. Interactions 
between the loop and residues near the N-terminus of an adjacent subunit play an important 
role in stabilizing the disengaged conformation of the loop (23). 
In addition to the absolute requirement for divalent cations, certain monovalent 
cations (K* and Tf among others) further enhance catalysis by FBPase (3,5,13). The 
precise mechanism by which monovalent cations exert their influence, however, has yet to 
be determined. Monovalent cation activation is in some fashion related to loop 52—72. If 
mutations of specific residues of the dynamic loop increase the AT, for Mg2*, then so far 
without exception, K* no longer enhances catalysis (25,26). On the other hand, K* does 
not increase the fraction of total subunits with an engaged loop in the presence of saturating 
Mg27F6P/Pi (26). Hence, improved catalysis comes not from an increase in the fraction of 
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subunits with an engaged loop, but rather from a more stable transition state in the presence 
ofK*. 
Previous work of Lipscomb and co-workers (27) focused on the association TF and 
K* with FBPase in the absence of divalent cations and/or in the presence of AMP. Under 
these conditions FBPase is certainly inactive. The investigation clearly shows the 
association of Tf and K" at metal loci 1, 2 and 3, usually the observed binding sites for 
essential divalent activators. But how do monovalent cations interact with FBPase under 
conditions that support catalysis? Presented below are a series of product complexes of 
FBPase in the presence of Mg2* and Tf. FBPase here is co-crystallized from an 
equilibrium mixture of products and reactants, containing Mg2* at a saturating 
concentration and Tl* ranging from zero to 70-fold in excess of its observed ATa value. 
Under these conditions of crystallization FBPase is active. In the presence of Mg2", Tf no 
longer occupies metal sites 1 and 2, but interacts at four sites, three of which have not been 
observed in cation complexes of FBPase. 
Experimental Procedures 
Materials— FI6P2, F26P%, NADP* and AMP were purchased from Sigma. Glucose-6-
phophate dehydrogenase and phosphoglucose isomerase came from Roche. Other 
chemicals were of reagent grade or equivalent. The FBPase-deficient Escherichia coli 
strain DF657 came from the Genetic Stock Center at Yale University. 
Expression and Purification of FBPase— Expression and purification of FBPase followed 
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the procedures of Burton et al. (28) with minor modification (20). E. coli strain DF657, 
deficient in FBPase, was used in order to avoid contamination of recombinant FBPase by 
endogenous enzyme. Protein purity and concentration was confirmed by SDS-PAGE (29) 
and by the Bradford assay (30), respectively. 
Crystallization of FBPase— Crystals of FBPase were grown by the method of hanging 
drops. Crystals of R-state complexes grew from equal parts of a protein solution [10 
mg/mL FBPase, 10 mM KP; (pH 7.4), 5 mM MgCfe, 5mM F6P, with or without 0.1 mM 
EDTA, in different concentrations of thallium acetate (0, 1, 5, 20, or 100 mM)] and a 
precipitant solution [100 mM Hepes (pH 7.0), 5% of tertiary-butyl alcohol, 27% (v/v) of 
glycerol, and 8% (w/v) polyethylene glycol 3350]. Crystals of T-state complexes grew 
from [10 mg/mL FBPase, 10 mM KP, (pH 7.4), 5 mM MgCl?, 20 mM of thallium acetate, 5 
mM F6P, and 5 mM of AMP] and a precipitant solution [100 mM Hepes (pH 7.0), 5% of 
tertiary-butyl alcohol, and 10 % (w/v) polyethylene glycol 3350]. The droplet volume was 
4 nL. Wells contained 500 |iL of the precipitant solution. Crystals with dimensions of 0 .2 
mm x 0.2 mm x 0.2 mm grew in three days at room temperature. Conditions of 
crystallization for R-state FBPase differ from those of previous studies (17,20), and result 
in crystals that in some cases diffract to near atomic resolution (see below). 
Data Collection— Data from FBPase complexes with 20 mM Tf (T-state and R-state) 
were collected at synchrotron beam line X12C, Brookhaven National Laboratory, using a 
CCD detector developed by Brandeis University, at a temperature of 100 K. The energy 
(12658 eV) of X-rays coincided with the atomic absorption edge ofTT. Data from the 
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crystalline complex with 1 mM of Tf were collected at synchrotron beam line X4A, 
Brookhaven National Laboratory on an ADSC, CCD detector at a temperature of 100 K 
and an energy of 12658 eV. Data from the crystalline complex with 100 mM Tf were 
collected at synchrotron beam line 14BM, APS-BioCars, Argonne National Laboratory, on 
an ADSC, CCD detector at a temperature of 100 K and an energy of 12658 eV. All Tf 
complexes co-crystallized in the presence of 100 |iM EDTA and 5 mM Tl* without EDTA 
were collected on an R-AXIS FV*7Rigaku rotating anode at a temperature of 100 K, using 
CuK<% radiation, passed through an Osmic confocal mirror system. Data from synchrotron 
sources were reduced and scaled by Denzo/Scalepack (31). Data from the R-AXIS IV" 
were processed with CrystalClear (32). 
Structure Determination, Model Building, and Refinement—Crystals grown for this study 
are isomorphous to PDB code leyi (R-state) or leyj (T-state). Structure determinations 
were initiated by molecular replacement using calculated phases from either leyi or leyj. 
Electron density maps were calculated using the program CNS (33). For structures 
reported here, the anomalous data set was accepted only if it resulted in significant 
anomalous difference density at the positions of sulfur and phosphorus atoms. 
Modifications to structural models were done through XTALVIEW (34). Models were 
refined against X-ray data using CNS with force constants and parameters of 
stereochemistry from Engh and Huber (35). Final cycles of refinement used SHELX (36) 
with restraints on bond and angle distances. B-parameters of Tl* were fixed to averages 
over B-parameters of coordinating side-chains. Occupancies of Tl* were refined with 
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SHELX, and confirmed in XTALVIEW against 2Ç*s-5aic omit maps and anomalous 
diflFerence maps. 
Kinetic experiments— Assays employed the coupling enzymes, phosphoglucose isomerase 
and glucose-6-phosphate dehydrogenase (1). The coupling enzymes were dialyzed 
exhaustively in order to remove NHf. Thallium acetate solutions were prepared 
immediately prior to their use in assays. Tf up to a concentration of 15 mM had no effect 
on the coupling enzymes. Assays were initiated by the addition of magnesium acetate 
(final concentration of 5 mM), instead of magnesium chloride, to avoid the precipitation of 
TTbyCr. The concentration of FI6P2 in all assays was 20 |iM. The reduction of NADP* 
to NADPH was monitored spectroscopically at 340 nm. Concentrations of T1+ were 0.0, 
1.0, 1.5, 2.0, 2.5, 3.0, 5.0, 8.0 and 10.0 mM. All kinetic assays were performed at room 
temperature in triplicate. Initial rates were determined using ENZFITTER (37). The Hill 
coefficient for TT-activation came from a least squares fit of the following: 
V={VmS ,!(Kt + S")] + 3.0863, 
where V is the observed initial velocity at a specific concentrations of Tf, S is the 
concentration of Tf, n is the Hill coefficient, K» is the affinity constant for Tf, and 3.0863 
is the initial velocity of the reaction in the absence ofTf. 
Results 
Purity of FBPase and the Influence of TV on Kinetics—FBPase used here migrates as a 
single band on SDS-PAGE, and exhibits no evidence of proteolysis. A previous report 
regarding Tf activation of FBPase from mouse liver neither provided experimental details 
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nor indicated whether TT-activation was cooperative (38). TT does not influence the 
coupling enzymes of the assay system, hence the rate of formation of NADH is directly 
related to the rate of formation of F6P. The maximum level of Tl'-activation for the 
recombinant porcine enzyme is 20%, with a Hill coefficient of 1.15±0.09 and a K* of 
1.3±0.1 mM. (The ATa for mouse liver enzyme is 16 mM). At TF concentrations in excess 
of 15 mM, the specific activity of FBPase declines. Maximal IC-activation for the 
recombinant porcine enzyme is 18% (26), with a Hill coefficient of unity and a K* of 17 
mM (39). 
Quality of Crystals— Conditions of crystallization of R-state FBPase differ from those 
employed in past work (17,20) in two respects: (/) FI6P2 replaces F6P/Pi and (/'/) glycerol is 
present as a cryo-protectant. Co-crystallization with substrate, rather than products, should 
not alter the results. The enzyme is active under the conditions of crystallization, and thus 
products and substrates should be at their equilibrium concentrations regardless of the 
starting conditions. The addition of glycerol (27% v/v) and the reduced concentration of 
polyethylene glycol 3350 (from 10% to 8% w/v), however, has resulted in an unexpected 
dividend. Crystals, grown in the absence of glycerol, exhibit a wide variation in X-ray 
diffraction properties after exposure to glycerol and rapid freezing in liquid nitrogen. 
Crystals soaked in glycerol are fragile, and become disordered in 9 out of every 10 
instances. On the other hand, FBPase crystals grown in the presence of glycerol undergo 
rapid freezing with reproducible results. Under the new conditions of crystal growth, R-
state, FBPase crystals can diffract to 1.3 Â resolution, whereas previous crystals exhibit 
diffraction to 2.3 Â. The co-crystallized Tl* complexes reported below have a resolution 
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limit of 1.8 A. The reduced resolution probably arises from the combination of several 
distinct complexes within the same crystal that differ by their sites of TP-association (see 
below). 
In all structures reported below, save the Tf/Mg27AMP/product complex, FBPase 
crystallizes in the same space group (1222) and in isomorphous unit cells (Table 1). The 
enzyme is in its R-state, with dynamic loop 52—72 in an engaged conformation, as defined 
previously by Zn2*/product complex (17,20). In the engaged conformation the side-chain 
of Tyr57 occupies its hydrophobic pocket (26). We observed no significant differences in 
the presence and absence of 0.2 mM EDTA. In the T17Mg27AMP/product complex, 
FBPase adopts a T-state global conformation, with a disengaged loop 52—72 (20). As 
these complexes have been reported in detail in prior publications (17,20), we focus here 
on changes in the active site in response to different conditions of crystal growth. 
The choice of wavelength here optimizes anomalous scattering from Tf without 
introducing an anomalous signal from Mg2*. At an energy of 8040 eV (X=1.524 A), 
thallium and magnesium have f of -4.03 and 0.172 electrons, respectively, and f1 of 8.12 
and 0.177 electrons, respectively. At an energy of 12658 eV (X=0.979 Â), thallium and 
magnesium have f of -18.9 and 0.0876 electrons, respectively, and f' of 3.93 and 0.0714 
electrons, respectively (40). (f and f' are the real and imaginary components of anomalous 
scattering from a specific atom). So magnesium contributes virtually nothing to anomalous 
scattering, and in fact no anomalous difference density appears at the metal-binding loci of 
Mg2* complexes, even though distinct anomalous difference density appears at sulfur 
atoms (data not shown). Thallous ions bound at low fractional occupancy (0.1, for 
110 
Table 1. Statistics of data collection and refinement. Mg2* is present in all complexes at 5 
mM. 
Tl" concentration (mM) 0* 1* 5' 20* 100' lb 5b 20b 20= 
Resolution limit (À) 1.9 1.8 1.9 2.1 2 1.9 1.9 2.15 2.15 
Wavelength of X-rays 1.5415 0.9795 1.5415 0.9795 0.9795 1.5415 1.5415 1.5415 0.9795 
Space group 1222 1222 1222 1222 1222 1222 1222 1222 P2,2,2 
No. of measurements 170156 238835 288138 92869 97976 182349 172612 163129 293146 
No. of unique refl. 26098 30311 28039 17604 20719 26022 27106 19545 40229 
Completeness of data (%): 
Overall 89.2 87.4 95.9 86.5 82.8 89 92.9 99.9 99.9 
Last shell 49.2 86.8 69.9 43.7 49.2 48.8 61.3 99.1 99.9 
RV 0.038 0.075 0.023 0.03 0.052 0.024 0.021 0.071 0.104 
No. of refl. in 
refinement6 24351 28983 26216 15652 18341 24246 25343 18552 38218 
No. of atomsf 2723 2815 2737 2787 2689 2743 2765 2710 5519 
No. of solvent sites 183 253 176 211 146 199 197 165 425 
R-factor* 0.1927 0.2001 0.1968 0.1703 0.2042 0.1843 0.1915 0.2108 0.1824 
Rftee* 0.2461 0.2471 0.2559 0.2487 0.2661 0.2366 0.2453 0.2801 0.2511 
Mean B (À2): 
Entire protein 28.2 24.6 25.8 28.2 28.6 24.8 25.8 32.6 24.4 
Residues 61—69 51 50 61 96 82 51 69 94 90 
Root-mean-squared deviations: 
Bond lengths (A) 0.007 0.008 0.007 0.006 0.006 0.007 0.007 0.006 0.006 
Bond angles (deg.) 1.9 1.9 1.8 1.7 1.8 1.8 1.9 1.8 1.8 
Ill 
Table 1. (Continued) 
Dihedral angles (deg.) 25.6 24.8 24.6 24.9 25.2 25.1 25 25.3 25.7 
Improper angles 
(deg.) 1.33 1.27 1.25 1.28 1.23 1.24 1.27 1.27 1.71 
Metal site occupancies: 
Site 1, Mg:YTl* 100/0 84/10 95/6 58/3 0/0 80/10 75/5 78/2 100/0 
Site 2, Mg2YrT 100/0 100/0 68/5 50/7 100/0 80/3 82/4 60/8 0/15 
Site 3, Mg2" 50 10 0 0 0 40 0 0 0 
Site 3a, Tl* 0 0 11 30 33 0 13 30 15 
Site 3b, Tl" 0 0 10 18 18 4 10 17 10 
Site 4, Tl* 0 0 9 25 33 0 6 14 15 
Site 5, Tl" 0 0 10 25 35 0 9 23 14 
Occupancies of 1-OH group of F6P: 
Productive 100 50 35 0 0 50 40 0 0 
Nonproductive 0 50 65 100 100 50 60 100 100 
*EDTA absent 
''EDTA present at 0.2 mM. 
tDTA absent and AMP present at 5 mM. 
dRgym = Ej Zi 11 ij - < I j > | / Li Zj Iij, where i runs over multiple obervations of the same 
intensity, and j runs over all crystallographically unique intensities. 
eAll data in the resolution ranges indicated. 
includes hydrogens linked to polar atoms. 
SR-factor = 2|[Fobsl-[Fcaic[[/2(Fob»|, [Fobsl > 0. 
^-factor based upon 5% of the data randomly culled and not used in the refinement. 
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instance) may be indistinguishable from tightly bound water molecules in typical electron 
density maps, but be identified unambiguously in an anomalous difference map. Finally, if 
Mg2- and Tf mutually exclude each other at a binding site, then anomalous scattering data 
allows a direct estimate of the Tf occupancy, and an indirect estimate of Mg2" occupancy 
at that site. Hence, the anomalous data eliminates much ambiguity in the interpretation of 
electron density associated with possible metal sites, and as presented below, reveals a far 
more complex set of interactions than had been suggested by previous studies (27). 
Crystal Structure of the Mg2"/Product Complex— Data from improved crystals reveal 
electron density at site 3 consistent with Mg2* and a coordinated water molecule (Fig. 1). 
Asp68 and Glu97 along with two oxygen atoms of Pi complete the inner coordination shell 
(square pyramidal geometry) of the site-3 Mg2". When assigned fractional occupancies of 
0.5, thermal parameters for the Mg2* and the water molecule at site 3 match those of nearby 
atoms of the active site. Fractional occupancies of 0.5 for residues 61—69 of dynamic loop 
52—72 also result in thermal parameters, which match those for other atoms of the active 
site. The water molecule coordinated to site-3 Mg2" hydrogen bonds with the side-chain of 
Glu98 and is close to the side-chain of Asp74. Magnesium cations at sites 2 and 3 in 
combination with their coordinated water molecules, Pi, Asp74, Glu97, and Glu98, define 
an interconnected assembly of atoms with well-defined geometry (Fig. 1). The 1-OH 
group of F6P coordinates the Mg2" at site 1 and is in contact with the P atom of Pi (distance 
of separation approximately, 2.8 Â). Furthermore, the 1-0 atom of F6P is equidistant 
(approximately, 2.7 Â) from three oxygen atoms of Pi. The angle defined by the 1-0 atom 
of F6P, the P atom of P; and the remaining (distal) oxygen atom of Pi is 172°. The distal 
Fig. 1. Stereoview of electron density associated with metal cations in the active 
site of FBPase. The Mg2+(5 mM) complex has density from a 2fobs-fcalc map 
contoured in blue at 2a with a cutoff radius of 1 Â (top). The Mg2+(5 mM)/Tr(20 
mM) complex has density from a 2fobs-fcalc map contoured in blue at 2a with a 
cutoff radius of 1 Â and density from an anomalous difference map contoured in red 
at 4a with a cutoff radius of 1 Â (middle). The Mg2"(5 mM)/Tl+(20 mM)/AMP(5 
mM) complex has density from a 2fobs-fcalc map contoured in blue at 2a with a 
cutoff radius of 1 Â and density from an anomalous difference map contoured in red 
at 4o with a cutoff radius of 1 Â (bottom). This illustration used XTALVIEW (34) 
and RASTER3D (44). 
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oxygen atom of P, coordinates to Mg2* at sites 2 and 3. The spatial relationships between 
the 1-OH group of F6P, the Mg2* at site 1, and bound P; are essentially identical to those 
reported in the previous Mg27product complex (20). The Mg2* at site 3 and its coordinated 
water molecule are probably important to the catalytic mechanism of FBPase, as discussed 
more thoroughly below. 
Crystal Structure of the TV(ImMJ/Mg2*/Product Complex— The addition of Tl* to a 
concentration of 1 mM in crystallization experiments, results only in modest differences 
relative to the Tl*-free complex above. The 1-OH group of F6P now fractionally occupies 
two conformations, pointed toward the P-atom of P; and away from that atom. The later 
conformation for the 1-OH group was observed in the Zn27product complex (17,20). 
Some anomalous difference density appears at sites 1 and 2, at positions slightly displaced 
from density associated with Mg2* cations (Table 1). The anomalous density may result 
from the association of Tl* to active sites having no P;. Tl* cannot occupy sites 1 and 2 
defined by Mg2* in the presence of Pi, because of unacceptably short distances between 
oxygen atoms and the metal cation. Mg2* remains at site 3, and a small peak of anomalous 
density appears at site 3a, described in greater detail below. 
Crystal Structure of the Tt(5mM)/Mg2 /Product Complex— At a concentration of 5 mM 
Tl*, strong anomalous density appears at sites 3a, 3b, 4 and 5 (Fig. 1). Atoms that lie 
within 3 Â of the thallous ions are in Table 2. Site 3a corresponds to site 3 of Villeret et al. 
(27). Tl* at site 3a (as for sites 3b, 4, and 5) is far from full occupancy (Table 1). 
Furthermore, the fractional amount of the 1-OH group, directed away from the P-atom of 
Pi, has increased (Table 1), and in fact Tl* at site 3a could coordinate the 1-OH group of 
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F6P. The binding of TV to sites 3a and 3b must be mutually exclusive, as their distance of 
separation is only 2.7 A. No electron density is present for Mg2* at site 3, and segment 
61—69 is less ordered than in the 1 mM TP complex, as evidenced by the increase in 
averaged thermal parameter for this segment (Table 1). Tl~ at sites 3a and 3b have 
displaced Arg276 from the active site. TT at site 4 occupies the position of the water 
molecule, coordinated to the site-3 Mg2* in the Tf-free complex. Tf at site 5, however, 
coordinates the side chains of Serl23 and Asp74 without the displacement of Mg2* and its 
coordinated water molecule from site 2. In the 5 mM Tf complex, however, the distal 
oxygen atom of P, is 3.4 and 3.1 Â from thallous ions at sites 4 and 5, respectively, 
approximately 0.5 Â beyond that generally observed for inner-sphere coordination of Tl" 
(41). 
Crystal Structures of the IT(20 and 100 mAQ/Mg2"/Product Complex— The trend defined 
by the 1 and 5 mM Tl* complexes is essentially complete at a concentration of 20 mM Tf. 
Tl* at sites 3a, 3b, 4 and 5 do not reach full occupancy, nor does a Tf concentration of 100 
mM significantly increase cation levels at sites 3—5 (Table 1). In fact, at 100 mM Tl" no 
metal cation occupies site 1 (Mg2* is displaced). In the 20 mM Tl* complex, electron 
density is absent for segment 61—69, the 1-OH group of F6P is directed entirely away 
from the P-atom of Pi, and the side-chain of Arg276 is displaced from the active site. 
Crystal Structure of the 77*(20 mM)Mg*/AMP Product Complex— Villeret et al. (27) 
reported a TT(10 mM)/AMP complex with the substrate analog 1,5-anhydroglucitol 6-
phosphate. The complex reported here differs in the substitution of products for an 
inhibitor and the inclusion of Mg2*, an essential activator of FBPase. In the complex of 
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Villeret et al. Tl"" occupies sites 1, 2 and 3a, using our nomenclature for the naming of 
metal sites in FBPase. In our complex, Mg2* is at site 1, whereas Tl" occupies sites 2, 3 a, 
3b and 4 (Fig. 1). Occupany factors for all Tf sites are approximately 0.15, but the Mg2" at 
site 1 is at full occupancy (Table 1). We observed Tl" at sites 3b and 4, not observed by 
Villeret et al. Reported differences in metal ligation undoubtedly arise from differences in 
crystallization conditions (principally the presence or absence of Mg2"), but as AMP-
ligated FBPase is an inhibited form of the enzyme, the relevance of either structure to the 
phenomenon of monovalent cation activation is unclear. 
Discussions 
The presence of Mg2" at site 3 is correlated with the appearance of ordered structure for 
segment 61—69 of the dynamic loop 52—72. The apparent effect of Mg2* at site 3 is 
consistent with a well-ordered loop 52—72 in the Zn27product complex, in which Zn2~ 
fully occupies metal site 3. Residues 61—69 define a reverse-turn loop that lies 
immediately over the active site (Fig. 2). Results here demonstrate that loop 52—72 need 
not leave its engaged state, the hallmark of which is the insertion of the side chain of Tyr57 
into its hydrophobic pocket, in order to allow the exchange of products/substrate between 
the active site and the bulk solvent. Residue 61 is a glycine, which evidently is a point of 
articulation for segment 61—69. Residues 61—69 could cycle between conformations, 
one of which stabilizes Mg2* at site 3 by coordination to Asp68, whereas other 
"disordered" conformers of segment 61—69 allow the disassociation of Mg2* from site 3 
and products from the active site. Mutations of Asp68 cause the K* for Mg2" to rise 30-fold 
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Fig. 2. The dynamic loop (residues 52—72) of FBPase. Bonds for residues 61—69 are 
in bold solid line. 
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(lancu, C. V., Fromm, H. J., and Honzatko, R. B ., unpublished results), corroborating the 
putative role ascribed to Asp68 as a chelator of a catalytically essential Mg2*. Hence, the 
transition of loop 52—72 between engaged, disordered and disengaged conformations is 
probably a phenomenon associated with allosteric inhibition by AMP, whereas mobility in 
the small flap, represented by segment 61—69, may be necessary for catalytic turnover of 
an R-state, engaged-loop conformer. 
On the basis of the revised structure for the Mg2*-ligated active site, we suggest a 
modest revision (Fig. 3) in the catalytic mechanism for FBPase presented previously by 
Choe et al. (20). Mg2* at sites 2 and 3 coordinates the distal oxygen of P, (the oxygen atom 
to be displaced by the in-line attack of the 1-OH group of F6P). Each of these magnesium 
cations also coordinates a water molecule, either of which could provide a proton to 
neutralize the negative charge on leaving oxygen atom. The same oxygen atom of Glu98 is 
a proton acceptor in hydrogen bonds with both water molecules, and the proton in either of 
these hydrogen bonds could well move to the leaving oxygen atom of Pi. Glu98 is required 
for catalysis; mutations at position 98 cause at least a 10,000-fold decrease in activity under 
conditions which support full activity of the wild-type enzyme (42). The hydrogen atom on 
the 1-OH group of F6P (coordinated to site-1 Mg2*) moves to an oxygen atom of the 
phosphate (3 oxygen atoms of Pi are all 2.7 À from the 1-0 atom of F6P). The oxygen of 
Pi, which hydrogen bonds with backbone amides 122 and 123 may be the most likely 
acceptor for the proton transferred from the l-OH group of F6P. 
The kinetics of monovalent cation activation are generally consistent with a simple 
mechanism, whereby the cation binds to a site distinct from those of the divalent cations 
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(27,39). Kinetics data, however, cannot exclude more complicated mechanisms, and the 
structures above reveal the potential for a very complex mechanism of monovalent cation 
activation. On the surface, the structures here agree well with the kinetics. The Hill 
coefficient for TP-activation is 1.15, and the sum over occupancy factors for Tl* at sites 
3—5 is 1.2. The ATa for TP-activation is 1.34 mM and the sum over occupancy factors for 
Tf sites of the 5 mM complex is approximately one-half of that at saturating levels of Tl". 
The agreement between structure and kinetics, however, may only be a coincidence. The 
crystallographic work here measures the binding of Tf to an active site ligated by products, 
whereas the enzyme assay probes the influence of Tf on a substrate-ligated active site. To 
the best of our knowledge, there are no reports in the literature concerning monovalent 
cation activation of the reverse reaction catalyzed by FBPase. 
The structures above admit at least three possible interpretations regarding the 
mechanism of monovalent cation activation/inhibition in FBPase kinetics: (/) The 
structures represent dead-end product complexes, not observed in the kinetics of the 
forward reaction because the coupled assay maintains F6P at vanishingly low 
concentrations. (/'/') All Tl* sites participate in activation. The structures represent, aside 
from small perturbations, functional systems that accurately reflect a complex mechanism 
of monovalent cation activation, (i/z) Some TP sites may inhibit and others enhance 
catalysis with the net effect of activation over the entire population of FBPase complexes. 
The most straightforward interpretation is that the T17Mg2*/product complexes here 
represent a non-productive state of FBPase. As the concentration of Tl* increases to 20 
mM, Mg2* moves out of site 3, the 1-OH group of F6P moves away from the P-atom of Pi, 
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and thermal parameters of segment 61—69 increase significantly (Table 1). Clearly, an 
active system requires the 1-OH of F6P to be in contact with the P-atom of Pi and in a 
proper geometric relationship with the leaving oxygen atom. These minimal attributes are 
evident when Mg2* occupies metal sites 1—3, but are absent in a Tf/Mg2*-ligated active 
site. 
Macromolecular structures, however, are dynamic. One cannot rule out the 
possibility in solution of the 1-OH group of F6P rotating into position for an in-line attack 
on Pi in the Tl'/Mg2" complexes. In fact, even in the crystal structures here, the 1-0 atom 
of F6P, if rotated to the in-line orientation, is 2.6 Â from the P-atom of Pi. (The observed 
distance of separation in the Mg2* complex is 2.8 Â). This tighter fit in the TlTMg2* 
complexes may be responsible for the displacement of the 1-OH group from an in-line 
orientation, but one could argue as well that a tighter fit could promote catalysis. A 
vibrational mode, which every so slightly expands the active site, could allow the 1-OH 
group of F6P to rotate in-line with respect to P;. The same vibrational mode, would then 
contract the active site, forcing the reaction along toward its transition state. 
Finally, each crystalline complex here represents an average of two or more states 
of metal ligation. The pure-Mg2* complex is a mixture of active sites with and without 
Mg2" at site 3. In the TI~(20 mM)/Mg2* complex, Mg2* at site 3 and Tl* at sites 3b and 4 
are mutually exclusive (Table 2), Tl" at sites 3a and 3b are mutually exclusive (Table 2), 
and metal sites 3, 3a, 3b, 4, and 5 are mutually antagonistic (occupancy factors sum to near 
unity; Table 1). As evidenced by the TT(100 mM)/Mg2' complex, metal site 1 and metal 
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Table 2. Metal site coordination. Listed are atoms within 2.5 Â of Mg2+and 3.0 Â of Tf. 
Coordinating residue/atom Distance (Â) 
Site 1°, Mg2": 
Pi 02 2.23 
Pi 03 2.35 
Glu97 OE2 2.38 
Aspl 18 ODI 2.23 
Aspl21 ODI 1.92 
Glu280 OE1 2.05 
Site 2°, Mg2*: 
Pi 02 2.01 
Glu97 0E1 2.06 
Leul12 0 2.30 
Aspl 18 0D2 2.31 
Site 3", MgZT: 
Pi 03 2.49 
Pi 04 2.45 
Asp68 0D2 1.98 
Glu97 0E2 2.19 
Wat 2.22 
Site 3a", Tf: 
F6P01 3.02 
Tl 3b 2.69 
Site 3b°, Tf: 
Pi 03 2.80 
Glu97 0E2 2.71 
Site 4°, Tf: 
Asn64 ND2 2.52 
Glu98 0E2 2.77 
Site 5°, Tf: 
Asp74 ODI 2.78 
Leul 12 0 2.70 
Serl23 OG 2.75 
aMg2+(5 mM)/Tf(20 mM) complex 
6 Mg2+(5 mM)/Tf(l mM) complex 
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sites 3 a, 3 b, 4 and 5 could be antagonistic as well, and in fact, inhibition by elevated 
concentrations of Tf may arise from the displacement of Mg2" from site 1. 
On the other hand, Tl" at site 5 may not interfere with the binding of Mg2" to sites 
1—3. Each of the lone pair orbitals of the distal (leaving) oxygen atom of Pi, could 
coordinate a metal cation (Mg2" at sites 2 and 3, and Tl" at site 5). Tl"-binding to sites 3 a, 
3 b and 4, which displace Mg2* from site 3, may be inhibitory, but a complex of Mg2"(sites 
1—3)/Tl"(site 5) may be active. In order to account for enhanced activity, however, the 
latter Mg27TT complex must offset inhibition due to Tl" interactions elsewhere. 
Regardless of whether Tl" sites 3—5 are activating or inhibiting, studies here have 
identified three new loci (sites 3b, 4 and 5) at the active site of FBPase for cation 
association. These new sites may or may not be relevant to coupled assays of the forward 
reaction catalyzed by FBPase. Under in vivo conditions, however, where FBPase can 
select from a multitude of cations (Mg2*, Mn2", Zn2", Ca2~, K", and Li") at physiological 
concentrations and combine these cations together with products or substrate, all cation 
binding sites revealed here could be important in determining the net flux of reactants 
through gluconeogenesis. 
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CHAPTER 5. METAPHOSPHATE IN THE ACTIVE SITE OF 
FRUCTOSE 1,6-BISPHOSPHATASE 
A paper to be submitted in Science. 
Jun-Yong Choe, Herbert J. Fromm, and Richard B. Honzatko 1 
Abstract 
Crystals of fructose-1,6-bisphosphatase grow from an equilibrium mixture of 
substrates and products. Under the conditions of crystallization the enzyme is active. At 
neutral pH, products of the reaction (orthophosphate and fructose 6-phosphate) bind to 
the active site in a manner consistent with an associative reaction pathway. At neutral 
pH, but in the presence of inhibitory concentrations of K\ or at pH 9.6, metaphosphate 
and a hydroxide ion replace orthophosphate. To the best of our knowledge, the crystal 
structures reported here at near atomic resolution represent the first direct observation of 
metaphosphate in a condensed phase, and suggest that fructose-1,6-bisphosphatase is 
capable of hydrolyzing its phosphate ester by a dissociative pathway.Hydrolysis of 
phosphate esters is essential to living systems. The reaction is involved in metabolism, 
regulation, and biosynthesis; intermediary metabolites are phosphate esters, DNA and 
RNA are phosphodiesters. Phosphate hydrolysis reactions are accomplished by enzymes 
1 Corresponding author. Telephone: (515) 294-6116. Fax: (515) 294-0453. E-mail: 
honzatko@iastate.edu. 
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such as phosphatases, mutases, kinases, and nucleases. In most cases, metal ions are used 
as cofactors for the phosphate hydrolysis. The chemical reaction can be either two 
different proposed mechanisms (1). The first is SN2 associative mechanism in which a 
nucleophile attacks the phosphate, the nucleophile and a leaving group create a 
pentacovalnet transition state, and then the reaction produces a free phosphate. The 
second is SnI dissociative mechanism which occurs with the elimination of a 
metaphosphate. However, the distinction between these two mechanism is difficult to 
be assessed experimentally in most cases of enzyme mechanical studies. 
Report 
Phosphoryl transfer reactions are central to biochemical processes that sustain 
life. Phosphatases, mutases, kinases and nucleases all catalyze phosphoryl transfers 
reactions. The transfer of the phosphoryl group of a phosphate ester to water is a reaction 
catalyzed by phosphatases. In most cases, metal ions are essential cofactors in reactions 
catalyzed by phosphatases. The hydrolysis of phosphate esters proceeds either by way of 
a trigonal-bipyramidal transition state (associative mechanism), or through the formation 
of an unstable intermediate of metaphosphate (dissociative mechanism) (1-6). The 
metaphosphate anion (PO3") was first proposed as an intermediate in the hydrolysis of 
phosphate esters nearly 50 years ago (7-8). Although it exists as a stable entity in the gas 
phase, where it is relatively unreactive (9), metaphosphate is unstable in aqueous 
solutions, and its existence is inferred only by indirect evidence (9-15). The likelihood of 
trapping metaphosphate in the active site of an enzyme is remote, because of the 
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proximity of acceptor molecules (nucleophiles) in the active site. Yet an enzyme offers 
an advantage in that it reduces the free energy of the transition state. So if 
metaphosphate, generated in the active site of an enzyme, is denied access to an acceptor, 
then the active site itself can serve as a thermodynamic trap. Reported here are 
complexes of fructose-1,6-bisphosphatase at near atomic resolution, in which a partial 
reverse reaction (synthesis of a phosphate ester) has led to the formation of 
metaphosphate in the active site. 
FBPase (16) is a key regulatory enzyme in gluconeogenesis. The inhibition of 
FBPase in mammals results in reduced levels of serum glucose in the fasting state. 
Hence, FBPase is a target for the development of drugs in the treatment of non-insulin 
dependent diabetes, which afflicts over 15 million people in the United State (17). 
FBPase can be in either of two quaternary conformations, the R-state (catalytically 
active) or the T-state (inactive). AMP and fructose 2,6-bisphosphate both inhibit 
catalysis by FBPase, the former through an allosteric mechanism (18,19) and the latter by 
direct ligation of the active site (20-22). Divalent metals (Mg2", Mn2* or Zn2~) are 
essential for FBPase activity (23,24) and monovalent metals (K", Rb", Tf or NH3~) 
further enhance reactions rates (25,27). The enzyme-mediated reaction is pH dependent. 
Plots of initial velocity versus Mg2* are sigmoidal (Hill coefficient of 2) at neutral pH, 
but hyperbolic at pH 9.6 (29). 
In past crystal structures of FBPase, orthophosphate has been at the active site 
(30,31). All ligated complexes of FBPase reported here crystallize from an equilibrium 
mixture of products and substrates, and in fact the enzyme itself is active under 
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conditions of crystallization. Presumably, the state of the active site represents a 
minimum free energy under the conditions of the crystallization experiment. Three 
complexes (Table 1) are presented here: (/) metaphosphate, fructose 6-phosphate (F6P) 
and Mg2* at pH 9.6 (hereafter the high-pH complex), (//) metaphosphate, F6P, Mg2" and 
K" (200 mM) at pH 7 (hereafter the high-K" complex), and (iii) orthophosphate (Pi), F6P, 
Mg2* and K" (30 mM) at pH 7 (hereafter the control complex). Conditions that result in 
the formation of metaphosphate differ only in pH (7 versus 9.6) or the concentration of 
K" (30 versus 200 mM). The kinetic mechanism of FBPase catalysis changes from 
steady-state at pH 7 to rapid-equilibrium at pH 9.6 (29), and K~ is inhibitory at 
concentrations of 200 mM of 68 mM], but activating at concentrations of 30 mM [ATa 
of 17 mM] (32). Hence, differences in ligation of the active site in crystals may reflect 
changes in the active site and/or reaction pathway in solution. 
The control complex (Table 1) presents essentially what has been observed in 
previous product complexes of FBPase (31), albeit at a higher resolution. 
Orthophosphate is clearly at the active site and Mg2* occupies sites 1, 2 and 3 (Fig. la). 
The 1-OH group of F6P coordinates the Mg2* at site 1, and is positioned optimally for an 
associative reaction mechanism in reverse. The crystalline product complex may 
represent a step on the reverse reaction pathway, but it almost certainly does not represent 
the central kinetic complex (the inter-conversion of FI6P2 and F6P/Pi at the active site). 
Liu and Fromm (21) determined a value of 2 for the equilibrium constant of the central 
kinetic complex. Hence, the ratio of FI6P2 to F6P/Pi should be approximately 3 to 2. 
The electron density is consistent, however, with only F6P/P;. 
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Table 1. Crystallization, data collection, structure determination, and refinement 
statistics. Crystals of FBPase were grown by the method of hanging drops. Crystals in 
30 mM or 200 mM of K* grew from equal parts of a protein solution [10 mg/mL FBPase, 
50 mM Hepes, 5 mM MgCfe, 5 mM FI6P2, 30 mM or 200 mM KC1] and a precipitant 
solution [100 mM Hepes (pH 7), 5% of /-butyl alcohol, 27% or 21% (v/v) of glycerol, 
and 8% (for 30 mM KC1) or 14% (for 200 mM KC1) (w/v) polyethylene glycol 3350]. 
Crystals at pH 9.6 grew from equal parts of a protein solution [10 mg/mL FBPase, 10 
mM KPi, 5 mM MgCU, 5mM FI6P2] and a precipitant solution [100 mM glycine (pH 
9.6), 5% of /-butyl alcohol, 25% (v/v) of glycerol, and 10% (w/v) polyethylene glycol 
3350]. The droplet volume was 4 |iL. Wells contained 500 gL of the precipitant 
solution. Crystals with dimensions of 0.2 mm x 0.2 mm x 0.2 mm grew in three to five 
days at room temperature. The crystals belong to space group 1222 (a=53, b=80, c=165). 
Data from the control complex were collected on a MSC/Rigaku RAXIS IV~/rotating 
anode at 100 K, using CuKa radiation passed through an Osmic confocal mirror system. 
Data from the high-K* complex were collected at the synchrotron beam line X4A, 
Brookhaven National Laboratory, on an ADSC quantum4 CCD at 100 K, using a 
wavelength of 0.9795 Â. Data from the high-pH complex were collected at APS-BioCars 
(beam line 14BM), Argonne National Laboratory on an ADSC quantum4 CCD at 100 K, 
using a wavelength of 1.0 A. Data from synchrotron sources were reduced and scaled by 
Denzo/Scalepack (36). Data from the RAXIS IV** were processed with CrystalClear 
(37). Crystals grown for this study are isomorphous to PDB code leyj. Structure 
determinations were initiated by molecular replacement using calculated phases of leyj, 
and then refined by CNS (38) with force constants and parameters of stereochemistry 
from Engh and Huber (39). Anomalous difference and electron density maps were 
calculated using the program CNS. Model building and modification were done using 
XTALVIEW (40). MOLSCRIPT (41) and RASTER]D (42) were used for the 
illustration. 
Crystalline complex HighpH HighK" Control 
Resolution limit (Â) 1.3 1.6 1.9 
Number of measurements 347535 187681 204001 
Number of unique reflections 83972 39885 26035 
Completeness of data (%): 
Overall 92.6 83.5 88.8 
Last shell/resolution-range (A) 65.8/(1.30-1.35) 35.6/(1.60-1.66) 50.0/(1.90-1.97) 
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Table 1. (Continued) 
Reym 0.024 0.017 0.038 
Number of refl. in refinement 77354 38245 24287 
Number of atoms 2715 2745 2784 
Number of solvent sites 187 218 251 
Rfactor 0.220 0.208 0.207 
Rfr=eC 0.258 0.228 0.245 
Resolution of refinement (Â) 1.3-5.0 1.6-5.0 1.9-5.0 
Mean B (À2) for protein 23.6 24.0 28.6 
Root-mean-squared deviations 
Bond lengths (Â) 0.004 0.005 0.005 
Bond angles (deg) 1.2 1.2 1.4 
Dihedral angles (deg) 22.6 23.0 22.7 
Improper dihedral angles (deg) 0.78 0.76 0.75 
*R«ym= 2jZi|Iij -<Ij >|/Iiljlij, where / runs over multiple observations of the same intensity, 
and j runs over all crystallographically unique intensities. 
**R&ctor= £||Fobs|-|Fcilc||/2|Fobs|, I Fobs I > 0. 
cRfactor based upon 10% of the data randomly culled and not used in the refinement. 
Figure I. Stereoviews of active sites of FBPase. (/I) Complex of Mg2+, F6P and 
orthophosphate at pH 7. (B) Complex of Mg2+, fC, F6P and metaphosphate at pH 7. 
(Q Complex of Mg2*, F6P and metaphosphate at pH 9.6. Electron density (blue) 
covers metaphosphate/hydroxide anions or orthophosphate at a contour level of 3 a, 
using a cut off radius of 1 Â. Anomalous difference density (red) cover bound K* at a 
contour level of 3 c, using a cut off radius of 1 Â. 
135 
V120 r'-''M3 ' 3 3X | 
D121 
B280 
R276 
D118, 
D12 
E280 
D118, 
D121 
D118 
V120 
tB280 i 
D118 
V120 
136 
An increase in the concentration of K" from 30 to 200 mM results in several 
differences (Fig. lb). Firstly, as evidenced by the anomalous signal, K* displaces Mg2" 
from site 1 of the active site, and in fact, this may be the mechanism of inhibition at high 
concentrations of K". Glu97, which coordinates Mg2" at sites 2 and 3 at low 
concentrations of K" (Fig. la), does so with more favorable geometry in the complex 
with 200 mM K" (Fig. lb). Perhaps as a consequence, Mg2* at site 3 has gone from 
square-pyramidal to octahedral coordination. Furthermore, the 1-OH group of F6P no 
longer coordinates the metal at site 1, and has rotated away from the in-line geometry 
observed in the control complex. Most striking, however, is the change in electron 
density of the ligand at the 1-phosphoryl pocket. The electron density is planar (rather 
than tetrahedral), and a separate sphere of electron density lies 2.5 Â away from its 
center. Metaphosphate fits the planar density well, and a hydroxide ion fits equally well 
to the sphere of electron density. This hydroxide ion coordinates to magnesium cations at 
sites 2 and 3, and hydrogen bonds with Asp74. The mutation of Asp74 to alanine reduces 
catalysis by at least 50,000-fold relative to the wild-type enzyme (33). 
The high-pH complex (Fig. lc) differs from both the control and the high-K" 
complexes. Glu97 now coordinates magnesium cations at sites 1 and 2, and so Mg2* at 
site 3 has lost one of two of its coordinating side chains. Perhaps as a consequence, Mg2" 
occupies two sites (3 and 4 in Fig. lc). Glu98 coordinates to Mg2* at site 4, whereas 
Asp68 coordinates to Mg2* at site 3, but the binding of metal cations here must be 
mutually exclusive as metal sites 3 and 4 are only 2.5 Â apart. The B-parameters of Mg2* 
at sites 3 and 4 are 20 and 18 Â2, respectively, and their fractional occupancies are 0.4 
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and 0.5, respectively. The electron density at the 1-phosphoryl pocket appears as a 
flattened trigonal pyramid. A molecule of metaphosphate, slightly distorted from 
planarity, provides the best fit to the density. As in the high-K" complex (Fig. lb), a 
sphere of electron density, consistent with a hydroxide ion, is 3.3 Â from the P-atom of 
the metaphosphate. Also, the 1-OH group of F6P is out of its in-line orientation. 
Although the control complex infers an associative mechanism in the hydrolysis 
of FI6P2, FBPase evidently can generate metaphosphate and retain it. To the best of our 
knowledge, the structures reported here constitute the first direct observation of 
metaphosphate in a condensed phase. The crystalline complex evidently supports the 
second step of a dissociative mechanism, which interconverts PO3 /OH" and HPO42". The 
first step of a dissociative mechanism is not accessible, because of the mutual rotation of 
the plane of metaphosphate and the 1-OH group of F6P away from in-line geometry (Fig. 
lb&c). Some of the variations observed in the kinetic mechanism of FBPase at neutral 
and alkaline pH could reflect a change in mechanism from associative to dissociative (or 
the reverse) or a change in the relative rates of the two steps of a dissociative pathway. 
The metaphosphate complexes here, clearly present Asp74 as the key residue in 
abstracting a proton from an acceptor water molecule, which is bound in turn to 
magnesium cations at sites 2 and 3. 
The hydrolysis of most phosphate esters in organic model systems occurs by a 
dissociative mechanism. The structures above indicate that the same chemistry may 
occur in the active site of FBPase. In fact, Herschlag and Jencks (34) present a scheme 
(Chart II or HI) that is strikingly similar to FBPase complexes observed here in the 
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relative placement of Mg2*, a metal-coordinated hydroxide ion and a planar intermediate. 
Furthermore, there are striking parallels between the active site of FBPase and that of 
alkaline phosphatase (35), suggesting the chemistry of model systems is broadly 
applicable to enzymes that catalyze the hydrolysis of phosphate esters. 
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CHAPTER 6. CONCLUSION 
Summary 
A crystal structure of FBPase in a complex with three zinc cations and the 
products fructose 6-phosphate (F6P) and phosphate (Pi) revealed loop 52-72 for the first 
time in a well defined conformation with strong electron density. Loop 52-72 interacts 
primarily with the active site of its own subunit. Asp68 of the loop hydrogen bonds with 
Arg276 and a zinc cation located at a putative metal activation site. The loop 52-72 has 
been implicated in regulatory and catalytic phenomena by studies of site directed 
mutagenesis. The allosteric regulation of catalysis by AMP occurs through the 
displacement of the loop 52-72 from active site. Asn64 forms a hydrogen bond with the 
catalytic residue Glu98. Tyr57 is in a hydrophobic pocket and segment 61-69 could 
cycle between at least two conformations in releasing products and binding substrate. 
Crystal structures of metal-product complexes of fructose 1,6-bisphosphatase 
(FBPase) revealed competition between AMP and divalent cations. In the presence of 
AMP, the Zn2*-product and Mg2+-product complexes have a divalent cation present only 
at one of three metal binding sites (site 1). The enzyme is in the T-state conformation has 
disengaged loop 52-72. In the absence of AMP, the enzyme crystallizes in the R-state 
conformation, with loop 52-72 associated with the active site. In structures without 
AMP, three metal-binding sites are occupied by Zn2~ and two of three metal sites (sites 1 
and 2) by Mg2*. Evidently, the association of AMP with FBPase disorders loop 52-72, 
the consequence of which is the release of cations from two of three metal binding sites. 
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In the Mg2+ complexes (but not the Zn2v complexes), the 1-OH group of fructose 
6-phosphate (F6P) coordinates to the metal at site 1 and is oriented for a nucleophilic 
attack on the bound phosphate molecule. A mechanism is presented for the forward 
reaction, in which Asp74 and Glu98 together generate a hydroxide anion coordinated to 
the Mg2* at site 2, which then displaces F6P. Development of negative charge on the 
1-oxygen of F6P is stabilized by its coordination to the Mg2- at site 1. 
The product/Mg^-complex of FBPase was investigated at various concentrations 
of TT. There are six Tl" sites. Three of these were described previously by Lipscomb 
and co-workers as metal sites 1, 2 and 3. Metal site 3 of Lipscomb is identical to our site 
3b. In addition our study identifies three new metal site: site 3a, located in proximity to 
site 3b, but binds to Glu97, site 4, coordinated by Glu98 and Glu97, and site 5, ligated by 
Asp 74 and Ser 123. All of metal sites could be important in vivo, either as sites of 
activation or inhibition. 
The location of potassium also has been determined from the anomalous signal. 
Potassium displaces Mg2* from metal site 1. Thallium is putatively an analogue of 
potassium. However, a comparison between the complexes with thallium and potassium 
reveals clearly just one potassium in the first metal site, but four thallium sites (3a, 3b, 4 
and 5) without significant displacement of Mg2-r from site 1 or 2. Therefore, mechanisms 
of catalytic enhancement by potassium and thallium may differ. 
Direct evidence of metaphosphate trapped within the active site of FBPase 
suggests the possibility of a dissociative that the catalytical mechanism for FBPase. 
Cleavage of the ester bond of the 1-phosphoryl group of the fructose 1,6-diphosphate 
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could precede the nucleophilic attack of water. The reaction is assisted by the guanidine 
group of Arg276, carboxyl side chains of Asp 121 and Glu280 associated with metal site 
1. The reaction yields an intermediate metaphosphate and fructose 6-phosphate. The 
metaphosphate anion (PO3") associated with three metals is transformed to HPO42' by an 
attacking water molecule. The water coordinates with Asp74, and essential residue for 
catalysis. 
Consequently, work here reveals the engaged conformation dynamic loop 52-72 
and how that loop mediates the competition between AMP and divalent cations, the direct 
participation of metal site 1 in catalysis, new sites for the binding of monovalent cations 
and a key intermediate in catalytic mechanism. 
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APPENDIX 1. DIRECTED MUTATIONS IN THE POORLY 
DEFINED REGION OF PORCINE LIVER FRUCTOSE-1,6-
BISPHOSPHATASE SIGNIFICANTLY AFFECT CATALYSIS AND 
THE MECHANISM OF AMP INHIBITION 
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Asa**, Asp™, Lys7*, Lys71, and Asp74 of porcine liver 
fructose-l,6-bisphosphatase (FBPase) are conserved res­
idues and part of a loop for which no electron density 
has been observed in crystal structures. Yet mutations 
of the above dramatically affect catalytic rates and/or 
AMP inhibition. The Asp74 — Ala and Asp74 — Asn mu­
tant enzymes exhibited 50,000- and 2,000-fold reduc­
tions, respectively, in kM relative to wild-type FBPase. 
The pH optimum for the catalytic activity of the Asp74 —» 
Glu, Asp** — Glu, Asn*4 — Gin, and Asn"4 — Ala mutant 
enzymes shifted from pH 7.0 (wild-type enzyme) to pH 
8.5, whereas the Lys7' — Ala mutant and Lys71*7* — Met 
double mutant had optimum activity at pH 7.5. Mg** 
cooperatively, Ï. for fructose 1,6-bisphosphate, and 
for fructose 2,6-bisphosphate were comparable for the 
mutant and wild-type enzymes. Nevertheless, for the 
Asp74 -» Glu, Asp" — Glu, Asn*4 -» Gin, and Asn*4 —» Ala 
mutants, the binding affinity for Mg** decreased by 40-
125-fold relative to the wild-type enzyme. In addition, 
the Asp74 — Glu and Asn*4 — Ala mutants exhibited no 
AMP coopérativity, and the kinetic mechanism of AMP 
inhibition with respect to Mg** was changed from com­
petitive to noncompetitive. The double mutation Lys71-71 
— Met increased X, for AMP by 175-fold and increased 
Mg1* affinity by 2-fold relative to wild-type FBPase. The 
results reported here strongly suggest that loop 51-72 is 
important for catalytic activity and the mechanism of 
allosteric inhibition of FBPase by AMP. 
Fructose-1,6-bisphosphatase (D-fructose-l,6-bisphosphate 
1-phosphohydrolase, EC 3.1.3.11; FBPase1), a key regulatory 
enzyme in gluconeogenesis, catalyzes the hydrolysis of fructose 
1,6-bisphosphate (Fru-1,6-P2) to fructose 6-phosphate and P, in 
the presence of divalent metal ions such as Mg2*, Mn2', and 
Zn2' (1, 2). The activation of the enzyme by Mg2* exhibits 
sigmoidal kinetics with a Hill coefficient of 2 at neutral pH, but 
is hyperbolic at pH 9.6 (3, 4). FBPase is inhibited synergisti-
cally by AMP (as an allosteric effector) and fructose 2,6-
bisphosphate (Fru-2,6-Pz; as a substrate analog) (5-7). In con­
• This work was supported by Research Grant NS 10546 from the 
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Fru-1.6-Pj, fructose 1,6-bisphosphate; Fru-2.6-P„ fructose 2,6-
bisphosphate. 
trast, AMP and Fru-2,6-P2 act as strong activators for 
phosphofructokinase, a major regulatory enzyme in the oppos­
ing glycolytic pathway. 
In mammals FBPase is a homotetramer with a subunit Mr of 
37,000 (8). Each subunit of the te tramer (designated Cl, C2, 
C3, and C4) has an allosteric AMP domain (residues 1-200) 
and a catalytic Fru-1,6-P2 domain (residues 201-335), with the 
AMP-binding site being -28 À away from the substrate-bind-
ing site (9-11). Structures of AMP complexes of the enzyme 
define the T-state, whereas structures in the presence sub­
strate analogs and without AMP represent the R-state. The 
structural transition (R- to T-state) involves a 17* rotation of 
the C1-C2 dimer with respect to the C3-C4 dimer and a 1.9* 
rotation of the AMP domain relative to the Fru-1,6-P2 domain 
within each subunit (10). The R- to T-state transition results in 
conformational changes at interfaces between subunits CI and 
C2 and subunits CI and C4 (as well as interfaces related to 
these by the symmetry of the te tramer). Metal-binding sites ( up 
to three total) are at or near the active site at the interface 
between the two domains of the enzyme (12, 13). Mg2" and 
AMP are mutually exclusive in their binding to FBPase (14, 
15). In fact, AMP inhibition is nonlinear and noncompetitive 
with respect to Fru-1.6-P2 and nonlinear and competitive with 
respect to Mg2". Yet crystallographic studies reveal similar 
metal coordination in the absence and presence AMP (either one 
Mg2* ion or two Zn2* or two Mn * ions), although small pertur­
bations in the active site are attributed to the 1.9* rotation of the 
AMP relative to the Fru-1,6-P2 domain due to AMP binding (13). 
Site-directed mutagenesis of the residues involved at subunit 
interfaces of porcine liver FBPase revealed significant changes 
in the kinetic mechanism of AMP inhibition and coopéra tivity 
(16-19). However, a detailed mechanism of catalysis and allos­
teric regulation based on changes in interacting residues has 
been elusive. Perhaps published structures of FBPase do not 
reveal all of the essential structural elements for catalysis and 
regulation. Mutation of Arg4*. a residue that precedes a disor­
dered loop (residues 54-71), causes dramatic changes in FB­
Pase kinetics (17). Comparison of the amino acid sequences of 
mammalian FBPases reveals Glv", Gly81, Asn*4, Asp™, Asp74, 
Lys71, and Lys72 as conserved residues within this disordered 
loop. Furthermore, loop 54-71 is proteolytically sensitive in all 
known FBPases (20). To determine whether loop 54-71 plays a 
major role in FBPase kinetics, mutant enzymes Asn*4 — Gin, 
Asn*4 -» Ala, Asp™ — Glu, Lvs71 — Ala, Lys71-72 — Met (double 
mutation). Asp74 — Ala, Asp74 -* Asn, and Asp74 — Glu were 
expressed in Escherichia coli, purified to homogeneity, and eval­
uated by initial velocity kinetics. The above mutations have pro­
found effects on both catalysis and regulation of FBPase. 
EXPERIMENTAL PROCEDURE 
Materials—Fru-1,6-P„ Fru-2,6-P„ NADP, AMP, ampicfllin, tetracy­
cline. and isopropyl-0-o-thiogalactopyranoside were purchased from 
Sigma. DNA-modifying and restriction enzymes, T4 polynucleotide Iti-
Tha paper is avaSaMe on Kne at httpV/w**jbC4*g 17511 
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TABLE I 
Kinetic parameters for wUd'type and mutant forms of fructose- Î, 6-bisphosphatase 
Enzyme Km. Fni-LS-P, K,. AMP" A'„ Fni.2.S-P: K.. Mg3' HiU ejjjBdent 
** vJT V irur 
Wild-type. pH 7.5 21 = 2.2 2.8 r 0.1 20.5 = 5 0.24 = 0.08 0.49 = 0.01 1.94 = 0.04 
Lys71" — Met, pH 7.5 34 = 4.1 1.6 = 0.2 3525 = 296 1.78 - 0.05 0.29 = 0.01 1.78 = 0.05 
Lys7' — Ala. pH 7.5 16 = 1.9 2.8 : 0.2 189 = 25 0.29 = 0.05 0.27 = 0.01 2.2 = 0.05 
Asp" — Glu. pH 7.5 6.4 = 0.8 1.31 = 0.17 27.2 = 3.1 0.065 = 0.01 7.19 = 0.2 1.43 = 0.04 
Wild-type. pH 8.5 9.1 = 2.6 2.2 = 0.08 53.7 = 6.4 0.24 r 0.02 0.14 = 0.03 2.2 = 0.1 
Asp7* — Ala. pH 8.5 0.0004 NIX ND ND ND ND 
Asp7* — Asn. pH 8.5 0.01 - 0.002 ND ND ND ND ND 
Asp7* — Glu. pH 8.5 1.2 = 0.1 1.03 = 0.1 5.25 = 0.47" 0.13 = 0.04 17.7 = 1.2 1.26 = 0.06 
Asn4* — Ala, pH 8.5 7.1 = 0.8 1.42 r 0.08 12.7 = 0.1" 0.072 = 0.01 5.45 = 0.39 1.42 = 0.07 
Asn4* — Gin, pH 8.5 5.4 : 0.4 1.7 = 0.1 14.1 = 0.2 0.099 = 0.01 6.61 = 0.26 1.44 = 0.04 
" The K, was obtained from plots of L/velocitv versus l/[Fru-l,6-P5] at 5 m M Mg5*. 
" The {fill coefficient for AMP inhibition is 1.0. 
' ND, not determined. 
nase, and T4 DNA ligase were either from New England Biolabs Inc. or 
Promega. Glucose-6-phosphate dehydrogenase and phosphoglucose 
isomerase were supplied by Boehnnger Mannheim. Tryptone, yeast 
extract, and agar were from Difco. Other chemicals were of reagent 
grade or the equivalent. 
E. coli strains BMH 71-18 mutS ((Ai. supE. Mlac-proAB), 
!mulS::TnJ0\ [f proAB, tacPZlMlS]) and XL-lBlue (recAJ. tndAl. 
gyrA96, thi-1. hsdR-17. supE44, thi-1. relAl, lac [T proAB. 
LacPZMlS, TnltXTef)] came from CLONTECH and Stratagene, re­
spectively. FBPase-defident £. coli strain DF 657 (tonA22. 
ompF627(Ttr). relAl. pit-10, spoTl. ±(fbpl287) was from the Genetic 
Stock Center at Yale University. 
Mutagenesis of FBPase—Mutations were accomplished by the intro­
duction of specific base changes into a double-stranded DNA plasmid. 
Eight mutagenic primers (5 '-TGGCTCCACGCAGGTGACAGG-3', 5 -T-
GGCTCCACGGCCGTGACAGGT-3'. 5'-GTGACAGGTGAGCAAGTG-
AAG-3'. 5 -GTGATCAAGTGGCGAAGTTGGATG-3', 5-GTGATCAAG-
TGATGATGTTGGATGT-3 ', 5 -GAAGTTGGCGGTCCTCTCCA-
3', 5-GAAGAAGTTGGAAGTCCTCTC-3', and 5-GAAGTTGGAGGTC-
CTCTCCAA-3') were used to mutate Asn" — Gin. Asn*4 — Ala. Asp" 
— Glu, Lys71 — Ala. Lys"-73 — Met, Asp7* — Ala, Asp7* — Asn, and 
Asp7* — Glu. A selective primer (5-CAGCCTCGCGTCGCGAACGCC-
AG-3') was used to change the unique Xhol site to the original Nrul site 
on the pET-lla vector. The double-stranded FBPase expression plas­
mid (pET-FBP) and mutagenic and selective primers were denatured, 
annealed, and polymerized using the Transformer™ site-Directed mu­
tagenesis kit (21). Mutations were confirmed by XkoUNrul digestion 
and by fluorescent dideoxy chain termination sequencing at the Nucleic 
Add Facility at Iowa State University. The plasmids with mutations 
were transformed into £. coli strain DF 657. The plasmid DNA was 
isolated from the overnight culture, and sequence analysis was per­
formed on the entire FBPase gene. 
Expression and Purification of Wild-type and Mutant FBPases—The 
expression and purification of wild-type and mutant forms of FBPase 
were carried out as described previously (22) with slight modification. 
After centrifugation to remove cell debris, the supernatant was sub­
jected to heat treatment, 30-70% """«"in" sulfate precipitation, 
Sephadex G-200 column chromatography, and CM-Sepharose column 
chromatography. Wild-type and mutant FBPases eluted as a single 
peak from the CM-Sepharose column by a NaCl gradient from 20 to 400 
mx in 10 mit malonate buffer, pH 6.0. Protein purity was evaluated by 
12% SDS-polyaciylamide gel electrophoresis according to ' "»»i; (23). 
Protein concentrations were determined as described by Bradford (24) 
using bovine serum albumin as the standard. 
Kinetic Studies—Specific activity during purification was deter­
mined by the phosphoglucoisomerase and glucoses-phosphate dehy­
drogenase coupled spectrometric assay at either pH 7.5 or 9.6 (I). All 
other kinetic experiments were done at either pH 7.5 or 8.5 and 25 "C 
using a coupled spectrofluorometric assay (15). Initial rate data were 
analyzed using a computer program written in MINITAB language 
with an a value of 2.0 (25). Cooperatively was evaluated using either the 
ENZFTITER program (26) or the MINITAB program. 
Circular Dichroism Spectrometry—CD studies on the wild-type and 
mutant FBPases were carried out in a Jasco J710 CD spectrometer in 
a l-mm cell at room temperature using a 0.2 mgftnl concentration of the 
enzyme. Spectra were collected from 200 to 260 nm in increments of 1.3 
run, and each spectrum was blank-corrected and smoothed using the 
software package provided with the instrument. 
RESULTS 
Purification, of Wild-type and Mutant Forms of FBPase— 
Purification of mutant and wild-type enzymes followed previ­
ous protocols (22). Mutant enzymes exhibited elution patterns 
similar to wild-type FBPase, except for Lys71 — Ala and 
Lys71-72 — Met, which eluted from the CM-Sepharose column 
at 100 mM NaCL On the basis of SDS-polyacrylamide gel elec­
trophoresis, all enzymes exhibit identical mobilities (Afr - 37, 
500) with no evidence of proteolysis (27) and purity greater 
than 95% (data not shown). Activity ratios (pH 7.5:9.6) for the 
wild-type. Lys71 — Ala, and double mutant Lys71,72 — Met 
enzymes confirmed the absence of proteolysis. 
Secondary Structure Analysis—The CD spectra of wild-type 
and mutant FBPases are essentially superimposable from 200 
to 260 nm (data not shown), indicating the absence of global 
structural alteration changes caused by the mutations. 
Catalytic Rates of FBPase Mutants—Initial rate studies were 
done at saturating concentrations of Fru-1,6-P2 or Mg2* that 
do not cause substrate inhibition. Kinetic parameters are in 
Table I. The values for the Asp74 — Ala and Asp74 — Asn 
mutants decreased 50,000 and 2.000 times, respectively, 
whereas a shift in the pH of optimum activity from pH 7.5 to 8.5 
was exhibited by the Asp74 — Glu mutant with only a 20-fold 
reduction in A similar alteration in the pH of optimum 
activity occurred with mutants Asn64 — Gin, Asn®4 — Ala, and 
Asp™ — Glu. On the other hand, replacements Lys71 — Ala 
and Lys71,72 —* Met did not alter the pH of optimum activity. In 
Table I, the kinetic parameters for the Asp74 — Glu, Asn64 — 
Gin, Asn64 -» Ala. and wild-type FBPases were measured at pH 
8.5, and for mutants Asp®8 —• Glu, Lys71 — Ala, and Lys71-72 — 
Met at pH 7.5. A slight change in Fru-1,6-P2 affinity was 
observed in all mutants relative to wild-type FBPase. 
Mg*~ Activation—The activity of wild-type FBPase as a 
function of Mg2* concentration is sigmoidal at neutral pH with 
a Hill coefficient of ~2, but is hyperbolic at pH 9.6 (3, 4). The 
Hill coefficient for Mg2* and the K„ for Mg2* of the wild-type 
and mutant forms of FBPase were determined here at a satu­
rating Fro-1,6-P2 concentration (30 #im) at pH 7.5 or 8.5. Hill 
coefficients at pH 8.5 dropped from 2.2 for the wild-type en­
zyme to ~1.4 for the Asp74 — Glu, Asn®4 —» Gin, and Asn®4 — 
Ala mutants, and at pH 7.5 from 2.0 to 1.4 for the Asp®8 — Glu 
mutant. Increases of 126-, 51-, 47-, and 39-fold in Ka values for 
Mg2* were found for the Asp74 —• Glu, Asp®8 — Glu, Asn®4 — 
Gin, and Asn®4 -» Ala mutants, respectively, relative to the 
wild-type enzyme. The Lys71 — Ala and Lys7'72 — Met mutant 
enzymes as well as wild-type FBPase showed sigmoidal kinet­
ics for Mg2* at pH 7.5. On the other hand, the affinity for Mg2* 
at pH 7.5 increased 2-fold for the Lys71 — Ala and Lys71-72 — 
Met mutant enzymes relative to wild-type FBPase. 
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FIG. I. Plot of reciprocal of initial velocity in arbitrary fluo­
rescent units ccrau reciprocal of [Mg2*!1 for Lys"-7* — Met 
FBPase. The concentrations of AMP used were 0 (•), 6.6 (0), 13.3 (•), 
and 26.6 Q #im The coupled fluorescence assay was used at 25 'C in 50 
mn Tris buffer, pH 7.5, containing 0.1 M KCl and 20 #IM Fru-1,6-Pa. The 
lines are theoretical based upon Equation 1 when n • 2, and the points 
were experimentally determined. 
Fru-2,6-Ps Inhibition—Fru-2,6-P2 is a competitive inhibitor 
of Fru-1,6-P: and competes with the substrate for the active 
site of FBPase (7, 29). K, values for Fru-2,6-P2 decreased by 
< 4-fold for all mutant enzymes compared with the wild-type 
enzyme. On the other hand, the Lys71-72 — Met mutant exhib­
ited a 7-fold increase in Kt for Fru-2,6-P2. 
Kinetics of AMP Inhibition—AMP is an allosteric regulator 
of FBPase (30). The action of AMP inhibition is nonlinear and 
noncompetitive with respect to Fru-1,6-P2 (31), but nonlinear 
and competitive relative to Mg2* for wild-type FBPase at either 
neutral or alkaline pH (15). AMP binding to FBPase is cooper­
ative with a Hill coefficient of -2 (4). The wild-type and Lys71 
—Ala, Lys71-72 — Met, Asp88 — Glu, and Asn84 — Gin FBPases 
exhibited competitive inhibition patterns for AMP relative to 
Mg3*, whereas the Asp74 — Glu and Asn84 — Ala mutants 
showed noncompetitive inhibition. Fig. 1 shows double-recip­
rocal plots of 1/velocity versus l/IMg2*]2 at various fixed con­
centrations of AMP for the Lys71-72 — Met mutant of FBPase. 
The data of Fig. 1 are consistent with a steady-state random 
mechanism represented by Equation 1, 
^if"FK1 "£"£)) ®»-i) 
where v. A, B. I, Kw K„ K„ KM KUu and Kw represent 
initial velocity; maximal velocity; the concentrations of Mg2*, 
Fru-1.6-P2, and AMP; the Michaelis constants for Mg2* and 
Fru-1,6-P2; the dissociation constant for Mg2*; and the disso­
ciation constants for AMP from the enzyme-AMP, enzyme 
AMP-AMP, enzyme-Fru-l,6-P2-AMP, and enzyme-Fru-l,6-P3-
AMP-AMP complexes, respectively, n represents the Hill 
coefficient for AMP. When n = 2, the binding of AMP to FBPase 
is cooperative; on the other hand, there is no coopéra tivity 
when it = 1. In the case of the wild-type. Lys71 — Ala, Asp88 — 
Glu, and Asn*4 —• Gin FBPases, the kinetic data (similar to 
those shown in Fig. 1) fit best to Equation 1 when n = 2. The 
•goodness of fit" was 4% when n = 2 as opposed to 11% when 
n = l. 
Fig. 2 illustrates double-reciprocal plots of 1/velocity versus 
1/IMg2*]2 at various fixed concentrations of AMP for the Asp74 
— Glu mutant of FBPase. The family of lines intersect to the 
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Fic. 2. Plot of reciprocal of initial velocity in arbitrary flu» 
rescent units versus reciprocal of [Mg3*!1 for Asp'4 — Glu FB­
Pase. The concentrations of AMP used were 0 (•), 2 (O), 4 <•), and 10 
(•) tin. The coupled fluorescence assay was used at 25 *C in 50 om Tris 
buffer, pH 8.5, containing 0.1 M KCl and 20 mm Fru-l.S-P,. The lines are 
theoretical based upon Equation 2 when n » 1. and the points were 
experimentally determined. 
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FIG. 3. Plot of reciprocal of initial velocity in arbitrary fluo­
rescent units Mirai reciprocal of Fru-1,6-P, for Asn*4 —Ala 
FBPase. The concentrations of AMP used were 0 (•). 3.3 (O), 6.6 <•), 
and 10 (•) hm. The coupled fluorescence assay was used at 25 *C in 50 
OM Tris buffer, pH 8.5, containing 0.1 M KCl and 5 OM Mg2*. The lines 
are theoretical based upon Equation 3 when n » 1. and the points were 
experimentally determined. 
left of the 1/velocity axis in Fig. 2. A similar result was found 
with the Asn84 -* Ala mutant (data not shown). The data for 
both mutants are indicative of noncompetitive inhibition by 
AMP relative to Mg2* and are consistent with Equation 2, 
,Eq
-
21 
where v, V*. A, I, Ka, K„ and Ku are defined as above, and n 
represents the Hill coefficient for AMP. The data for Asp74 — 
Glu and Asn84 —Ala all fit best to Equation 2 when n = 1. The 
goodness of fit is 5 and 6% when n = 1 for Asp74 — Glu and 
Asn84 —» Ala, respectively, and >18% when n - 2. 
The double-reciprocal plots of 1/velocity versus l/IFru-l,6-P2I 
at various fixed concentrations of AMP for the wild-type. Lys71 
—• Ala, Lys71-72 —• Met, and Asp88 —• Glu enzymes gave a family 
of lines intersecting to the left of the 1/velocity axis (data not 
shown). Consequently, the mechanism of AMP inhibition for 
the Lys71 -* Ala, Lys71-72 —» Met, Asp88 — Glu, and wild-type 
FBPases is noncompetitive. The K: values for the Lys71-72 — 
Met and Lys71 —• Ala mutants increased 175- and 10-fold 
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FIG. 4. Stereo view of the location of 
Asp74 and Glu** relative to the metal 
ion at site 2, the 1 phosphate group, 
and the attacking water molecule. 
Wot, water. F6P, fructose 6-phosphate. 
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FIG. 5. Stereo view of the active-site 
area around Asn*4 and Asp". FSP, 
fructose 6-phosphate. 
relative to the wild-type enzyme, respectively. AMP inhibition 
relative to Fru-1,6-P2 for Asp74 — Glu, Asn®4 —» Gin, and Asn*4 
— Ala gave a family of parallel lines (Fig. 3), indicating un­
competitive inhibition. Equation 3 with n - 1 best accounts for 
the data, 
l i z r k.\ 
ë = viV^Â) (E«-3) 
where v. Vv, A, I, n, and K, represent initial velocity, 
maximal velocity, the concentration of Fru-1,6-P2, the concen­
tration of AMP, the Hill coefficient, the Michaelis constants for 
Fru-1,6-P2, and the dissociation constant for AMP from the 
enzyme-AMP complex, respectively. The goodness of fit was 
<6%. Thus, coopérât!vity for AMP inhibition is lost in addition 
to the change of the kinetic mechanism. 
DISCUSSION 
Amino acid sequences of all known mammalian FBPases are 
well conserved, particularly in segment 52-72, where 10 amino 
acids are highly conserved, suggesting an important functional 
or structural role. In all published crystal structures of FBPase 
(9-13), however, little or no electron density is present for 
residues 52-72, which is indicative of conformational disorder 
or proteolytic damage. The latter possibility is unlikely as 
microsequencing detected no proteolysis (10). Reduced *a[ val­
ues for the Asp74 -» Ala, Asp74 —Asn, and Asp74 — Glu FB­
Pases by 50,000-, 2,000-, and 20-fold, respectively, along with 
the shift in the pH of optimum activity from neutral to alkaline 
for the latter mutant, demonstrate the importance of position 
74 in catalysis. Given the sensitive nature of position 74, con­
formational changes in the adjacent segment 52-72 could le-
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verage significant alterations in the catalytic properties of FB­
Pase. Mutations Asn64 — Ala, Asn84 — Gin, and Asp68 — Glu, 
for instance, change the pH of optimum activity from neutral to 
alkaline and decrease *at values from 3- to 4-fold relative to 
that of the wild-type enzyme, and the double mutation Lys71-72 
— Met elevates the Kt for AMP nearly 175-fold. The activity 
profiles of the Asp74 — Glu, Asn64 -* Ala, Asn®4 — Gin, and 
Asp68 — Glu mutants are very similar to those obtained with 
the proteolyzed enzyme in which residues 1-64 and 1-25 are 
missing (32-34). 
The analysis above is strengthened by the crystal structure2 
(2.3-À resolution, fi-factor = 0.165, A-free = 0.24) of recombi­
nant wild-type porcine liver FBPase with the products Fru-6-P, 
P„ and Zn2*, which reveals strong electron density for loop 
52-72 and a significant network of hydrogen bonds involving 
Asp68 , Asn®4, and other residues of the active site. In the 
proposed catalytic mechanism of hydrolysis of Fru-1,6-P2 (12, 
13), a water molecule, bound to a metal cation, is activated for 
a nucleophilic attack of the 1-phosphate. The side chains of 
Asp74 and Glu9®, relative to the attacking water and to the 
metal ion at the 'catalytic* site (called metal site 2 in crystal 
structures of FBPase) (Fig. 4), are in position to act as general 
base catalysts. The distance between OD2 of Asp74 and OE2 of 
Glu98 and the cation at site 2 is —3.3 A, but neither side chain 
is in the inner coordination sphere of that cation. Replacement 
of Glu9® by glutamine resulted in a 1,600-fold reduction in 
relative to wild-type FBPase (35). The Asp74 — Asn mutation 
caused a decrease in catalytic rate of the same order of magni­
tude, whereas the Asp74 -» Ala mutation resulted in almost the 
total loss of catalytic activity. Thus, Asp74 and Glu9® may act in 
concert to remove a proton from the attacking water molecule. 
Asn®4 and Asp" are also in the active site (Fig. 5), with the 
former hydrogen bonding with Glu97 and Glu9® and the latter 
with Arg27®. Evidently, Asn®4 maintain# Glu97 and Glu9® in 
proper orientations for metal binding and the activation of the 
attacking water molecule. The above is consistent with the re­
duction in the HHl coefficient for Mg2" and the 50-fold decrease 
in affinity for Mg2*, exhibited by the Asn®4 —« Ala and Asn®4 — 
Gin mutants relative to wild-type FBPase. Mutation of Arg27® to 
methionine reduces activity by 2,000-fold, abolishes Mg2* coop-
era tivity, and alters the kinetic mechanism of FBPase (36). Evi­
dently, the Asp**-Arg27® hydrogen bond is a determinant for 
many of the kinetic properties of FBPase; its loss could destabi­
lize loop 52-72 and impair the catalytic function of Asp74. 
AMP induces a modest structural change in the helix (H2) 
immediately preceding loop 52-72, and in all AMP-bound com­
plexes of FBPase, loop 52-72 is disordered (13, 28). The new 
crystal structure has an ordered loop in the absence of AMP. 
Hence, AMP could inhibit FBPase by the disruption of inter­
actions between loop 52-72 and the active site. As Asn®4 and 
Asp®® probably stabilize metal binding to the active site, the 
observed competition between AMP and Mg2* in kinetics and 
NMR investigations may stem from the displacement of loop 
52-72 from the active site due to the AMP-induced perturba­
tion of helix H2. 
The 175- and 10-fold increases in K, of AMP inhibition with 
respect to Fru-1,6-P2 for the Lvs71-72 — Met and Lys71 — Ala 
enzymes, respectively, could originate from the destabilization 
of loop 52-72 in its disordered, AMP-induced conformation. 
AMP may be less effective in the displacement of loop 52-72 of 
the double mutant (in which positions 71 and 72 are methio­
nine instead of lysine) because of the unfavorable thermody­
namics of exposing two methionyl side <-hain« to the solvent. 
2 J-Y. Choe, H. J. Fromœ, and R. B. Honzatko. manuscript in 
preparation. 
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Indeed, the double mutant apparently exhibits preference toward 
the active R-state, relative to the less active or inactive T-state. 
Its increases 3-fold, and its K, for Mg2* decreases 2-fold, 
whereas its K{ for AMP and Fru-2,6-P2 increases 175- and 7-fold, 
respectively. In fact, the double mutant may represent the 
kinetic properties of FBPase locked into the R-state. 
Mutations that bring about a change in the kinetic mecha­
nism of FBPase from competitive to noncompetitive (AMP in­
hibition relative to Mg2*) are possible in the context of a 
steady-state random mechanism (16, 17) and now can be un­
derstood in terms of a conformational mechanism. To a first 
approximation, loop 52-72 is the instrument by which AMP 
exerts its allosteric effect on the active site. In the wild-type 
system with a fully functional loop, AMP and Mg2* (presum­
ably at site 2) are probably antagonists with respect to the 
conformation that they stabilize for loop 52-72. Hence, in wild-
type FBPase, loop 52-72 strongly couples the AMP- and Mg2*-
binding sites. In some mutants of loop 52-72, however, the strong 
coupling of the AMP and the cation site is diminished; AMP binds 
and perturbs the metal at site 2, thereby causing inhibition, but 
is no longer completely effective in displacing the cation from a 
catalytically productive association with the active site. 
A rational basis for an uncompetitive mechanism is more 
challenging, however. Four separate mutations (Asp74 •— Glu, 
Asn®4 — Ala, Asn®4 — Gin, and Arg49-» Cys) change AMP 
inhibition with respect to Fru-1.6-P2 from noncompetitive to 
uncompetitive. The uncompetitive mechanism implies that 
AMP binds as an inhibitor only when Fru-1,6-P2 is productively 
bound at the active site. Hence, these mutations may stabilize 
a conformation of loop 52-72 that does not favor the binding of 
AMP (as an inhibitor), but permits the association of Fru-1,6-P2 
with the active site. Productively bound Fru-1,6-P2 could then 
induce a conformational change in loop 52-72 that re-estab­
lishes the coupling between the AMP and the substrate-bind-
ing site. A more detailed explanation of the above phenomenon, 
however, must await crystallographic and ligand binding stud­
ies of mutant FBPases. 
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abstract: Wild-type porcine fructose-1,6-bisphosphatase (FBPase) has no tryptophan residues. Hence, 
the mutation of Try57 to tryptophan places a unique fluorescent probe in the structural element (loop 
52—72) putatively responsible for allosteric regulation of catalysis. On the basis of steady-state kinetics, 
circular dichroism spectroscopy, and X-ray crystallography, the mutation has little effect on the functional 
and structural properties of the enzyme. Fluorescence intensity from the Trp57 mutant is maximal in the 
presence of divalent cations, fructose 6-phosphate and orthophosphate, which together stabilize an R-state 
conformation in which loop 52—72 is engaged with the active site. The level of fluorescence emission 
decreases monotonically with increasing levels of AMP, an allosteric inhibitor, which promotes the T-state, 
disengaged-loop conformation. The titration of various metal-product complexes of the Trp57 mutant 
with fructose 2,6-bisphosphate (F26P%) causes similar decreases in fluorescence, suggesting that F26Pz 
and AMP individually induce similar conformational states in FBPase. Fluorescence spectra, however, 
are sensitive to the type of divalent cation (Zn2*, Mn2*, or Mg2*) and suggest conformations in addition 
to the R-state, loop-engaged and T-state, loop-disengaged forms of FBPase. The work presented here 
demonstrates the utility of fluorescence spectroscopy in probing the conformational dynamics of FBPase. 
Fructose-1,6-bisphosphatase [d-fructose-1,6-bisphosphate 
1 -phosphohydrolase, EC 3.1.3.11 (FBPase1)] catalyzes the 
hydrolysis of fructose 1,6-bisphosphate (F16P;) to fructose 
6-phosphate (F6P) and inorganic phosphate (P,) (1, 2). 
FBPase. along with fructose-6-phosphate 1-kinase, defines 
a futile cycle in the gluconeogenic/glycolytic pathways. 
Hence, FBPase activity is regulated tightly, being inhibited 
by F26Pi and AMP (3-5). The kinetic mechanism of AMP 
inhibition is nonlinear and noncompetitive with respect to 
FI6P2 and nonlinear and competitive with respect to Mg24* 
(6, 7). FBPase requires divalent cations (Mg2*, Mn2*, or 
Zn2*), and rates of reaction vary sigmoidal 1 y with metal ion 
concentration (Hill coefficient of 2) (8-10). AMP binds to 
allosteric sites, which are 28 Â from the nearest active site 
(II). F26P2 exhibits competitive inhibition kinetics with 
respect to FI6P2, and binds to the active site as a substrate 
analogue. AMP and F26P% inhibit FBPase synergistically (J— 
5). Indeed, the kas for AMP decreases in the presence of 
F26P: (12). 
' This work was supported m part by National Institutes of Health 
Research Giant NS 10546 and National Science Foundation Grant 
MCB-9603595. This is journal paper 18896 from the low* Agriculture 
and Home Economic Experiment Station, Ames, IA. Project 3191, and 
is supported by Hatch Act and State of Iowa funds. 
'The atomic coordinates and smensefscm (codes 1FJ6 and 1F19) 
have been deposited in the Protein Data Bank. Research CoUabcntory 
for Structural Bioinformincs (RCSB). 
* Corresponding author. Telephone: (515) 294-4971. Fax: (515) 
294-0453. E-mail: hjfromm8iastate.edu. 
1 Abbreviations: FBPase. fructose-1,6-buphospbiase; F26P2, fruc­
tose 2,6-bisphosphate; FI6P1, fiuctose 1,6-bisphosphate; F6P. fructose 
6-phrwphatr, P» inorganic phosphate; AMP, ulrnrmnr monophosphate; 
SOS—PAGE, sodium dodecyl sulfate—polyacrylamide gel electro­
phoresis: CD. circular dichroism. 
FBPase is a homotetramer [subunit with an M, of 37 000 
(JJ)], which exists in at least two conformational states called 
R and T (14,15). AMP. with or without F26Pz, stabilizes 
the inactive T-state (16—18). The active R-state is favored 
by substrates or products in combination with metal cations 
(14, 19). Directed mutations implicate loop 52-72 in the 
allosteric regulation of FBPase (20,21). Product complexes 
with FBPase in the presence of Mg2* and Zn2* reveal an 
ordered loop, closely associated with the active site. Product 
complexes with AMP, on the other hand, reveal a disordered 
loop, and all but one metal cation displaced from the active 
site (22). A mechanism for allosteric regulation of catalysis 
in FBPase, proposed by Choe et al. (19), involves two 
conformational states of loop 52—72 (called engaged and 
disengaged). AMP and, presumably, F26P2 stabilize a 
disengaged loop, whereas metal cations stabilize an engaged 
loop. 
Although crystallographic studies provide rich detail, they 
are difficult to perform over a broad range of experimental 
conditions. Furthermore, the process of crystallization selects 
typically only one family of closely related conformera from 
what might be a diverse population of conformera in solution. 
Hence, to complement X-ray diffraction studies, and provide 
information regarding FBPase conformera over a variety of 
experimental conditions, we have introduced a spectroscopic 
probe into loop 52-72. As porcine FBPase has no tryptophan 
residues, a directed mutation can easily introduce a unique 
fluotopbore. Tyr57 of loop 52—72 is an attractive target for 
tryptophan substitution. Tyr57 has a large side chain, which 
exists in different environments in the engaged and disen­
gaged conformation of loop 52—72. Reported here are the 
kinetic and structural properties of the Trp57 mutant of 
FBPase, and its conformational response, as assessed by 
10.102 l/bi000609c CCC: $19.00 C 2000 American Chemical Society 
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steady-state fluorescence spectroscopy, to a variety of metal 
cations and physiologically relevant ligands 
EXPERIMENTAL PROCEDURES 
Materials. F16P2, F26Pj, NADP*, AMP, ampicillin, and 
IPTG were purchased from Sigma. DNA-modifying and 
restriction enzymes, T4 polynucleotide kinase, and ligase 
were from Promega. Glucose-6-phophaie dehydrogenase and 
phosphoglucose isomerase were from Roche. Tryptone, yeast 
extract, and agar were from Difco. Other chemicals were 
reagent grade or the equivalent Escherichia coli strains BMH 
71-18 mutS and XL 1-Blue came from don tech and Stragene, 
respectively. FBPase-deficient strain DF 657 was from the 
Genetic Stock Center at Yale University. 
Mutagenesis of FBPase. The mutation was introduced by 
changing specific bases in the double-stranded plasmid using 
the Transformer site-directed mutagenesis kit (23). The 
primer for the Tyr57 — Trp mutation was 5-CGCAC 
CTCTGGGGAATGG-3' (codon for tryptophan underlined 
in boldface). The selection primer, 5-CAGCCTCGCCTC-
GAGAACGCCA-3' (digestion site underlined in boldface), 
changed an original Nrtd to a Xhol site on the plasmid. 
Unanticipated mutations were ruled out by sequencing the 
entire gene, after which the mutant plasmid was used in the 
transformation of £L coli DE 657 (DE3) cells. The Iowa State 
University sequencing facility provided DNA sequences, 
using the fluorescent dye dideoxy terminator method. 
Expression and Purification of Wild-Type and Mutant 
FBPases. Expression and purification of FBPase were 
performed as previously described (24) with minor alter­
ations. After cell breakage, the enzyme was concentrated by 
adding enough ammonium sulfate to produce a 70% saturated 
solution. The precipitate was then taken up in 20 mM Tris 
(pH IS) and desalted on a G-100 Sephadex column using 
the resuspension buffer. Fractions with FBPase activity were 
loaded onto a Cibacron Blue column and eluted with a NaCl 
gradient (0.5— 1 M). FBPase appeared at approximately 0.8 
M NaCl. The eluent was then dialyzed against 20 mM Tris-
HC1 (pH 8 J) and loaded onto a DEAE-Sephadex column 
and eluted with a NaCl gradient (from 0 to 0.3 M). FBPase 
appeared at a salt concentration of 0.15 M. The protein purity 
was determined by SDS-PAGE (12% gel) (25). The protein 
concentration was determined by the method of Bradford 
(26), using bovine serum albumin as a standard. 
Kinetic Experiments. All assays employed the coupling 
of phosphoglucose isomerase and glucose-6-phosphaie de­
hydrogenase (I). The specific activity, i», and pH 7.5/pH 
9 J activity ratios were determined by directly monitoring 
the reduction of NADP* to NADPH at 340 nm. All other 
kinetic experiments monitored the fluorescence emission 
from NADPH at 470 nm, using an excitation wavelength of 
340 nm (7). Initial rate data were analyzed using programs 
written either in MINITAB (25) or by ENZFITTER (26). 
Circular Dichroism (CD) Spectroscopy. Spectra were 
recorded from 200 to 260 nm in steps of 1J nm on a Jasco 
J710 spectrometer in a 1 mm cell at room temperature using 
a protein concentration of approximately 0.25 mg/mL. 
Spectra were recorded in 20 mM Tris (pH 7 J) and with 20 
mM Tris, 5 mM Mg2*, 5 mM KP„ and 5 mM F6P. with and 
without AMP (400 pM) or F26Pz (240 pM). Each spectrum 
was blank-corrected and smoothed using the software 
provided with the instrument 
Biochemistry, VoL 39. No. 36, 2000 11101 
Crystallization of the Trp57 Mutant. Crystals of both T-
and R-state product complexes grew from hanging drops with 
a total volume of 4 pL. T-State crystals grew from equal 
volumes of a protein solution [10 mgZmL Trp57 mutant, 100 
mM Hepes (pH 7), 2 mM ZnQz. 5 mM F6P, 10 mM KP, 
(pH 7), and 5 mM AMP] and a precipitant solution [100 
mM Hepes (pH 7) and polyethylene glycol 3350 (17% w/v)]. 
R-State crystals grew from equal volumes of a protein 
solution, as above only without AMP, and a precipitant 
solution [100 mM Hepes (pH 7) and polyethylene glycol 
3350 (6% w/v)]. Wells contained 500 /d. of the precipitant 
solution. Crystals grew in approximately 2 days at 37 °C. 
Data Collection. Data were collected from one T-state 
crystal (dimensions of 03 mm x 0.2 mm x 0.3 mm) and 
one R-state crystal (dimensions of 0 J mm x 0.3 mm x 0.4 
mm) at Iowa State University on a rotating anode/Siemens 
X-1000 area detector at 120 K, using Cu Ka radiation passed 
through a graphite monochromator. Data were reduced by 
XENGEN (29). 
Model Refinement. Initial phases were calculated from the 
Zn2*—product complex of wild-type FBPase (IS) for the 
R-state structure and from the AMP—Zn2*—product complex 
(22) for the T-state structure. Refinement employed XPLOR 
(30) as described previously (19). Constants of force and 
geometry for the protein came from Engh and Huber (31). 
In early rounds of refinement, models were heated to 2000 
K and then cooled to 300 K in steps of 25 K. In later rounds 
of refinement the systems were hated to 1000 K and cooled 
in steps of 10 K. After the slow cooling protocol was 
complete, the models were exposed to 120 steps of conju­
gated gradient minimization, followed by 20 steps of 
individual ^ -parameter refinement Individual ^ -parameters 
were subject to the following restraints: nearest neighbor, 
main chain atoms, 1.5 A2; next-to-nearest neighbor, side 
chain atoms, 2.0 À2; nearest neighbor, side chain atoms. 10 
A2; and next-to-nearest neighbor, side chain atoms, 2.5 A2. 
Water molecules were fit to difference electron density of 
2-5<j or better and were added until no significant decrease 
was evident in Rtm- For comparison of the mutant and wild-
type structures, we employed programs from the CCp4 suite 
of programs (32). 
Steady-State Fluorescence Measurements. Fluorescence 
data were collected using a SLM 8100C fluorimeter from 
Spectronic Instruments. To avoid exciting tyrosyl side chains, 
an excitation wavelength of 295 nm was used. Emission 
spectra were recorded in steps of 2 nm from 310 to 400 nm, 
using a slit width of 2 mm. Enzyme concentrations were 
from 0.2 to 0.5 ftM. Each spectrum was an average of five 
to seven scans. Ligands were added to a solution of 
tryptophan (100 fiM), to ascertain whether they alone 
influenced the fluorescence emission from tryptophan. Blanks 
were subtracted from all spectra, and corrections for protein 
dilutions were made. Conditions under which specific spectra 
were recorded are provided in the text tables, and figure 
legends. 
AMP titration data were analyzed by nonlinear least-
squares fits, using the following equation: 
Fo Kt + L" 
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Table 1: Kinetic Parameters for Wild-Type and Tyr57 — Trp FBPases 
activity 
ratio TM MVF16P! Af.-Mg2* 
(pH 7.5/pH 9S) (s"') (#iM) (mM1) Hill coefficient witbMg2* *,-F26P: 0>M) /so-AMP" U<M) K* activation* 
wild-type 3J 22.0 ±0.1 1.75 ± 0.08 0.67 ±0.04 
Trp57 mutant 33 24.0 ± 0.07 3.39 ±0.09 0^3 ±0.06 
1.9 ± 0.1 
1.9 ±0.1 
0.264 ± 0.005 
0.84 ±0.05 
1.61 ± 0.05 
8.5 ± 0.4 
16.8 ± 03 
16.6 ± 0.4 
* The Hill coefficient of AMP inhibition is 2.0, as determined from a plot of Mg2* concentration vs AMP concentration at a concentration of 20 
fiM F16P;. ' Percent increase in initial velocity in the presence of Mg2* (5*y and F16Pj (5f#). caused by the addition of KO (ISO mM). 
where Af is the change in fluorescence caused upon addition 
of Iigand L, Fa is the fluorescence in the absence of ligand, 
Ki is the dissociation constant, and n is the Hill coefficient 
RESULTS 
Kinetic Properties of Wild-Type FBPase and the Tyr57 
— Trp Mutant Wild-type and mutant proteins behave 
identically in chromatographic separations and are at least 
95% pure, as determined by SDS-PAGE. The ratio of 
catalytic rates at pH 7.5 to 9-5 indicates an intact (nonpro-
teolyzed) FBPase. The mutation of Tyr57 to tryptophan does 
not affect kinetic parameters significantly (Table 1). The K, 
values for inhibition by AMP and F26P: increase 5- and 
4-fold, respectively, relative to that of wild-type FBPase. 
Other mutations of loop 52—72 cause increases in K values 
for AMP and F26P; (20, 21) and. along with the Trp57 
mutant described here, may simply reflect the well-
documented binding synergism of these ligands (6—5). Data 
from initial nue assays indicate no change in the mechanisms 
of inhibition by AMP and F26P%. 
Secondary Structure Analysis. The CD spectra of wild-
type and Trp57 FBPases are identical from 200 to 260 nm 
(data not shown). CD spectra for the Trp57 mutant change 
in response to AMP, as noted in previous work on the wild-
type enzyme (75). The Trp57 mutant also responds to the 
addition of F26P%, yielding a CD spectrum that is identical 
to that observed in the presence of AMP. 
Crystal Structures of R-State and T-State Trp57 FBPase. 
Crystals of the Trp57 mutant grown in the presence of Zn2* 
and products (F6P and PJ belong to space group 1222 (a — 
51.57 A, b = 82.47 A, and c = 165.57 A) and are 
isomorphous with respect to the R-state, Zn2*—product 
complex of the wild-type enzyme (19). Similarly, crystals 
of the Trp57 mutant grown in the presence of Zn2*, products, 
and AMP belong to space group P2,2,2 (a — 59.82 k, b — 
165.48 A, and c — 79.29 A) and are isomorphous with 
respect to the T-sute, Zn2*—prod un—AMP complex of the 
wild-type enzyme (22). Statistics for data collection and 
refinement for both crystal forms are in Table 2. The 
stereochemistry of the models is generally very good as 
determined by PROCHECK (33). The method of T trmti 
(34) indicates an uncertainty in coordinates of approximately 
03 A for both structures. 
Residues 22—27,142, and 143 arc in weak electron density 
and have high thermal parameters in the R-state complex. 
The root-mean-square deviation between C° atoms of the 
Trp57 mutant and wild-type FBPases is 0.28 A for the entire 
model and 0.2 A for loop 52—72. Deviations of up to 1.6 A 
are in regions of weak electron density, as noted above. 
Distinct and strong electron density covers Trp57 and 
residues is its vicinity (Figure 1). The indole moiety of TrpS7 
occupies the same pocket as the side chain of Tyr57 of the 
Table 2: Statistics of Data Collection and Refinement for Trp57 
Complexes 
R-state T-state 
ligands bound F6P. P„ Zn2* F6P. P„ Zn2*, AMP 
resolution (A) 2.5 2.5 
no. of measurements 38291 79656 
no. of unique reflections 11308 25328 
completeness of dau (%) 
dau set 88 90 
last shell (2.7-2J A) 74 83 
"ire* 5.00 6.86 
no. of reflections in refinement* 9914 23834 
no. of atoms 2646 5153 
no. of solvent sites 111 175 
R-Ucof 0.178 0.192 
*«=' , 0259 0272 
mean 8 (A2) 22 32 
roa-mom-squirt deviations 
bond lengths (A) 0.009 0.008 
bond angles (deg) 1J6 123 
dihedral angles (deg) 24.7 24.8 
iuipiupei dihedral angles (deg) 1J4 123 
' ftqa, = Ç£|/, — (y|/L5Vy, where i ruas ove multiple observations 
of the same intensity and j runs over crystallographieally unique 
intensities. ' All data in the resolution range of 5—2J A.c A-factor = 
Z||F»| - Ifakll/ZlFoel. where |F«,| > 0. ' R-factor based upon 10% 
of the data randomly culled and not used in the refinement. 
wild-type enzyme, and is in contact with Ala51, Gly52, 
Leul26, Leu 129, and Aspl27 of its own subunit and Val 196, 
Metl72, and Metl85 from the adjacent subunit (C1-C2 
interface). 
Residues 55—70, 142, 143, and 267—269 are in weak 
electron density in the T-state complex. Indeed, although 
residues 63—70 are part of the model, they are associated 
with electron density no higher than the noise level of the 
map. The root-mean-square deviation between C° atoms of 
the mutant and wild-type structures is 0.39 A over the entire 
model and 0.28 A for residues 52—62 of the loop. Deviations 
of >1 A appear among residues 63—70,142,143, and 267— 
269, bccausr of absent or weak electron density. A modest 
level of electron density, however, covers Trp57 (Figure 2). 
In fact the indole group of Trp57 occupies the same space 
as the side chain of Tyr57 in the wild-type T-state complex 
(22). The indole moiety of Trp57 is in contact with De53 
and De56 of its own subunit and Vall96, DelO, and Del94 
of an adjacent subunit (C1-C2 interface). Trp57 is more 
exposed to solvent in the T-state (8.1 A2 accessible surface 
area to a 1.4 A probe sphere) than in the R-state (6.4 A2 
accessible surface area). Higher ^ -parameters in die T-state 
relative to those in the R-state suggest greater conformational 
mobility for Trp57 in the T-state structure. Indeed, position 
57 is in proximity to residues 63—70, which are disordered 
completely and without electron density. The only difference 
between wild-type and Tip57 FBPases in the T-state concerns 
the binding of Zn2*. In the wild-type structure, there is only 
one metal ion bound (at site 1), whereas in the mutant 
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Figure 1 : Structure of the Trp57 mutant in the R-state. Displayed 
is a stereo view of electron density from a IF m — Foie map 
associated with Tip57 at a contour level of 1 a (top) and an 
illustration of two subunits (labeled C3 and C4) of FBPase (bottom). 
Helices H1—H3 are «presented as cylinders in both subunits, 
whereas loop 52-72 (engaged conformer, bold line) and Trp57, 
F6P. and P, (ball-and-stick models) are presented only for subunit 
C4. The bottom image was drawn with MOLSCRIPT (50). 
structure, in addition to the metal at site 1, electron density 
appears at site 2, which is consistent with a Zn2-1- canon at 
<40% occupancy or a water molecule. 
Steady-State Fluorescence from the TrpS7 Mutant Ligands, 
alone or in combination, do not influence the fluorescence 
emission from a 100 pM tryptophan solution. In addition, 
the metal site proximal to Trp57 in the R- and T-states is 15 
and 23 À away, respectively. These distances exclude most 
quenching mechanisms except resonance energy transfer and 
electron transfer. Resonance energy transfer is not possible, 
simply because Mg*\ Zn2*, and Mn2* do not absorb in the 
range of fluorescence emission from tryptophan. Electron 
transfer between the excited-state tryptophan and Mir* is 
possible, but is not reflected in the experimental data. The 
emission spectra of product complexes with Mn2* and Zn2* 
are equal in intensity, whereas that of Mg2* is relatively low 
(see below). Electron transfer between Mn2* and Trp57, 
however, should reduce the emission intensity from the 
Mn2*—product complex relative to that from Mg2* or Zn2* 
complexes. Similarly, resonance energy transfer between 
bound AMP and Trp57 is not possible, because AMP does 
not absorb in the range of fluorescence emission of tryp­
tophan. Recorded differences in fluorescence emission, then, 
must come from ligand-induced conformational changes, 
which alter the environment of Trp57. 
All changes in fluorescence emission reported here are 
relative to the emission from the Trp57 mutant in the absence 
of ligands and divalent metal cations. The emission spectrum 
from the Trp57 mutant in the presence of Zh2* (50 >iM), 
F6P (5 mM). P; (5 mM), and saturating AMP (400 gM) has 
a Àee of340 nm and a fluorescence intensity approximately 
IHK 11*53 
VH196» VH196* 
a. 
Figure 2: Structure of the Trp57 mutant in the T-state. Displayed 
is a stereo view of electron density from a 2F*, - Fa* map 
associated with Trp57 at a contour level of Iff (top) and an 
illustration of two subunits (labeled C3 and C4) of FBPase (bottom). 
Helices HI—H3 are represented as cylinders in both subunits, 
whereas loop 52-72 (disengaged conformer, bold line) and Trp57, 
F6P, P„ and AMP (ball-and-stick models) are presented only for 
subunit C4. The bottom image was drawn with MOLSCRIPT (JO). 
equal to that of the ligand-free enzyme (Figure 3 and Table 
3). In the absence of AMP, the level of fluorescence emission 
increases by 69% and A™, shifts to 350 nm. The emission 
spectrum Â-.. from the Trp57 mutant in the presence of 
F26?2 (240 #<M), with or without Zn2*, F6P, and Pj, is 15% 
higher than that from the Zn2*—product—AMP complex, 
with a Xau of 342 nm. The addition of F26Pz to the Zn2*— 
product-AMP complex, however, causes no detectable 
change in fluorescence emission (data not shown). 
The emission spectra in the presence of F6P (5 mM), Pj 
(5 mM), and AMP (400 pM) with Mg2* (5 mM) or Mn2* 
(0.5 mM) are identical to that of the Zn2*—product—AMP 
complex (Figure 3 and Table 3). In the absence of AMP 
and in the presence of products, however, Mg2* causes a 
much smaller increase in the level of fluorescence emission 
(23%) and a smaller shift in A—, to 346 nm than does either 
Zn2* or Mn2*. The addition of K* (as KCl), at levels (150 
mM) sufficient to saturate the monovalent cation site, caused 
no change in fluorescence emission. The emission spectrum 
in the presence of products, F26P: and Mg2*, however, is 
nearly identical to that of the corresponding complex with 
Zn2*. The level of fluorescence emission from the Trp57 
mutant in the presence of products, F26P; and Mn2*, is 46% 
higher than that of the metal—product-AMP complexes, 
compared to 15% and 11% increases, respectively, when 
Zn2* and Mg2* are used. 
The change in fluorescence from the Zn2*-product 
complex in response to the titration of AMP establishes a 
Ki for AMP of 16 /M and a HOI coefficient of 2.1 (Figure 
4). These values are very close to the /so-AMP (22 pM) and 
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no 
FIGURE 3: Fluorescence spectra of the Trp57 mutant under different ligation conditions. (A) Enzyme under R-state conditions of ligation 
(5 mM F6P and 5 mM KPJ in the presence of SO fiM Zn2* (bold line). OJ mM Mn2" (asterisks), 5 mM Mg2* (open circles), and no metal 
(solid line). (B) Enzyme under T-state conditions of ligation (5 mM F6P, 5 mM KP„ and 0.4 mM AMP) in the presence of SO pM Zn2* 
(bold line), 0.5 mM Mn2" (asterisks), 5 mM Mg2" (open circles), and no metal (solid line). (C) Enzyme in the presence of F26P2 (240 #M) 
and products (5 mM F6P and 5 mM KPJ in the presence of SO «M Zn2* (bold line), 0.5 mM Mn2* (asterisks). 5 mM Mg2* (open circles), 
and no metal (solid line). 
Table 3: Fluorescence Emission from Ligned Complexes of Trp57 
FBPase 
5mMF6P S mM F6P ed KP, 5mMF6PandKP, 
and KP, with 400/iM AMP with 240 #«M F26P2 
divalent canon 
none 
Zn2* (SOfiM) 
Mg1* (5 mM) 
Mn2" (0.5 mM) 
p *•»» (mn) f (nm) F* *•* (nm) 
1.00 340 1.00 340 1.00 340 
1.69 350 0.96 340 1.15 342 
123 346 0.96 342 1.11 340 
1.59 350 1.00 340 1.46 348 
* Relative fluorescence emission at from the Trp57 mutant 
without divalent canons in the presence of F6P (5 mM) and KP, (5 
mM). 
3 0.15 
100 ISO 200 
FIGURE 4: AMP titration of the Trp57 mutant as monitored by 
fluorescence emission. The enzyme is in S mM F6P, 5 mM P„ and 
SO mM Zn2*. AMP is added up to a final concentration of 0.2 mM. 
Hill coefficient (2.0) determined by kinetics at saturating 
Mg2* concentrations (5 mM). 
DISCUSSION 
Hie mutation of Tyr57 to tryptophan results in only minor 
changes in the functional and structural properties of FBPase. 
Crystal structures of the Zn2*—product complex of the Trp57 
mutant in the presence end absence of AMP are virtually 
identical to those of the wild-type enzyme under the same 
crystallization conditions. Using Mg2* as the cation activator, 
many of the functional properties of FBPase (pH 7.5/pH 9.5 
activity ratio, te». Km for FI6P2, potassium activation, and 
Hill coefficients for Mg2* and AMP) are indistinguishable 
from those of the wild-type enzyme. The 4- and 5-fold 
increases in Af, values for F26Pi and AMP, respectively, do 
indicate a mutation-dependent change in functional proper­
ties; however, the elevated K, values probably result from 
the enhanced stability of the R-state relative to the T-state 
of the mutant Elevated K, values for both AMP and F26P; 
are consistent with the model of Choc et al. (79), which 
requires AMP-bound and F26Pybound states of FBPase to 
have disengaged loops. Any mutation, which stabilizes an 
engaged loop 52-72, should increase the K, values of AMP 
and F26Pz. Under extremes in Iigand concentration (AMP 
absent and AMP saturating) and the presence of Zn2*-
product complexes, the Trp57 mutant adopts the R- and 
T-state conformations of the wild-type enzyme. Furthermore, 
initial velocity assays indicate no change in the kinetic 
mechanisms of inhibition by AMP (competitive with respect 
to Mg2* and noncompetitive with respect to F26P*) and 
F26Pz (competitive with respect to FI6P2). Evidently, 
tryptophan at position 57 is a nonperturbing spectroscopic 
probe of enzyme function and conformation. 
Common quenchers of tryptophan fluorescence are water, 
the peptide bond, and specific amino acid side chains (35). 
The indole group of Trp57 in the T-state is neither close to 
a side chain particularly effective as a quencher, nor does 
its exposure to solvent differ significantly from that in the 
R-state (8.1 vs 6.4 Â2). FBPase, however, is not a static 
structure. Thermal parameters are an approximate measure 
of conformational dynamics, and on the basis of such 
parameters, the indole of Trp57 undergoes greater confor­
mational movement in the T-state than in the R-state. We 
may observe electron density for only the most solvent 
inaccessible conformer for Trp57 in the T-state. Other 
conformera would convolute the electron density of Trp57 
with that of the solvent resulting in a uniform carpet of 
electron density, indistinguishable from noise. The wave-
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FIGURE 5: Schematic of the electrostatic perturbation due to Asp 127 
on the fluorescence emission energy from Trp57. The difference 
dipole moment àp is the dipole moment of ground-state indole 
subtracted from the dipole moment of the 'L, excited state. Its 
orientation here is based on information provided by Callis (57). 
The change in energy between ground and excited states due to a 
point negative charge positioned between the oxygen atoms of the 
side chain of Asp 127 is —Ap x E. Given the geometrical 
relationship of Asp 127 to Trp57, the electrostatic perturbation 
decreases the separation in ground state and 'L, energy levels, 
causing a red shift in the fluorescence emission. 
length of maximum fluorescence emission for tryptophan 
(Âne) in water is 352 nm and decreases in more hydrophobic 
environments (36). The observed Â» for Trp57 in the T-state 
is approximately 340 nm, which is consistent with a mixture 
of solvent-exposed and hydrophobic environments for the 
indole group. 
Trp57 in the R-state occupies a pocket lined primarily with 
hydrophobic side chains. The thermal parameters for the 
indole moiety in the R-state reflect a fully occupied confor­
mational state, with moderate conformational movement The 
A,* for an indole under such circumstances should be blue-
shifted relative to tryptophan in solution, but occurs at 
approximately 350 nm. This anomalous behavior of the 
indole group in the R-state may arise from its specific 
electrostatic environment which may be dominated by the 
negative charge of Asp 127 (Figures 1 and 5). The difference 
dipole vector, determined from the dipole moments of the 
ground and excited (1L1) states of indole, lies in the plane of 
the fused ring and is directed approximately as shown in 
Figure 5. The electrostatic field caused by Asp 127 will 
decrease the energy separation between the ground and 
excited states. That decrease is consistent with the 10 nm 
red shift in the R-state spectrum relative to the T-state 
spectrum. 
The environment of Trp57 in the R-state may influence 
fluorescence emission by other mechanisms as well. Al­
though the imino group of the indole ring does not make a 
hydrogen bond in the crystal structure, backbone carbonyl 
126 and the side chain of Asp 127 need move by no more 
than 1 À to hydrogen bond with the indole group. Hydrogen 
bonding with the indole would contribute to the observed 
red shift, noted above. Additionally, several surrounding side 
chains arc effective quenchers of fluorescence (35). Asp 127, 
His253, Cysl83, and Tyr258 are 3.4, 6.8, 7.1. and 7_5 A. 
respectively, from the indole moiety in the R-state. In the 
absence of one or several of these side chains, the level of 
fluorescence emission from Trp57 could increase signifi­
cantly. 
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A two-state system (disengaged loop, T-state and engaged 
loop, R-state) cannot account for the variation in fluorescence 
spectra observed in the study presented here. First the Trp57 
mutant in the absence of metal activators and other ligands, 
has a disengaged loop, as evidenced by its low level of 
fluorescence emission. In fact the fluorescence spectrum in 
the absence of all ligands is nearly indistinguishable from 
spectra of metal-product—AMP complexes (Figure 3). On 
the basis of CD spectroscopy, however, the Trp57 mutant 
in the absence of ligands, is in the R-state. Evidently, the 
fluorescence spectrum of the Trp57 mutant is not sensitive 
to the quaternary conformation of FBPase (T- or R-state), 
as is CD spectroscopy, but is instead sensitive to the 
conformational state of loop 52-72 (engaged or disengaged). 
Work of Lipscomb and colleagues has revealed R-state, 
disengaged loop conformes of wild-type FBPase under a 
number of crystallization conditions (37-39). Hence, an 
R-state, disengaged loop conformer for FBPase is probably 
a well-populated state for the enzyme in solution. 
Variations in fluorescence emission levels of metal-
product complexes could reflect differences in the equilib­
rium populations of R-state coitformers (engaged vs disen­
gaged loop). If so, then Mg21- would be the least effective 
of the divalent cations in stabilizing the R-state, engaged 
conformation of FBPase. Indeed, of the divalent cation 
activators, Mg2* binds to FBPase with much lower affinity 
than either Mn3* or Zn2*, and its level of fluorescence 
emission is significantly lower than that of Mn2* or Zn2*. 
Although attractive for its simplicity, the above explanation 
for the low level of fluorescence emission from the Mg2*-
product complex is difficult to reconcile with the absence 
of a K*-induced increase in the level of fluorescence 
emission. K* putatively binds to or near metal site 3, which 
is unoccupied by Mg2* at a concentration of 5 mM (22). 
Directed mutations of loop residues, which weaken Mg2* 
association, also abolish K* activation (27). Hence, if the 
low level of fluorescence emission observed from the Mg2*— 
product complex is due to an equilibrium mixture of engaged 
and disengaged conformers, then the addition of K* should 
stabilize the engaged loop and thereby enhance fluorescence 
emission. Such is not the case. Evidently, if K* docs bind 
to metal site 3, it does not influence the time-averaged 
environment of Trp57. The low level of fluorescence 
emission from the Mg2*—product complex then may reflect 
a different conformational state for FBPase (see below). 
On the basis of difference spectroscopy, AMP and F26P; 
stabilize the same conformation of FBPase (40), presumably 
a T-state, disengaged loop conformation. Fluorescence emis­
sion spectra from the Trp57 mutant in the presence of 
saturating F26P% or saturating AMP, however, arc not 
identical. The time-averaged environment of Trp57 is prob­
ably less solvent accessible in metal—F26P% complexes, than 
in metal—AMP complexes. Conceivably, metal—F26P% 
complexes may be an equilibrium mixture of loop-engaged 
and disengaged conformers. If so, then Mn2* must stabilize 
more of the metal—F26Pi complex in the engaged loop 
conformation, than either Zn2* or Mg2*. Indeed, F26P% is 
almost 50-fold less effective as an inhibitor of FBPase when 
assayed with Mn2* than with either Mg2* or Zn2* (47). 
Alternatively, the conformation of metal-F26P% complexes 
of the Trp57 mutant may represent distinct conformational 
states of loop 52—72, rather than an equilibrium mixture of 
158 
11106 Biochemistry, Vol 39. No. 36. 2000 
engaged and disengaged loops. Available crystal structures 
of F26P: complexes of FBPase may not be faithful repre­
sentations of metal—F26P2 complexes, because of the 
degradation of F26P: to F6P on one hand (42, 43) and the 
inclusion of AMP on the other (17, 44). As the emission 
spectra of metal—product—F26Pî—AMP and metal—product-
AMP complexes arc identical, AMP evidently stabilizes the 
same T-state, disengaged loop conformation to the exclusion 
of all other conformers. 
Fluorescence spectra of the Trp57 mutant are clearly 
consistent with a dynamic loop, sensitive to cation activators 
and specific ligands. The crystallographic structures (R-state, 
engaged loop; R-state, disengaged loop; and T-state, disen­
gaged loop), however, may represent only some of the well-
populated conformational states of FBPase in solution. 
Cation-dependent differences in fluorescence emission from 
the Trp57 mutant are real and are in harmony with reports 
of differing kinetic mechanisms and anomeric specificity with 
Mg2" and Mn2* (1, 45-47). As a consequence of the 
symmetry inherent in crystal structures, FBPase has been 
represented in solution as a tetramer, which retains three 
intersecting axes of symmetry. Reports arc in the literature, 
however, regarding half-of-sites reactivity and pairwisc 
association of AMP (48,49), which necessarily requires the 
loss of at least one symmetry axis of the tetramer. These 
asymmetric conformers of FBPase may account for the 
variety of conformational states inferred by fluorescence 
spectroscopy. 
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Loop 52-72 of porcine fructose-l,6-bisphosphatase 
may play a central role in the mechanism of catalysis 
and allosteric inhibition by AMP. The loop pivots be­
tween different conformational states about a hinge lo­
cated at residues 50 and 51. The insertion of proline 
separately at positions 50 and 51 reduces kM by up to 
3-fold, with no effect on the Km for fructose 1,6-bisphos­
phate. The K. for Mg2"- in the Lys" — Pro mutant in­
creases -15-fold, whereas that for the Ala51 — Pro mu­
tant is unchanged. Although these mutants retain wild-
type binding affinity for AMP and the fluorescent AMP 
analog 2'(3')-0-(trinitrophenyl)adenosine 5 monophos­
phate, the Kj for AMP increases 8000- and 280-fold in the 
position 50 and 51 mutants, respectively. In fact, the 
mutation Lys" — Pro changes the mechanism of AMP 
inhibition with respect to Mg** from competitive to non­
competitive and abolishes K* activation. The £, for fruc­
tose 2,6-bisphosphate increases -20- and 30-fold in the 
Lys" —» Pro and Ala" — Pro mutants, respectively. Flu­
orescence from a tryptophan introduced by the muta­
tion of Tyr1' suggests an altered conformational state 
for Loop 52-72 due to the proline at position 50. Evi­
dently, the Pro" mutant binds AMP with high affinity at 
the allosteric site, but the mechanism of allosteric reg­
ulation of catalysis has been disabled. 
Fructose-1,6-bisphosphatase (D-fructose-l,6-bisphosphate 1-
phosphohydrase, EC 3.1.3.11; FBPase)1 catalyzes the hydroly­
sis of fructose 1,6-bisphosphate (Fru-1,6-P2) to Fru-6-P and P, 
(for a review, see Refis. 1-3). FBPase is a tetramer of identical 
subunits (Afr = 37,000). Each subunit has binding sites for 
Fru-1,6-P{, Fru-2.6-Pz, and metal ions (which, taken together, 
define the active site) and a distinct AMP-binding site (4-6). 
The two binding loci within the same subunit are 28 A apart, 
lying for the most part in separate folding domains (called the 
AMP and Fru-1,6-P2 domains). The four subunits of the tet­
ramer occupy the corners of a rectangle, labeled clockwise CI 
through C4, starting with the upper left-hand comer (7). FB­
Pase exists in at least two conformational states, called R and 
T, which differ by a 17* rotation of the C1-C2 subunit pair with 
respect to the C3-C4 subunit pair about one of three intersect­
* This work was supported in part by National Institutes of Health 
Research Grant NS 10546 and National Science Foundation Grant 
MCB-9603595. This is Journal Paper 18895 of the Iowa Agriculture and 
Home Economic Experiment Station, Ames, IA, Project 3191. The cans 
of publication of this article were defrayed in part by the payment of 
page chaises. This article must therefore be hereby marked "advertise­
ment" in accordance with 18 U.S.C. Section 1734 solely to indicate this 
fact. 
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1 The abbreviations used are: FBPase, fructose-1,6-bisphosphatase; 
Fru-1,6-Pj, fructose 1,6-bisphosphate; Fru-2,6-P„ fructose 2.6-tnsphos-
phate; TNP-AMP, 2'(3'XWtrini6opbenyl)adfnn*ine 5'-monophosphate. 
ing 2-fold axes of the tetramer (7, 8). 
Loop 52-72 could play an important role in the allosteric 
mechanism of AMP inhibition, existing in at least two confor­
mational states (9, 10). In the absence of AMP, the loop inter­
acts with the active site (engaged loop conformation), position­
ing the side chain of an essential catalytic residue. Asp74 (9, 
11). The binding of AMP to its allosteric pocket putatively 
displaces the loop from the active site and stabilizes the disen­
gaged loop conformation (9, 10). Subunits with disengaged 
loops evidently have reduced affinity for essential metal ions 
and, as a consequence, may be impaired with respect to catal­
ysis. Mutations of conserved residues in Loop 52-72 have sig­
nificant effects on catalysis and allosteric inhibition of catalysis 
by AMP (11). 
The metabolic flux through FBPase is sensitive to prevailing 
levels of AMP and Fru-2,6-P2. AMP inhibits FBPase allosteri-
cally with a Hill coefficient of 2 (12, 13), whereas Fru-2.6-P2 
inhibits FBPase by direct ligation of the active site with a Hill 
coefficient of unity (1-3). Inhibition of FBPase by AMP is non­
linear and noncompetitive with respect to Fru-1,6-P2, but non­
linear and competitive with respect to Mg2* (6,14). In contrast, 
inhibition of FBPase by Fru-2,6-P2 is linear and competitive 
with respect to Fru-1,6-P2 and noncompetitive with respect to 
Mg3*. Due to the equilibrium reaction catalyzed by adenylate 
kinase, concentrations of AMP in vivo are nearly constant 
under normal physiological conditions, whereas the concentra­
tion of Fru-2,6-Pj varies in response to extracellular regulators 
such as glucagon and epinephrine. Hence, Fru-2,6-P2 is the 
probable dynamic regulator of FBPase in vivo, but AMP still 
plays a significant role. Fru-2,6-P2 lowers the apparent inhibi­
tion constant for AMP at least 10-fold (15) by decreasing the k^g 
of AMP ( 16). Levels of AMP association with the allosteric sites 
of FBPase will then necessarily change in response to Fru-
2,6-P2 levels, even if the concentration of AMP in vivo is con­
stant. AMP/Fru-2,6-P2 synergism may arise from the ability of 
each ligand to stabilize a common thermodynamic state of 
FBPase (disengaged Loop 52-72) through different mecha­
nisms (9). 
For Loop 52-72 to move between its various states, signifi­
cant conformational change must occur in hinge elements at 
residues 50 and 51 and residues 71 and 72. The combined 
mutation of lysines 71 and 72 to methionine dramatically in­
creases the Ki for AMP, presumably due to the stabilization of 
the R-state over the T-state conformer of FBPase (11). If the 
loop-mediated mechanism of AMP inhibition is valid, muta­
tions at the second hinge element must qualitatively cause a 
similar increase in the Kt for AMP, yet mutations of Lys" to 
methionine (17) and glutamine and alanine (18) cause virtually 
no change in the Kt for AMP. What is clear from crystal struc­
tures, however, is a large difference in main chain angles (*, <p) 
at position 50 in the R- and T-states of FBPase (7,9,10). Here 
we explore the consequence of mutations Lys" — Pro and 
29986 This piper is available on fine at httpV/www.jbcorg 
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Ala51 — Pro, which directly influence the backbone conforma­
tion of residues 50 and 51. The mutations have little effect on 
the binding affinity of a fluorescent analog of AMP, but in­
crease the kinetic K, value for that analog by several orders of 
magnitude. The kinetic Km value for Fru-1,6-P2 is unchanged 
by the mutations, but the Ka for Mg2* rises 15-fold in the case 
of the Pro50 mutant and is 40-fold less active under standard 
conditions of assay. The data suggest that Loop 52-72 is an 
essential element in the allosteric mechanism of FBPase. 
EXPERIMENTAL PROCEDURES 
Materials—Fru-1,6-P;, Fru-2,6-P2, NADP", AMP, ampicillin, and 
isopropyI-0-D-thiogalactopyranoside were purchased from Sigma. DNA-
modifying and restriction enzymes, T4 polynucleotide kinase, and li-
gase were from Promega. Glucose-6-phosphate dehydrogenase and 
phosphoglucose isomerase came from Roche Molecular Biochemical*. 
Tryptone, yeast extract, and agar were from Difco. Other chemicals 
were of reagent grade or equivalent Escherichia coli strains BMH71-1S 
mutS and XLl-Blue came from CLONTECH and Stratagene, respec­
tively. FBPase-deficient strain DF657 came from the Genetic Stock 
Center at Yale University. 
Mutagenesis of Wild-type FBPase—Mutations were accomplished by 
specific base changes in double-stranded plasmid using the Transform­
er™ site-directed mutagenesis kit (CLONTECH). The mutagenic prim­
ers for the Lys36 — Pro. Ala" — Pro, and Tyr17 — Trp mutants were 
S -GTCCGCCCGGCGGGCATC-3'. 5' -CCGCAAGCCGGGCATCGC-3'. 
and 5 '-CGCACiTCTGGGGAATTG3 respectively (codons for muta­
tion are in boldface and underlined). The selection primer 5-CAGC-
CTCGCCTCGAGAACGCCA-3' (the digestion site is in boldface ind 
underlined) changed an original NruI site on the plasmid into a Xhol 
site. The mutation and integrity of the gene were confirmed by sequenc­
ing the entire gene. The Iowa State University sequencing futility 
provided DNA sequences using the fluorescent dye dideoxy terminator 
method. 
Expression and Purification of Wild-type and Mutant FBPases— 
Protein expression and purification were performed as described previ­
ously (11), but with minor alterations. After cell breakage, FBPase was 
enriched and concentrated by 70% ammonium sulfate fractionation. 
The precipitate was taken up in 20 mn Tris (pH 7.5) and desalted on a 
Sephadex G-100 column using 20 mM Tris ipH 7.5). The active fractions 
were loaded directly onto a Cibacron blue column and eluted with a 
0.5-1 m NaCl gradient. FBPase eluted at -800 mM NaCl. The eluent 
wis dialyzed against 20 mM Tris-HCl (pH 8.3), loaded onto a DEAE-
Sephadex column, and then developed with a 0-300 mM NaCl gradient. 
FBPase eluted at a salt concentration of 150 mM, and its purity was 
confirmed by SDS-polyaaylamide gel electrophoresis (19). Protein con­
centration was determined using the Bradford assay (20) with bovine 
serum albumin as a standard. 
Circular Dichroism Spectroscopy—CD studies on wild-type and mu­
tant FBPases were done at room temperature on a Jasco J710 CD 
spectrometer in a 1-cm cell using a protein concentration of 0.35 mg/ml. 
Spectra were collected from 200 to 260 nm in increments of 1.3 nm. 
Each spectrum was blank-corrected and smoothed using the software 
package provided with the instrument. 
Kinetic Experiments—Assays for the determination of specific activ­
ity. and activity ratios at pH 7.5 and 9.5 employed the coupling 
enzymes phosphoglucose isomerase and glucoee-6-phosphate dehydro­
genase (1). The reduction of NADP* to NADPH was monitored directly 
at 340 nm. All other assays employed the same coupling enzymes, but 
monitored NADPH evolution by its fluorescence emission at 470 nm 
(excitation wavelength of340 nm). Initial rate data were analyzed using 
either programs written in the MINITAB language using an a value of 
2.0 (14) or ENZFITTER (21). The kinetic data were fit to a variety of 
models. Only models and parameters for the best fits are reported 
below. 
Steady-state Fluorescence Measurements—Fluorescence data were 
collected using an SLM 8100C fluorometer (Spectronic Instruments). 
The single tryptophan in the Trp" mutant was excited selectively using 
radiation of 295-om wavelength. Fluorescence emission spectra were 
recorded in steps of 1 nm from 310 to 400 nm using a slit width of 2 "»»" 
for both excitation and emission; Each spectrum was an average of five 
scans. Fluorescence from TNP-AMP employed excitation and emission 
wavelengths of 400 and 535 nm. respectively. Conditions under which 
specific spectra were recorded are provided below and in the tables and 
figure legends. Each point is the average of 151-s acquisitions. Enzyme 
concentrations ranged from 0.3 to 0.5 tiM- AH spectra were corrected for 
dilution and inner filter effects (absorbance of light by AMP and TNP-
AMP) using Equation 1 (22), 
Fr = (F- sxvyvjjio"--*-»1 (Eq. 1) 
where Fr is the corrected fluorescence, F is the fluorescence intensity 
experimentally measured, B is the background, V, is the volume of the 
sample for a specific titration point, V0 is the initial volume of the 
sample, A„ is the absorbance measured at the wavelength of excitation 
(295 nm for AMP and 410 nm for TNP-AMP), and Aw is the absorbance 
measured at the wavelength of emission (535 nm for TNP-AMP). As a 
control, ligands by themselves caused no change in fluorescence emis­
sion from a solution of tryptophan (100 #iM). 
TNP-AMP titration data were analyzed by nonlinear least-squares 
fits using Equation 2, 
IF 
F. ' K,- L" (Eq. 2) 
where if is the change in fluorescence caused by the addition of ligand 
(L). F0 is the fluorescence in the absence of ligand. is the theo­
retical """""""" change in fluorescence at saturating ligand concen­
tration, is the dissociation constant, and n is the Hill coefficient. 
Structural Modeling of FBPase Mutants—'The starting model for the 
engaged conformation of Loop 52-72 is the crystal structure of the 
Zn'" product complex of FBPase (PDB accession code 1CNQ), in which 
the tetramer assumes the R-state conformation (9). The starting model 
for the disengaged conformation of Loop 52-72 is a Zn*"-product-AMP 
complex of FBPase. in which the tetramer has the T-state conformation 
(10). The latter structure is similar to other T-state structures of FB­
Pase (7.23), differing primarily in the ligands present at the active site. 
Proline residues were placed individually at positions 50 and 51 using 
the software XTALVllw and a Silicon Graphics workstation. The ini­
tial models were passed through three protocols: 1) 100 cycles of con­
jugate gradient minimization; 2) 100 cycles of conjugate gradient min­
imization, followed by simulated annealing (starting temperature, 500 
K; final temperature. 300 K) (24) and then another 100 cycles of con­
jugate gradient minimization; and 3) the same procedure as Protocol 2. 
but using a starting temperature of 1000 K. During anneal­
ing and energy minimization, the C* atoms (except for residues 50-72) 
were restrained to their initial crystallographic positions by a harmonic 
pseudo-potential with a force constant of 50 kcal/mol. He justification 
for restraining all C" atoms outside of the loop is the 10-year history of 
FBPase crystal structures, which collectively reveal only small changes 
in the protein conformation outside of Loop 52-72. 
RESULTS 
Modeling of FBPase Mutants—A structural overview of the 
region of interest is provided in Fig. 1. The main chain * angle 
of Lys10 differs significantly in the T- and R-states, neither 
value being compatible with that of proline, where 4 must be 
close to -60*. Insertion of proline then results in an initial 
model with poor stereochemistry at position 50. Energy mini­
mization alone and energy minimization with simulated an­
nealing at a starting temperature of 500 K (Protocols 1 and 2 in 
"Experimental Procedures") leave the à angle of Pro50 some 30* 
away from its preferred value in both the T- and R-states. 
Further improvement in the stereochemistry of Pro™ requires 
a starting temperature of 1000 K in simulated »nn»«Hng (Pr»> 
toco! 3), the consequence of which is a significant drift of the 
Loop 52-72 away from either its T- or R-state conformation. 
Evidently, proline at position 50 is incompatible with the 
T-state disengaged and R-state engaged loop conformations. 
Proline at position 51, on the other hand, is less disruptive. 
The * angle of residue 51 is near -60* in both the R- and 
T-states of FBPase. Backbone amide 51 hydrogen bonds with 
backbone carbonyls 47 and 48 in the R-state and with backbone 
carbonyl 46 in the T-state. Proline substitution at position 51 
clearly disrupts the hydrogen bonds in both the R- and 
T-states. Moreover, the C* atom of proline makes close contacts 
of 1.9 and 1.8 À with backbone carbonyls 48 (R-state) and 46 
(T-state), respectively. Either energy minimization alone or 
energy minimization with simulated annealing (initial temper­
ature, 500 K) relaxes the contact in the R-state (the loop re­
29988 
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LysSO 
[Lys 50 
Fie. 1. Wild-type FBPase in the T- and R-state». The upper panels show only the C3-C4 subunit pair from the R-state Heft panel) and T-state 
night panel) tetramers. Loop 52-72 from sub unit C4 is represented by a thick black line. The regions within the dashed boxes are enlarged in the 
lower panels, showing the relative positions of Lys". Ala", and Tyr". This figure was prepared with MOLSCRIPT (32) and RASTERSD (33). 
mains engaged with the active site) by a 90* rotation of the 
plane of the polypeptide linkage between residues 47 and 48. 
The close contact of the T-state remains, however, at 2.4 and 
2.8 A after modeling Protocols 1 and 2, respectively. Contacts 
from within the subunit and from the neighboring subunit 
constrain the T-state conformation of residues 52-57 (Fig. 1). 
Furthermore, as backbone carbonyl 46 is an integral part of 
helix H2, it cannot relieve its close contact with Pro51 by a 
rotation of its polypeptide linkage. Hence, proline at position 51 
probably increases the internal energy of the T-state, destabi­
lizing it relative to the R-state of FBPase. 
Expression and Purification of Wild-type and Mutant FB­
Pases—Mutant and wild-type FBPases behaved identically 
throughout purification, including gel exclusion chromatogra­
phy. The wild-type and mutant enzymes were at least 95% pure 
with no evidence for proteolysis on the basis of SDS-poIyacryl-
amide gel electrophoresis. 
Secondary Structure Analysis—The CD spectra of wild-type 
FBPase in the T- and R-states diverge minimally, but repro-
ducibly in the vicinity of 210 nm (17). The CD spectra of the 
Ala51 —» Pro, Lys*0 —» Pro/Tyr57 —* Trp, and wild-type FBPases 
superimpose in the presence of P, (5 mil), Fru-6-P (5 mM), and 
saturating Mg2' (5 mM for the wild-type and Ala51 — Pro 
enzymes and 35 mM for Lys50 — Pro/Tyr17 — Trp). The addition 
of AMP (200 >IM) to the wild-type enzyme produced small 
changes in the CD spectrum near 210 mn. as noted above, but 
caused no change in the CD spectra of the Lys50 — Pro/Tyr37 — 
Trp and Ala51 —* Pro enzymes. (Concentrations of AMP in 
excess of 200 #tM degraded CD spectra due to the elevated 
absorbance of radiation.) The CD spectra of the Lys50 —* Pro 
mutant also differ from the corresponding wild-type spectra 
(Fig. 2). The CD spectrum of the Lys50 —• Pro mutant did not 
change in the presence of P. (5 mn). Fru-6-P (5 mM), and 
saturating Mg2* (50 mM) in the presence or absence of AMP 
(200 TTM). 
Catalytic Rates, Michaelis Constants for Mgs~ and Fru-1,6-
P& and K~ Activation—Initial rate kinetics employ maximal 
substrate concentrations, sufficient to saturate the active site, 
but low enough to avoid substrate inhibition. The ratios of 
catalytic rate constants at pH 7.5 and 9.6 are comparable for 
wild-type and Ala51 —» Pro FBPases (Table D, both consistent 
with reported activity ratios for an FBPase free of proteolysis. 
The activity ratios for the Lys50 — Pro and Lys10 —• Pro/Tyr57 
— Trp mutants are low, however; but as discussed below, the 
low value does not stem from limited proteolysis of that 
mutant. 
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All enzymes have comparable Km values for Fru-1,6-P= (Ta­
ble I); but beyond this, the quantitative similarities end. Under 
standard conditions of assay for the wild-type enzyme (5 mM 
Mg2* and 20 ijm Fru-1,6-P2, pH 7.5), the mutation of Lys50 to 
proline resulted in a 40-fold loss of specific activity. However, 
the decline in specific activity was due primarily to a 15-fold 
increase in the Ka for Mg2* for the Pro50 mutant. The kat value 
for the Pro50 mutant (saturated with Mg2*) is one-third of that 
for the wild-type enzyme. The Hill coefficients for Mg2" for the 
Ala51 — Pro, Lys" —* Pro/Tyr57 — Trp, and wild-type enzymes 
are similar, but are reduced significantly in the Lys" — Pro 
mutant. Potassium ion activation is retained in the Ala51 — 
Pro and Lys" —* Pro/Tyr57 —» Trp mutants at levels compara­
ble to that of the wild-type enzyme, but is abolished altogether 
in the Pro" mutant. 
Kinetics of AMP Inhibition—Concentrations of AMP needed 
for 50% inhibition increased 280-, 8000-, and 400-fold relative 
to that of the wild-type enzyme for the Ala51 — Pro, Lys" — 
Pro. and Lys" — Pro/Tyr57 — Trp mutants, respectively (Fig. 
3 and Table I). Additionally, the Lys" — Pro/Tyr57 — Trp 
double mutant displays biphasic behavior toward AMP. The 
data of Fig. 3 for the wild-type. Ala51 — Pro, and Lys" —• Pro 
enzymes were fit to Equation 3, 
('-(ÀÎ) 
where v is the observed velocity at a specific concentration of 
AMP, V0 is the fitted velocity in the absence of AMP, I is the 
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concentration of AMP, and ICM is the concentration of AMP 
that causes 50% inhibition. The exponent of 2 represents the 
Hill coefficient for AMP cooperativity, determined independ­
ently as described below. The data of Fig. 3 for Lys" — Pro/ 
Tyr57 — Trp FBPase were fit to Equation 4, 
(1 + (iôb) 4icW) 
(Eq.4) 
where u, V0, and I are as defined above for Equation 3 and 
ICso-tugh and ICwb- represent concentrations of AMP that 
cause 50% relative inhibition due to the ligation of high and low 
affinity sites, respectively. Ligation of the high affinity sites, as 
shown below, is cooperative with a Hill coefficient of 2, whereas 
the cooperativity with respect to the ligation of low affinity 
sites is an adjustable parameter (n) in Equation 4. The fitted 
value for n is 1.4. 
AMP inhibition of wild-type FBPase is nonlinear and non­
competitive with respect to Fru-1,6-P2 and nonlinear and com­
petitive with respect to Mg2*. The Ala5' — Pro mutant retains 
the nonlinear, competitive relationship between AMP and 
Mg2* (goodness-of-fit, 5.5%) (Fig. 4), consistent with Equation 
5, 
(Eq.3) 
»-§K)) (Eq. 5) 
where v, Vm, A, I, K*. K„ and n represent initial velocity, 
mnrimai velocity, Mg2* concentration, AMP concentration, the 
Michaelis constant for Mg2*, the dissociation constant for AMP 
from the enzyme-AMP complex, and the Hill coefficient for 
AMP, respectively. The binding of AMP is cooperative at n = 2, 
whereas cooperativity is absent when n = 1. Data from the 
wild-type and Ala51 — Pro enzymes are consistent with n = 2 
(AMP cooperativity). When assayed at low AMP concentra­
tions, Lys" — Pro/Tyr57 — Trp retains the competitive mech-
0.001 0.1 10 1000 
AMP.IIN 
100000 
FIG. 2. CD spectre for wild-type and Lys1* — Pro FBPases. Thin 
solid line. R-state wild-type enzyme with reaction products and Mg2*; 
dotted line, T-state wild-type enzyme with reaction products, Mg2*, and 
AMP: thick solid line. Lys" — Pro mutant under either R- or T-state 
conditions, mdeg, millidegrees. 
Fic. 3. AMP inhibition of wild-type and mutant FBPases. AMP 
titrations were of wild-type (•), Ala" — Pro ( • ), Lysw — Pro/Tyr17 —« 
Trp (•), and Lyi*° — Pro (a) FBPases in saturating Fru-1,6-P, (20 #im) 
and a Mg2" concentration equal to the K, for Mg2* of each enzyme. See 
"Results" for details regarding the fitted curves. 
TABU I 
Kinetic parameters for wild-type and mutant firms of fructose-l,6-bisphosphatase 
7.5/9.5 
ratio 
Specific 
activity* lor Fro-1,6-Pj K.fcr Ml2" Hill for Mf3" K, for Fru-2.6-P2 ICgeforAMP* K* activation' 
unas/mg/t fi" ** * 
Wild-type 3.3 35 = 2 22 = 1 L75 = 0.09 0.67 = 0.04 1.9 = 0.1 0.123 = 0.005 1.61 = 0.05 16.8 - 0.3 
Lys™ — Pro 0.93 0.85 r 0.06 6.7 - 0.3 2.1 = 0.2 10.7 = 0.8 L45 = 0.08 2.3 = 0.2 13400 = 20 -4.32 = 0.04 
Ala"-Pro 3.2 20 = 1 12.4 = 0.7 2.5 = 0.2 0.8 = 0.1 2.1 = 0.2 3.4 = 0.2 460 = 7 155 = 0.1 
Tyr37 — Trp' 3.3 38.6 = 0.1 24.0 = 0.1 3.39 = 0.09 0.53 = 0.06 1.9 = 0.1 0.84 = 0.05 8.5 = 0.4 16.6 = 0.4 
Lys™ — Pro/ 
Tyr57 — Trp L9 8.7 = 0.8 9.2 = 0.5 1.3 = 0.1 3.1 = 02 1.80 = 0.07 0.37 = 0.03 650 = 40' 14.6 = 0.1 
* Specific activity was determined at 5 om Mg3* and 20 jiM Fru-1,6-Pr 
* is defined as V fè— where Er is the total enzyme concentration. 
'The Hill coefficient for AMP ligation of high affinity sites is 2. See "Results" for details. 
* K* activation is the percent increase in V using ISO nut KCl versus 0 mM KCl at saturating Mg2* and Fru-1.6-P2. 
' Data are from Ret 25. 
'The reported value is for the high affinity site (IC,**#,). IC^^_ is 28 = 6 mM with a HOI coefficient of 1.4. See "Results" for details. 
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FIG. 4. Kinetic mechanism of inhibition of Ala" — Pro and 
Lys™-»Pro FBPases. A. AMP competes with Mg2* in the Ala" -«Pro 
mutant. Concentrations of AMP were 0($). 100 (•), and 225 mm (A). 
B, AMP inhibition is noncompetitive with respect to Mg2* in the Lys" 
— Pro mutant. Concentrations of AMP were 0 (•), 10 mM (•), 15 mM (A), and 20 mM (•). All assays were performed at saturating concen­
trations of Fru-1,6-P, (20 pM) and at 150 mM KCL The lines are based 
upon Equation 5 for A and Equation 6 for S using the parameters of 
Table LA.[A, arbitrary units. 
anism with n = 2. In contrast, AMP inhibition of the Lys50 —* 
Pro mutant fits best to a mechanism of noncompetitive inhibi­
tion with respect to Mg2* (goodness-of-fit, 3.1%) (Fig. 4), rep­
resented by Equation 6, 
<Eq
-
6) 
where the terms of Equation 6 are defined as for Equation 5 
and Ku represents the dissociation constant for AMP from the 
enzyme-Mg '^AMP complex. The data are consistent with n = 
2, reflecting AMP cooperativity. 
In wild-type, Ala31 -* Pro, and Lys" —• Pro/Tyr57 — Trp 
FBPases, the mechanism of AMP inhibition with respect to 
Fru-1,6-P2 is nonlinear and noncompetitive (Equation 7), 
(Eq
-
7) 
where v. Vm, I, and n are as defined above, KL and Ku represent 
the dissociation constants for AMP from the enzyme-AMP and 
the enzyme-Fru-l,6-P2-AMP complexes, respectively, B is the 
concentration of Fru-1,6-P2, and K6 is the Michaelis constant 
for Fru-l.S-P^ The high value for ICM associated with AMP 
inhibition of the Lys50 — Pro mutant (Table D precludes the 
determination of a kinetic mechanism. 
Kinetics of Fru-2,6-P; Inhibition—Fru-2,6-P2 is a competi­
tive inhibitor with respect to Fru-1,6-P2 for the position 50 and 
51 mutant FBPases. The data best fit to Equation 8 (goodness-
of-fit, 4.0%). 
FIG. 5. AMP/Fru-2,frP, synergism for wild-type (A) and Ala" — 
Pro (B) FBPases. The concentrations of Pru-2,6-P, were 0(f) and 
approximately one-fourth of the K, for Fru-2,6-P, (0.03 mm for wild-type 
FBPase and 0.86 mm for the Ala" —1 Pro mutant) (A). Assays had Mg2* 
concentrations equal to the Km for Mg2* of each enzyme and saturating 
levels of Fru-1.6-P, (20 MM). 
TABLE • 
Inhibition and binding constants for TNP-AMP for utild-typt and 
mutant forms of fructott-l.6-bisphosphatast 
tCMfcr TNP-AMP «i fer TNP-AMP 
w tu» 
Wad-type 7.4 = 0.7 13.1 = 0.6 
Lys™ —Pro ND* 14 = 4 
Ala" — Pro ND 37 = 2 
• Not determined due to weak inhibition by TNP-AMP. 
H(--K'-y) (Eq. 8) 
where u, Vm, I, B, K„ and K„ are as defined above. The kinetic 
mechanism of Fru-2,6-P2 inhibition is the same for mutant and 
wild-type FBPases, but the Kt for Fru-2,6-P2 is -20-, 30-, and 
3-fold higher in the Lys50 -» Pro, Ala51 — Pro. and Lys" — 
Pro/Tyr57 —» Trp mutants, respectively, relative to the wild-
type enzyme (Table D. 
Fru-2,6-Pz and AMP Synergism—AMP and Fru-2,6-P2 syn-
ergistically inhibited wild-type and mutant FBPases (Fig. 5). 
For all enzymes, the Hill coefficient for AMP is 2. At high 
concentrations of Fru-2,6-P2, the saturation curve for Fru-
1,6-P2 changes from hyperbolic to sigmoidal for mutant and 
wild-type enzymes. 
Steady-state Fluorescence Measurements—TNP-AMP inhib­
ited the wild-type enzyme competitively with respect to Mg2" 
and inhibited FBPase synergistically with Fru-2,6-P2- Fluores­
cence emission from TNP-AMP increased significantly in the 
presence of FBPase. In addition, AMP reduced the fluorescence 
from bound TNP-AMP, presumably through competition for 
the allosteric effector site (data not shown). TNP-AMP bound to 
wild-type. Lys" — Pro, and Ala51 -» Pro FBPases with high 
165 
Mutations in the Hinge of a Dynamic Loop 29991 
B 
Fig. 6. Fluorescence spectia of the Trp'* and Trp,7/Pro*° mu­
tants. In all eases, apoenzynes were in SO mM Hepes (pH 7.5). Product 
complexes had 5 mM Fru-6-P and 5 mM potassium P, with either 5 or 35 
mM Mg2* for the Trp17 and Trp17/ProM mutants, respectively. A, Trp57 
mutant. Black line, apoenzyme; open circles, product complex asterisks, 
product complex - 400 jiM AMP. B, Pro^/Trp" mutant. Black line, 
apoenzyme; open circles, product complex; asterisks, product complex -
20 mM AMP. A.U., arbitrary units. 
affinity, comparable to AMP. On the basis of fluorescence ti­
tration data (Table II), however, the Hill coefficient for TNP-
AMP is near unity in all cases. 
FBPase has no tryptophan, so the mutation of any single 
residue to tryptophan introduces a unique fluorophore. Fluo­
rescence emission from tryptophan at position 57 is sensitive to 
the conformational state of Loop 52-72. The indole of Trp5' is 
exposed to solvent in the T-state disengaged loop conformation, 
whereas it resides in a hydrophobic pocket in the R-state en­
gaged loop conformation. The Tyr57 — Trp mutant has been 
thoroughly studied by x-ray crystallography and initial velocity 
kinetics (25). Fluorescence emission spectra from the Pro50/ 
Trp57 double mutant differ significantly from those of the Trp57 
single mutant (Fig. €). Fluorescence emission from the single 
Trp57 mutant is mmrimmn in the presence of products/metals, 
conditions that promote the R-state engaged loop conformation 
(9,10). The addition of AMP reduced fluorescence emission to a 
level comparable to that observed from the Trp57 mutant in the 
absence of products and metals (apo form of FBPase). In con­
trast, the apo form of the Proso/Trp57 double mutant has the 
highest fluorescence emission. The addition of either product/ 
metals or product/metals/AMP caused only a decrease in fluo­
rescence emission. 
DISCUSSION 
Low activity ratios (-0.3) are a property of wild-type FBPase 
after limited proteolysis by papain or subtilisin (26). The max­
imum effect on the activity ratio due to proteolysis occurs when 
one subunit per tetramer is cut. Thus, for the wild-type en­
zyme, an activity ratio of 1, as observed for the Lys50 —» Pro 
mutant, requires an equal mixture of intact and once-proteo-
lyzed te trainers. Proteolysis of one of eight subunits then could 
account for a diminished activity ratio in any FBPase. In SDS-
polyacrylamide gel electrophoresis of the Lys50 — Pro mutant, 
however, no fragments typical of proteolysis were evident. Fur­
thermore, loss of AMP inhibition due to proteolysis of wild-type 
FBPase varied proportionately with the extent of subunit 
cleavage. The 8000-fold increase in for AMP far exceeds the 
effect on AMP inhibition due to proteolysis, even in a com­
pletely proteolyzed system. Hence, the kinetic properties of the 
Lys50 —« Pro mutant are not the consequence of proteolysis, but 
rather the influence of a proline at position 50. 
Allosteric inhibition of wild-type FBPase by TNP-AMP is 
essentially identical to that caused by AMP, the only difference 
being the absence of cooperativity in the kinetics and in the 
binding of the fluorescent analog. In fact, TNP-AMP is indis­
tinguishable from formycin 5 '-monophosphate in its inhibition 
and binding to wild-type FBPase. Formycin 5 '-monophosphate 
also exhibits a Hill coefficient of unity (27), and crystal struc­
tures of complexes of formycin 5-monophosphate and AMP 
with human FBPase are identical (28). The difference in Hill 
coefficient may stem from subtle differences in conformation, 
evident perhaps only in partially ligated states of FBPase. 
Nonetheless, the fluorescence data clearly demonstrate tight 
binding of TNP-AMP and the displacement of that analog from 
FBPase by the addition of AMP. Hence, wild-type and Pro50 
mutant FBPases are indistinguishable in their binding of TNP-
AMP and its displacement by AMP. 
On the basis of kinetics, however. Pro50 mutant FBPase is 
altogether insensitive to AMP. Inhibition of the Pro50 mutant 
by AMP requires an 8000-fold increase in ligand concentration 
and exhibits a different kinetic mechanism (noncompetitive 
versus competitive with respect to Mg2*). The apparent change 
in kinetic mechanism may arise from the unmasking of a 
secondary mechanism, due to the complete loss of allosteric 
inhibition by AMP. That secondary mechanism may be the 
direct coordination of AMP to the metal-ligated active site of 
Pro50 mutant FBPase. Hence, if AMP binds tightly to the Pro50 
mutant, as evidenced by the fluorescence data, but does not 
inhibit, then proline at position 50 must interrupt the trans­
mission of the allosteric signal. 
Kinetic data indicate the disruption of Loop 52-72 as the root 
cause for the loss of allosteric properties in Pro50 mutant FB­
Pase. The Ka for Mg2* is elevated 15-fold in the Pro50 mutant, 
and K* activation is lost. The kinetic mechanism of AMP 
inhibition with respect to Mg2* is competitive in wild-type 
FBPase. Hence, in wild-type FBPase, AMP elevates the appar­
ent dissociation constant of metals. A greatly elevated for 
Mg2*, accompanied by the complete loss of AMP inhibition, is 
consistent with an FBPase unable to achieve its high affinity 
state for metal cations. On the basis of recent crystal structures 
(10), the R-state engaged conformation of Loop 52-72 repre­
sents the high affinity state for metal cations and the catalyt-
ically productive state of FBPase. Pro™ mutant FBPase then 
cannot achieve a engaged loop conformation. 
Molecular modeling, CD spectroscopy, and fluorescence 
emission from Trp57 strengthen the argument above. The mu­
tation of Lys™ to proline destabilizes the R-state engaged loop 
and T-state disengaged loop conformations in slow cooling/ 
energy minimization protocols. The CD spectrum of Pro™ mu­
tant FBPase supports an altered state, conformationally unre­
sponsive to the binding of ligands. The indole group of Trp57 in 
the Pro™fl>pS7 double mutant does not enter its hydrophobic 
pocket, as evidenced by the low fluorescence emission in the 
presence of saturating products/metals. The several lines of 
evidence provided here suggest that Loop 52-72 in Pro™ mu­
tant FBPase can achieve neither its T-state disengaged nor its 
R-state engaged loop conformation. The complete loss of allo­
steric inhibition in Pro™ mutant FBPase suggests furthermore, 
that Loop 52-72 is an essential element in the allosteric regu­
lation of FBPase. 
The effects of the Ala51 — Pro mutation are less dramatic, in 
harmony with the results of modeling and CD spectroscopy. 
The Pro51 mutant retains K* activation and wild-type affinity 
for divalent cations, but exhibits a significant increase in the Kt 
for AMP. The mutation evidently destabilizes the T-state dis­
engaged conformation of Loop 52-72 relative to the R-state 
engaged conformation, again consistent with the results of 
modeling. In this respect, the Pro51 mutant and the Met71"2 
double mutant (11) have similar effects on FBPase function. In 
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both instances, lessened AMP inhibition probably arises from a 
perturbation in the equilibrium between engaged and disen­
gaged loop conformations in favor of the engaged state. 
The Kl for Fru-2,6-P2 increases 20- and 30-fold in the Lys50 
— Pro and Ala31 — Pro mutants, respectively. The change in 
binding affinity for Fru-2,6-Pz in these mutants must be indi­
rect and is most likely through a perturbation of conformation 
states accessible to Loop 52-72. The increase in Kt for Fru-
2,6-Pz due to loop mutations does not come with an increase in 
the Km for Fru-1,6-P2, as has been observed in other mutations 
that increase the K, for Fru-2,6-P2 (29). The observation above 
is consistent with findings that suggest that Fru-2,6-P2 and 
Fru-1,6-P2, although binding at the same site, evoke different 
conformational responses from FBPase. For instance, at high 
concentrations of Fru-2,S-P2, the Hill coefficient for AMP inhi­
bition changes from 2 toi. and the saturation curve for Fru-
1,6-P2 changes from hyperbolic to sigmoidal (3, 30). At low 
concentrations of Fru-2,6-P2, the Hill coefficient for Mg2* 
changes from 2 to 1 (31). Finally, Fru-2,6-P2 protects FBPase 
from loss of AMP inhibition and catalytic activity due to mod­
ification by acetylimidazole, whereas Fru-1,6-P2 protects only 
against loss of activity (31). Although a complete understand­
ing of the above phenomena will come with further study, 
mutations of the loop underscore a fundamental difference in 
FBPase in its Fru-2,6-P2- and Fru-l,6-P2-ligated states. 
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